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Abstract 
 
Background: wheezing in the first year of life affect both infant and parental quality of 
life. Risk factors as male gender, nursery attendance, presence of damp or mould stains 
at home, or family history of asthma and allergies, and protective factors such as 
breastfeeding more than six months have been previously described. The aim of this study 
was to investigate the prevalence and risk and protective factors for wheeze ever, 
recurrent wheeze and severe wheeze in infants in the region of Pamplona, Spain. 
Material and methods: this cross-sectional study was part of the International Study of 
Wheezing in Infants (in Spanish, Estudio Internacional de Sibilancias en Lactantes, or 
EISL). Between 2006 and 2008, participating families answered a standardised validated 
questionnaire on demographic and anthropometric factors, respiratory and allergy 
symptoms, family background, environmental factors, and exposures during pregnancy 
and birth. Bivariate analyses (using chi-squared test or Student’s t-test, as appropriate) 
were conducted, calculating odds ratios with 95% confidence intervals. Also, multivariate 
models were used to adjust for confounding variables. A p value lower than 0.05 was 
regarded as statistically significant. 
Results: 1,065 questionnaires were answered. Prevalence of wheeze ever was 32.5%. 
Prevalences of recurrent and severe wheeze were 10.6% and 9.6%, respectively. Male 
gender, pneumonia in the first year of life, infant eczema, higher number of colds, prenatal 
exposure to tobacco smoke, nursery attendance and presence of pets in the household 
were some of the risk factors identified. Conversely, a longer exclusive breastfeeding was 
found as protective factor. 
Conclusions: wheezing in infants is an important public health issue, that can lead to 
asthma in childhood. Prevalences found in this study were comparable to others found in 
European centres, but lower than those found in Latin American countries. Several 
preventable risk factors have been identified. 
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1.1 Wheezing and asthma 
Wheezing is a high-pitched whistling sound occurring during breathing, 
commonly during breathing out, coming from the bronchial tubes. Wheezing occurs when 
airways are narrowed or filled with mucus, due to several causes, like allergies, infections 
or irritation. 
Wheezing is a common symptom in infants. The variety of responses of their lung 
to external influences is reduced from a clinical point of view, being two of the most 
typical responses contraction of the smooth muscle and inflammation of the bronchial 
mucosa. These responses, initiated by different stimuli, lead to the onset of wheezing 
(García-Marcos et al., 2009). 
Recurrence is a common characteristic of wheezing, with approximately 30% of 
children who wheezed in the first six months of life also reporting wheezing at age three 
years (Sherriff et al., 2001). 
Many infants suffer from recurrent wheeze transiently, disappearing the disease 
in the early childhood, but other children may develop asthma in the future, affecting their 
quality of life in the adolescence and adulthood. 
Recurrent wheezing in the early life is a heterogeneous group of disorders with 
different pathophysiological mechanisms, but with a common symptom, the obstruction 
of the airway. This heterogeneity leads to a clinical variability which makes difficult to 
predict in a patient which will be the response to treatment and the long-term evolution. 
Wheezing shows non-specific symptoms, and many diseases manifest wheezing 
during early life, with a similar clinical presentation, which makes very difficult to 
distinguish and diagnose wheezing in infants (Villa-Asensi, 2009). 
The two more frequent causes of wheezing in children are bronchiolitis and 
asthma, but their diagnosis is difficult, which results in many children diagnosed as 
wheezers for the lack of a more precisely diagnosis. Other causes, although less frequent, 
include congenital anatomical abnormalities, aspiration of foreign bodies, other lung 
disorders as cystic fibrosis, and cardiac, immune and gastrointestinal disorders 
(Ducharme et al., 2014). 
It has been observed that wheezing have a significant impact in infant’s quality of 
life in the first years of life, affecting both the physical and mental functioning 
(Oostenbrink et al., 2006; Hafkamp-de Groen et al., 2013), quality of life in teenage years 
(Mohangoo et al., 2007), and also parental quality of life (Osman et al., 2001). 
Asthma is defined as a common chronic disorder of the airways characterized by 
recurrent and variable symptoms, airflow obstruction, bronchial hyperresponsiveness, 
and underlying inflammation. The interaction of these characteristics determines the 
clinical manifestations, severity of asthma and response to treatment. 
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The diagnosis of asthma should be determined by the presence of episodic 
symptoms of airflow obstruction, a partially reversible obstruction, and excluding other 
diagnoses. Other key indicators are the presence of wheezing, reporting a history of cough, 
recurrent wheezing, difficulties to breath or chest tightness, and the onset or worsening 
of symptoms upon exposure to dust, pollen or tobacco smoke (National Heart, Lung and 
Blood Institute, 2007). 
Asthma and wheezing have a relevant economic impact. One study conducted in 
United Kingdom estimated the treatment cost in children between one to five years old 
was 52.75 million pounds, which represented the 0.15% of the National Health System 
expenditure (Stevens et al., 2003). Another study conducted in the United States 
described a significant upward trend in medical expenditure related to asthma in teenagers, 
with an annual growth rate of 2.5% in the period 2000-2009. Between years 2005-2009, 
medical expenditure for treatment of asthma in children under five years amounted to 
2,500 million dollars, with approximately half of these costs related to hospitalizations 
(Jang et al., 2013). 
1.2 Clinical phenotypes 
Wheezing clinical phenotypes, helpful in taking therapeutic decisions, are more 
useful in medical practice than in epidemiological studies. A working group from the 
European Respiratory Society (ERS) defined two phenotypes according to the temporal 
pattern of wheeze (Brand et al., 2008). 
Episodic viral wheeze 
This phenotype is defined as wheeze in episodes, with the child not reporting 
wheezing between them. It is the most common phenotype in preschool age, although is 
not exclusive. Episodes of wheezing tend to occur seasonally. 
According to clinical evidences, they are associated with viral respiratory tract 
infections, being rhinovirus, respiratory syncytial virus (RSV), coronavirus, human 
metapneumovirus, parainfluenza virus and adenovirus the most common agents. 
Factors underlying the frequency and severity of episodes are not established yet, 
but severity of the first episode is related to atopy, exposure to tobacco smoke and 
prematurity at birth. 
Episodic wheeze tends to decline over time, disappearing at age six years, 
although can remain as episodic wheeze in school age, disappearing at older ages, or 
change into another phenotype, multiple-trigger wheeze. 
In contrast, other studies have shown evidence of children with severe episodic 
wheezing who had a higher risk of asthma at ages five to ten years, refuting that it can be 
considered a transient disease (Kappelle and Brand, 2012). 
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Treatment with inhaled corticosteroids in children with episodic wheezing is 
controversial. Some studies found that high doses of inhaled corticosteroids at the onset 
of the infection of the upper respiratory tract were an effective treatment for reducing 
severity and the need for oral corticosteroids, although the daily use of low doses did not 
show any clinical benefit (McKean and Ducharme, 2000). 
On the other hand, other studies described a small benefit of inhaled steroids in 
preventing viral wheeze, and no effects in reducing symptoms of upper respiratory tract 
infections (Clavenna et al., 2014), nor the progression from episodic to persistent 
wheezing (Bisgaard et al., 2006). 
The positive effects of daily treatment with leukotriene receptor antagonists 
(Montelukast) in reducing asthma exacerbations by approximately 30% were described 
in other study (Bisgaard et al., 2005). 
Multiple-trigger wheeze 
Contrary to episodic wheezing, this phenotype shows symptoms between episodes. 
Although viral respiratory tract infection is the main trigger of wheezing at early ages, 
some children also wheeze when they are exposed to other stimuli, such as tobacco smoke, 
laugh or exercise. 
Multiple-trigger wheeze has been also associated with lung function abnormalities 
(Sonappa et al., 2010), or atopic sensitisation in the first year of life: food allergies to eggs 
or cow’s milk, atopic dermatitis, or sensitisation to indoor allergens (Frey and von Mutius, 
2009). 
Cluster analyses defined two multiple-trigger wheeze phenotypes. Non-atopic 
uncontrolled wheezing was associated with nursery attendance and family history of 
asthma, and it was classified as moderate severe, whereas atopic multiple-trigger 
wheezing, which mostly affected boys, especially those who were atopic, was associated 
with the presence of mould or cockroaches, and overcrowded housing (Just et al., 2012). 
Treatment for this phenotype with inhaled corticosteroids, or combined with long-
acting β2-agonist, was found effective, with a greater lung function improvement when 
both treatment were used jointly (Mäkelä et al., 2012). 
Despite its therapeutic value, this clinical phenotypic classification has some 
drawbacks, such as the poor prediction in the patterns of wheezing in a year observation 
period (Schultz et al., 2010). Other disadvantages described were not allowing to 
difference wheezing by severity or frequency, or not predicting the future pattern, 
considering this classification into two phenotypes too simple, given the broad spectrum 
of recurrent wheeze disorders in preschool ages (Schultz and Brand, 2011). 
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In 2013, in the European Respiratory Society Annual Congress, this above-
mentioned proposed classification was discussed, concluding that the distinction between 
episodic and multiple-trigger wheeze was not so clear in all patients as first suggested, 
and was a poor predictor of long-term results, considering better predictors the severity 
and frequency of the episodes. 
As for treatment, in children with multiple-trigger wheeze, inhaled corticosteroids 
were considered the first therapeutic option, whilst in children who suffered episodic 
wheeze, treatment with inhaled corticosteroids or Montelukast was proposed if attacks 
were frequent, severe, or the doctor thought the symptoms were being underreported. The 
use or oral corticosteroids was limited to those children hospitalised with serious 
wheezing (Brand et al., 2014). 
1.3 Epidemiological phenotypes 
According to the duration of wheezing, several phenotypes have been defined, 
with no clinical value, but useful in epidemiological studies. 
In the longitudinal Tucson Children’s Respiratory Study, according to the history 
of wheezing, four categories were described: never wheezing (no lower tract respiratory 
illness in the first three years of life, and no wheezing at age six), transient early wheezing 
(at least one lower tract respiratory illness with wheezing in the first three years of life, 
but no wheezing at age six), late onset wheezing (no lower tract respiratory illness in the 
first three years of life, but wheezing at six years old), and persistent wheezing (at least 
one lower tract respiratory illness with wheezing during the first three years of life, and 
wheezing at age six). 
Maternal history of asthma, smoking mother, rhinitis or eczema in the first year 
of life, male gender and Hispanic ethnic were factors associated with persistent wheezing, 
while only maternal smoking was associated with transient early wheezing.  
Furthermore, at age six, 46% of children with persistent wheezing were diagnosed 
with asthma, compared to 22.5% who suffered from late onset wheezing, observing 
significant differences (Martinez et al., 1995). 
Other studies confirmed the applicability of these phenotypes in other populations, 
finding that children with persistent wheeze at ten years showed a significantly impaired 
baseline lung function and required more medical care and drug treatment compared to 
children who never wheezed (Kurukulaaratchy et al., 2003). 
In subsequent years, new analyses in the Tucson cohort led to characterise and 
define the following three new phenotypes of wheezing in childhood: transient wheezers, 
non-atopic wheezers, and atopic wheezers (Taussig et al., 2003). 
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Transient infant wheezers 
Defined as children with sporadic wheezing during the first two or three years of 
life, who did not suffer from wheezing after age three. More than 80% of children with 
wheezing in the first year of life belonged to this group, as well as 60% who wheezed in 
the second year, and 30-40% who wheezed in the third year of life. 
These children did not show a family history of asthma or atopic dermatitis, 
eosinophilia, high levels or immunoglobulin E (IgE), or markers of predisposition to 
allergies. The main risk factors were low levels of lung function before suffering from 
low tract respiratory infections, and have a young and/or smoking mother during 
pregnancy. 
These children had a reduced lung function at birth, which will recover over time, 
although never will reach the level of those children who never wheezed in early life. 
There was no increased risk of wheeze at ages eleven and sixteen compared to children 
who did not wheeze in the first six years of life, but in the subsequent years they could 
show a higher risk of chronic obstructive pulmonary disease due to their smaller airways. 
Non-atopic wheezers 
Wheezing episodes began before three years, usually related to RSV infection or 
bronchiolitis, and continued after the third year of life. Approximately 20% of wheezing 
infants are classified in this heterogenic group, in which 60% of children at age 6 are 
atopic. 
Children who suffered a lower tract respiratory infection caused by RSV showed 
three to five-fold higher risk of wheezing at six years, significantly decreasing the risk 
with age, and being non-significant at thirteen years. Although wheezing continued after 
three years, these children were not more likely to be atopic, being the main difference 
with children who did not suffer from RSV infection their lower levels of lung function 
at six and eleven years. 
Children included in this group showed a good response to bronchodilators, 
without significant differences in lung function after its use compared to healthy children. 
These results suggested that non-atopic wheezers developed an acute respiratory 
obstruction due to viral infection, with an alteration in the control of airway tone, which 
determined the increased risk, decreasing this abnormality with age. 
Atopic wheezers 
Children in this group had symptoms in the first six years of life. Two subgroups 
were distinguished: early atopic wheezers, classified as children with persistent wheezing, 
whose symptoms began in the first three years of life, and late atopic wheezers, previously 
classified as having late onset wheezing, whose symptoms started after age three years. 
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Both groups were likely to be sensitized at age six to common allergens, but early 
atopic wheezers showed lower lung function levels and higher IgE levels at six and eleven 
years. Results showed that, during the first three years of life, an earlier onset of 
symptoms and earlier atopic sensitisation might be important risk factors in the 
development of severe diseases and deficits in lung function in people who suffer from 
recurrent episodes of airway obstruction. 
In addition to these three phenotypes, Castro-Rodriguez and colleagues (2001) 
defined a fourth phenotype in this same cohort. 
Girls overweight/obese and early menarche 
Girls who started puberty before age eleven, and were overweight or obese, 
showed a higher prevalence of wheezing at eleven and thirteen years old. However, no 
differences in the prevalence were found in girls who started puberty after eleven years 
old, nor an increased risk of asthma symptoms in overweight or obese girls between six 
and eleven years old was found. 
The proposed explanation was that obesity altered the production of female sex 
hormones, causing changes in the risk of asthma. Another explanation was that, due to 
increased susceptibility to allergens in overweight girls, they could show an increased 
risk for suffering asthma. 
Although previous phenotypes were useful models, subsequent studies have 
helped to broaden the spectrum of phenotypes of wheezing in childhood. In the ALSPAC 
cohort six phenotypes from birth to age seven were defined, two of them not described 
previously (Henderson et al., 2008). 
Never/infrequent wheeze 
The 59% of children were included in this group, where 76.5% of children never 
wheezed, whilst 10% were wheezers at six months, with a decreasing prevalence from 
that age on. 
Transient early wheeze 
Prevalence of wheezing at eighteen months of life was between 50-60%, declining 
the prevalence at forty-two months of age. 
Prolonged early wheeze 
Prevalence of wheezing peaked at thirty months of age, declining to low 
prevalence at sixty-nine months. 
Intermediate onset wheeze 
Prevalence of wheezing was low until eighteen months, then rising rapidly to high 
prevalence at age forty-two months. 
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Late onset wheeze 
Prevalence was 20% until forty-two months, increasing over 50% in the 
subsequent months. 
Persistent wheeze 
Prevalence of wheezing at six months of age was 65%, reaching approximately 
90% in the subsequent months. 
Intermediate onset, late onset and persistent wheeze showed a strong association 
with atopy, unlike other early-onset wheezing phenotypes. Maternal history of asthma 
and allergy were associated with all phenotypes when compared to infrequent wheeze, 
finding the strongest associations with persistent wheeze. 
There were also associations between all phenotypes with diagnosed asthma at 
age ninety-one months, and with decrements of FEV1 and FEF25-75 and increased airway 
responsiveness compared with the never/infrequent wheeze (Henderson et al., 2008). 
1.4 Epidemiology 
Estimating the prevalence of wheezing is complicated, due to bias which may lead 
to an underestimation of the true prevalence, either by parental ignorance of the term 
“wheezing”, especially in adverse socioeconomic environments (Michel et al., 2006), or 
the wording of the question on wheezing in the questionnaires (Pescatore et al., 2015). 
Despite this fact, several studies have ascertained the prevalence of wheezing 
symptoms in infancy and childhood. At the end of the 90s, in United Kingdom a 
significant increase in the prevalence of wheezing, from 12% to 26% in children aged 
under 5 years, was observed (Kuehni et al., 2001). 
The prevalence of wheezing differed depending on the environment in which 
children were raised. Thus, several studies found that children exposed to a country 
environment showed lower prevalences than those living in urban environments 
(Genuneit, 2012; Horak et al., 2014). 
In Europe, the prevalence of wheezing in preschool and school ages varied greatly 
among different countries. In Spain, 9.9% of children between six and seven years old 
had currently wheezed, with geographical differences, being the prevalence higher in 
Northern regions (Carvajal-Urueña et al., 2005). 
In Portugal, the prevalence of wheezing in children aged three to five was 24.5% 
(Pereira et al., 2014), while in Italy, in the same age group, 12.1% of children had wheezed 
in the last twelve months (Peroni et al., 2009). In France, school age prevalence was 
10.7%, also finding geographical differences, with an increasing gradient from Eastern to 
Western provinces (Delmas et al., 2012). 
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Also, in Germany, an increased prevalence of wheezing in school age children, 
especially in girls, was observed. The 12.0% of boys and 7.5% of girls wheezed in 1994-
95, increasing to 13.6% and 12.7%, respectively, in 1999-2000 (Maziak et al., 2003). In 
addition, the same increasing trend was found in England, where the prevalence of 
wheezing in schoolchildren boys significantly increased from 21.0% to 27.6% in boys, 
and from 15.4% to 23.3% in girls (Shamssain, 2007). 
Another study conducted by Bisgaard and Szefler (2007) found that prevalence of 
asthma symptoms in children between one to five years ranged from 29% in Northern 
European countries (Denmark, 23%; United Kingdom, 29%; Germany, 36%) to 48% in 
Southern European countries (Italy, 45%; Spain, 50%; France, 51%). There were also 
differences in the severity, with 19% of children showing persistent symptoms in the 
Nordic countries compared with the 30% in the South. Furthermore, in the United States 
the prevalence was 27%, not detecting any geographical gradient, and 23% of children 
reporting persistent symptoms. 
In Latin America, the prevalence of wheezing was higher, and also differed among 
countries. In the Phase I of the International Study of Asthma and Allergies in Childhood 
(ISAAC), the prevalence of current wheeze in children aged six to seven years was 19.8%, 
ranging from 8.6% in Mexico to 32.1% in Costa Rica (Mallol et al., 2000). The third 
phase of this study found geographical differences, with higher prevalences in southern 
countries, attributing these differences to local ecological factors (Mallol et al., 2010). 
In China, the prevalence of wheezing in preschool children ranged between 14% 
to 24%, with higher prevalences in Eastern cities, and an uprising trend of asthma 
prevalence in children in the last twenty years (Zhang et al., 2013; Huang et al., 2015). 
Furthermore, in Taiwan, the prevalence of wheezing in school age was 8.8%, also finding 
an increasing trend in the prevalence of wheeze ever (Wu et al., 2011). 
In Japan, a nationwide study found that 19.9% of preschool children wheezed, 
being reported the disease more frequently in boys (Yoshida et al., 2009). In South Korea, 
the prevalence of asthma symptoms in the first three years of life was 16.5%, decreasing 
to 9.8% in older ages (Hong et al., 2012). In both countries, trends of prevalence levelled 
off in recent years (Yura et al., 2011; Kwon et al., 2011). 
In addition to these above-mentioned cross-sectional studies, several studies have 
been conducted to determine the incidence of the disease. 
A retrospective European study concluded that the incidence of asthma in men 
and women showed a different pattern. In childhood, girls show a lower risk of asthma, 
which increases during puberty and adulthood. On the contrary, incidence of wheezing in 
boys peaks during childhood, and decreases in the adolescence (de Marco et al., 2000). 
More recently, another study also showed similar findings. Incidence of asthma in boys 
was higher until age thirteen years, when female incidence increased. Further, an overall 
incidence rate of 6.71 per 1000 person-years in Dutch children and teenagers was 
observed (Engelkes et al., 2015). 
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In a Swedish hospitalised-population study, the incidence of wheezing was 3 cases 
per 1000 person-years in children between four months and four years old (Rylander et 
al., 1996), whilst asthma incidence rate in a nationwide prospective study in preschool 
children was 11 cases per 1000 person-years, observing a higher incidence in the first two 
years of life (Bröms et al., 2012). 
In the United States, the incidence rate in children and teenagers was 12.5 per 
1000 person years, with the highest rate in children aged up to 4 years, 23.4 per 1000 
person-years (Winer et al., 2012). 
1.5 Risk and protective factors 
Several risk factors associated with wheezing in early life have been described in 
the literature. One of the most important are respiratory tract infections, which are 
responsible for more than 80% of asthma exacerbations in school age children (Johnston 
et al., 1995). 
The most common agents in infections in children under six years old with 
wheezing were rhinovirus, RSV and bocavirus. The most common co infections were 
rhinovirus and RSV, rhinovirus and bocavirus, and RSV and human metapneumovirus 
(Chung et al., 2007). 
A molecular epidemiological study conducted in Japanese children identified viral 
agents as RSV, rhinovirus, human metapneumovirus, parainfluenza virus, enterovirus, 
influenza virus, adenovirus and bocavirus. Among these virus, RSV was detected as the 
most frequent agent in those children without a history of wheezing or asthma, whereas 
rhinovirus was frequently found in children who had suffered from wheezing (Fujitsuka 
et al., 2011). 
The role of RSV and rhinovirus as risk factors has been described in several 
studies. Kusel and colleagues (2007) found that lower tract respiratory infections caused 
by any of these agents in the first year of life increased the risk of recurrent wheeze and 
asthma in school age children sensitised in the first two years of life. Moreover, other 
studies concluded that severe respiratory diseases associated with rhinovirus were related 
to a significant increased risk of wheezing in the third year of life (Lemanske et al., 2005), 
and asthma at six years (Jackson et al., 2008). Likewise, RSV lower tract respiratory 
infections were associated with a higher risk of wheeze in early life (Stein et al., 1999). 
A relation between a high load of bocavirus with episodes of wheezing has also been 
described (Allander et al., 2007), as well as a direct correlation between viral load and 
duration of wheezing (Deng et al., 2012). 
Viruses are not the only microorganisms which play an important role in the onset 
of wheezing. Colonization of the respiratory tract by Streptococcus pneumoniae, 
Moraxella catarrhalis, Haemophilus influenzae, or a combination of these bacteria, was 
positively related to an increased risk of onset of wheezing and development of persistent 
wheezing and asthma in subsequent years (Bisgaard et al., 2007b). 
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Other bacteria, such as Mycoplasma pneumoniae or Chlamydia pneumoniae, were 
also found associated with recurrent wheeze (Esposito et al., 2000). 
Although some authors pointed to an independent effect of bacteria and virus 
(Bisgaard et al., 2010), other studies showed evidence of a link between bacterial 
colonization in virus-induced wheezing, which could aggravate the severity and 
persistence of the disease due to its impact on airways inflammation (Yu et al., 2010). 
Other established major risk factor is allergic sensitisation at early ages. 
Sensitisation to allergens, as dust mites or animal allergens, was positively associated 
with persistent wheezing in subsequent ages, and chronicity of asthma (Illi et al., 2006; 
Llanora et al., 2012). 
Parental history of asthma is another risk factor widely described in the literature. 
A review concluded that presence of asthmatics parents was associated with an increased 
risk of asthma in the offspring (Burke et al., 2003). Likewise, other studies also reported 
an increased risk of asthma and wheezing in schoolchildren whose father or mother were 
asthmatic, with a multiplicative effect if both parents were atopic or asthmatics (Bjerg et 
al., 2007). 
Another well studied factor is the exposure to tobacco smoke. Smoking during 
pregnancy was found as a major risk factor for wheezing and asthma in childhood, 
whether or not children were postnatally exposed to tobacco smoke (Gilliland et al., 2001). 
On the other hand, an increased risk for recurrent wheezing and asthma in the first year 
of life in children exposed to tobacco smoke, independently of the prenatal exposure to 
tobacco smoke, has also been reported by several studies (Lannerö et al., 2006; Kanoh, 
2012). 
Other risk factors previously found as risk factors for wheeze in early life were 
male sex (Chong Neto et al., 2008), and overweight, this latter associated with a twice 
higher risk for the onset of wheezing in preschool age (Saldiva et al., 2007), while obesity 
was significantly related to the development of severe asthma, especially in girls (Garcia-
Marcos et al., 2007). 
Also, environmental factors, such as pollution, were positively related to the onset 
of infant wheeze. In a Danish prospective birth cohort study, a significant association was 
observed between wheezing in a population at risk and exposure to traffic-related (NO2, 
NOX, CO) and PM10 particles (Andersen et al., 2008). Furthermore, exposure to traffic, 
especially stop-and-go traffic, was found associated with higher prevalence and an 
increased risk for wheeze (Ryan et al., 2005). 
Another environmental factor described in past investigations was the presence of 
mould and damp stains at home, found as risk factor for recurrent wheeze, and the most 
important factor in the development of severe wheeze in infants (Visser et al., 2010). 
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Conversely, protective factors against wheezing have also been described in the 
literature. One of the most studied was a longer breastfeeding period. An Australian study 
found that exclusive breastfeeding for at least four months reduced the risk of asthma at 
6 years (Oddy et al., 1999). In the same cohort, breastfeeding less than six months was 
found significantly related to an increased risk of hospital admission for wheezing (Oddy 
et al., 2003). 
1.6 Prediction of the epidemiological phenotype 
Although there is no tool able to certainly predict whether infants will continue 
wheezing or will develop asthma, the identification of these symptomatic children may 
allow to develop a strategy for intervention that could change the natural course of the 
disease (Martinez, 1999). The combination of clinical data and information obtained in 
the laboratory could lead to the identification of children at high risk of further developing 
symptoms in the future. 
The Asthma Predictive Index (API) was a tool used to identify the population at 
risk, based on the factors observed in the first three years of life. To allow a better 
classification of children with potential risk of asthma, two indexes and major and minor 
criteria were proposed. 
Major criteria 
 Parental medical diagnosis of asthma. 
 Medical diagnosis of eczema. 
Minor criteria 
 Medical diagnosis of allergic rhinitis. 
 Wheezing apart from colds. 
 Eosinophilia ≥4%. 
In the stringent index, if the infant suffered from recurrent wheeze in the first three 
years of life, and met at least one major criterion or two minor criteria, asthma prediction 
would be positive. On the other hand, if the loose index was used, an infant would suffer 
from asthma if met a major criterion or two minor criteria, although they did not wheeze 
repeatedly.  
The stringent index showed low sensitivity, whilst its specificity, and both positive 
and negative predictive values were high. Sensitivity in the loose index decreased with 
age, whereas specificity remained around 80%. The positive predictive value showed 
high values, although lower than in the stringent index, whilst negative predictive value 
showed similar values. 
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One of the strengths of these indexes is its simplicity, which allows its use in 
clinical practice worldwide. The decision on which index should be used depends on the 
effectiveness and potential side effects of the preventive measures recommended for 
children at risk (Castro-Rodriguez et al., 2000; Castro-Rodriguez, 2010). 
The API has been validated, considering that a positive score is a reliable predictor 
of asthma in wheezing children, being an objective test not subject to cultural differences. 
The main limitation is its low sensitivity, which make it unable to completely rule out a 
child who will not develop asthma in the future (Huffaker and Phipatanakul, 2014). 
As the API did not evaluate allergic sensitisation to aeroallergens, milk, eggs or 
peanuts, reported as significant predictors for the development of asthma in children, a 
modified version (mAPI) was created. In this index, because the clinical diagnosis of 
allergic rhinitis without confirmed sensitisation in young children was uncertain, it was 
replaced by allergic sensitisation to inhalant allergens and food. 
Major criteria 
 Parental medical diagnosis of asthma. 
 Parental medical diagnosis of atopic dermatitis. 
 Allergic sensitisation ≥1 aeroallergen. 
Minor criteria 
 Allergic sensitisation to milk, eggs or peanuts. 
 Wheezing apart from colds. 
 Eosinophilia ≥4%. 
Those children with at least four episodes of wheezing per year, who met at least 
one major criterion or at least two minor criteria, were considered at risk for developing 
asthma in the future. As the API, this modified version showed low sensitivity, but its 
specificity was very high, demonstrating its usefulness in the diagnosis of asthma in 
childhood (Guilbert et al., 2004; Chang et al., 2013). 
1.7 The International Study of Asthma and Allergies in Childhood 
The International Study of Asthma and Allergies in Childhood (ISAAC) was an 
international epidemiological research on asthma and allergies (rhinitis and eczema), 
developed from the merger of two projects which studied childhood asthma: an initiative 
in Auckland (New Zealand), which conducted an international comparative study of 
asthma severity, and another project in Bochum (Germany) which studied temporal trends 
and determinants of prevalence of asthma and allergies in children (Asher and Weiland, 
1998). 
The ISAAC study consisted in three Phases, each with its own objectives, 
methodology and study populations. 
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Phase I 
In Phase I, the study population were children in two groups: six and seven years 
old (when asthma tends to be more prevalent and hospital admissions are higher), and 
thirteen and fourteen years old (when asthma mortality is higher). 
The aims were to study the prevalence and severity of asthma, rhinitis and eczema 
in children from different centres, and make national and international comparisons, 
obtaining reference measurements for assessing future trends in the prevalence and 
severity, and providing a framework for further investigation of the role of lifestyle, 
environmental, genetic factors, and medical care in these diseases. 
In this phase, one hundred and fifty-six centres in fifty-six countries participated, 
using written and video questionnaires designed to measure the prevalence and severity 
of asthma and allergic diseases, which were translated into different languages (Asher et 
al., 1995; Asher and Weiland, 1998). 
Results from this first phase showed the highest prevalences of asthma symptoms 
in the United Kingdom, Ireland, Australia and New Zealand, and centres from North, 
Central and South America, while the lowest prevalences were found in Eastern Europe 
centres, Greece, China, Taiwan, Indonesia, India, Uzbekistan and Ethiopia. 
In general, prevalence of allergic rhinoconjunctivitis and eczema was lower in 
those centres which reported lower prevalence of asthma, except in some Scandinavian 
and African centres (ISAAC Steering Committee, 1998). 
Phase II 
The objective of this phase was to identify the determinants of the observed 
differences in prevalence rates. The specific objectives were to assess the variation in the 
prevalence and severity of clinical symptoms and markers of asthma, allergic rhinitis and 
eczema, study the associations between potential determinants and the occurrence and 
severity of asthma and allergies, make comparisons between centres, and investigate 
associations between genotypes known or suspected to play a role in childhood asthma 
and allergies with the measured phenotypes, and to investigate gene-gene and gene-
environment interactions. 
Thirty centres in twenty-two countries, using a study population of children aged 
nine to eleven years, participated in this second phase. The study protocol included the 
use of standardized questionnaires and flexural dermatitis test, skin prick test and 
bronchial provocation test. For laboratory test, blood samples for IgE analyses were 
required, and dust samples were collected for the analyses of airborne allergens and 
endotoxins (Weiland et al., 2004). 
In this phase, similar results were found in terms of international variation in the 
prevalence and severity of asthma symptoms, whereas a link between atopic sensitisation 
and asthma was only evidenced in affluent countries (Weinmayr et al., 2007). 
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Other remarkable results were the inverse association found between endotoxin 
levels and asthma symptoms, although there was no relation with allergic rhinitis 
(Gehring et al., 2008), and the discovery of four genes (IL4R, TLR4, MS4A2, TLR9) 
related to the onset of wheeze (Genuneit et al., 2009). 
Phase III 
This phase was developed to learn more about asthma, rhinoconjunctivitis and 
eczema etiologies. The aims of this phase were to examine time trends in the prevalence 
of asthma, allergic rhinoconjunctivitis and eczema in the centres participating in Phase I, 
describe the prevalence in those centres which did not participate in Phase I, and evaluate 
hypothesis proposed by the results obtained in that first phase. 
As Phase III was a repetition of Phase I, study population was similar (children 
aged six and seven years, and thirteen and fourteen years). The period considered between 
two phases was at least five years, with identical data collection, which allowed to 
determine the temporal trends in the prevalence of the disease. 
Over two hundred eighty centres in a hundred and six countries participated, 
which were classified as they had completed Phase I and participated in Phase III (one 
hundred sixteen centres), or had not participated in Phase I, but only in Phase III (one 
hundred sixty-eight centres) (Ellwood et al., 2005). 
Results showed that prevalence of asthma symptoms in most of countries, 
especially English language countries, which reported higher prevalences in Phase I, had 
declined, whilst in countries which showed intermediate or low prevalences in the 
previous phase, it had increased (Pearce et al., 2007). 
It can be considered the ISAAC study as an antecedent of the International Study 
of Wheezing in Infants, both for the outcome studied and its international nature, and the 
use of a similar methodology. 
1.8 International Study of Wheezing in Infants 
Definition and aims 
The International Study of Wheezing in Infants (in Spanish, Estudio Internacional 
de Sibilancias en Lactantes, or EISL) is an international multicentre cross-sectional study, 
designed to assess the prevalence, severity and characteristics of wheezing in infants 
during the first year of life in European and Latin American countries. 
The study began in 2005, with participating centres from Spain, Netherlands, 
Brazil, Chile, Mexico, Venezuela and Colombia. Figure 1 shows a map with the 
participating centres. More recently, centres from other Latin American countries 
(Honduras, El Salvador) have joined to the study. 
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Figure 1. Participating centres in the International Study of Wheezing in Infants. 
 
The study was developed to determine the prevalence, severity and frequency of 
wheezing, and its relation with other respiratory diseases, such as pneumonia, and risk 
factors for wheezing in the first year of life. 
The EISL study, as the ISAAC study, used standardized case definitions and 
methodology, which facilitated international collaboration and increased the value of the 
comparisons between centres. 
The methodology was based on the one used by the ISAAC study, and 
participating centres were those which successfully participated in Phase I and III of 
ISAAC. 
The main objectives of the International Study of Wheezing in Infants were: 
1) To determine the prevalence and severity of wheezing in infants during the first year 
of life in different European and Latin American centres, and to make national and 
international comparisons. 
2) To individually examine hypothesis that have been suggested by previous studies 
conducted in the past, and on the recommendation of international health institutions. 
3) To study the relation between recurrent wheezing and pneumonia in different 
European and Latin American centres, and to make national and international 
comparisons. 
4) To obtain reference measurements for assessing future trends in the prevalence and 
severity of the disease. 
5) To build a network among participating centres for future studies, and provide a 
framework for further research of etiologic and pathologic factors. 
Introduction 
 
18 
 
Epidemiological and ecological factors examined in this study, focused on 
wheezing in the first year of life, have not been previously considered, so there were no 
international comparative studies which has used the same methodology, and therefore 
ensured comparisons validity. (Mallol and García-Marcos, 2006) 
Importance of the study 
Despite recurrent wheeze represent a public health problem, particularly in 
developing countries, information on the prevalence, characteristics and complications of 
wheezing disorders was scarce. There was no previous published information from 
international multicentre studies using a standardised methodology, about the true 
prevalence of wheeze and recurrent wheeze in the first year of life in infants who lived in 
Europe and Latin America, nor comparative studies including developed and developing 
countries. 
Thus, the International Study of Wheezing in Infants offers a unique opportunity 
for scientific integration and creation of a network between participating centres, and its 
results provide valuable international epidemiological and ecological information on 
infant wheeze, its risk factors and complications (Mallol and García-Marcos, 2006). 
International Study of Wheezing in Infants in Europe 
In Spain, several centres in different cities participated in the study. In addition to 
Pamplona, other centres in cities such as Salamanca, Cartagena, Bilbao, Valencia, La 
Coruña or Madrid also participated in the EISL study (Mallol et al., 2010b; Pellegrini-
Belinchón et al., 2012). Also, in the Netherlands, the study was conducted in the region 
of Zwolle (Visser et al., 2010). 
In the region of Pamplona the study began in October 2006, following the 
methodology proposed in the international protocol. The participation in the EISL was an 
opportunity to work in a pioneer project studying a disease that, due to its prevalence and 
severity in infants and consequences in older ages, is considered an important public 
health issue. 
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2.1 Hypothesis 
The prevalence of wheezing in infants in the region of Pamplona is similar to 
others in European centres, but lower than in Latin American centres. 
Risk factors previously described in the literature, as lower tract respiratory 
infections, smoking during pregnancy, parental history or asthma, or mould/damp stains 
at home, are risk factors for wheeze ever, recurrent wheeze and/or severe wheeze. 
Exclusive breastfeeding more than six months is a protective factor for wheeze 
ever, recurrent wheeze and/or severe wheeze. 
2.2 Main objective 
To investigate the epidemiology and risk factors of wheezing in infants in the first 
year of life in the region of Pamplona, providing a framework for further research on the 
evolution of the prevalence and etiology of genetic, environmental, and lifestyle factors 
affecting the onset of wheeze. 
2.3 Specific objectives 
To describe the prevalence of wheeze ever, recurrent wheeze and severe wheeze 
in the first year of life in infants in the region of Pamplona. 
To study risk factors associated with wheeze ever, recurrent wheeze, and severe 
wheeze, focusing in those related to history of respiratory and allergy symptoms, family 
history of asthma and allergies, exposure to tobacco smoke, or household and 
environmental factors, previously found as risk factors for wheeze. 
To compare the results obtained with those from other centres where similar 
studies have been conducted following the protocol of the International Study of 
Wheezing in Infants. 
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3.1 Reference population 
The region of Pamplona is an area in the centre of Navarre, a province in the North 
of Spain, which includes Pamplona city (capital of the province) and its metropolitan area. 
An urban area, more densely populated, and a surrounding rural periphery are 
distinguished. 
The region of Pamplona includes the municipalities of Berrioplano, Ezcabarte, 
Berriozar, Ansoáin, Villava, Burlada, Huarte, Egüés, Pamplona, Orcoyen, Olza, Barañáin, 
Zizur Mayor, Aranguren, Noáin, Beriáin, Galar, Cizur, Tiebas-Muriarte de Reta, Zabalza, 
Echauri, Juluspeña and Olaibar. 
Pamplona city is situated four hundred fifty-nine metres above sea level. Its 
climate is a transition between Mediterranean and Atlantic. The average annual 
temperature is 12.4ºC, ranging from the lowest average temperatures in January (1.1ºC) 
to the highest in August (21.7ºC). Total annual rainfall is 772.5 millimetres (Pamplona 
city council webpage). 
In the region of Pamplona, population during the study was 315,988 in 2006, 
319,208 in 2007, and 328,511 in 2008. The largest age groups in this period were both 
men and women aged thirty to thirty-four and thirty-five to thirty-nine years. 
The foreign population ranged from 9.57% to 10.76% of the total population along 
the study period (2006-2008). European countries (Bulgaria and Romania) and Latin 
American countries (Colombia and Ecuador) were the most common countries of origin 
(Spanish Statistical Office webpage). 
3.2 Study population 
The study population were infants of the region of Pamplona who went to the 
healthcare centre for a health check-up at age fifteen months, within the Healthy Child 
Program (in Spanish, Programa del Niño Sano), to receive the correspondent vaccine. 
Sample size was 3,284 infants, divided into the twenty participating healthcare centres 
shown in Figure 2. 
It was estimated that each EISL centre should have recruited a random sample 
between 1,000 and 3,000 infants aged between twelve and fifteen months, to facilitate 
comparisons between countries. In those centres where the infant population in this age 
range did not meet the required size allowed, the sample should have been similar to the 
general population of infants in the age range. 
The study was conducted between December 2006 and June 2008. Random 
sampling was not carried out. Instead, every family who attended to the health check-up 
above mentioned was asked to participate. Infants whose parents did not complete the 
questionnaire were excluded from the study. Finally, from a sample of 3,284 infants, a 
total of 1,065 questionnaires (32.4%) were collected. 
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Figure 2. Participating healthcare centres in the region of Pamplona. 
 
(1) Huarte; (2) Villava/Atarrabia; (3) Burlada; (4) Berriozar; (5) Orcoyen; (6) San Jorge; (7) Rochapea; (8) 
Chantrea; (9) Casco viejo; (10) II Ensanche; (11) Iturrama; (12) San Juan; (13) Barañáin; (14) Zizur-
Echavacoiz; (15) Noáin; (16) Azpilagaña; (17) Mendillorri; (18) Ansoáin; (19) Milagrosa; (20) Ermitagaña. 
3.3 Data collection 
First, the Primary Care Management of Navarre’s Health Service was informed 
about the project, and data from the paediatric nurses from the participating healthcare 
centres were required. 
Appointments with the nurses were requested to explain the project, aims and 
methodology, what would be their role in it, and how it would be carried out in each 
healthcare centre. Nurses were informed that regular visits would be made or telephone 
contact would be maintained to resolve doubts that would arise or problems with the 
material, etcetera. It was emphasized that information about the project should be rigorous 
and complete, as the nurses were the spokespersons to the families. 
The Public University of Navarre was asked to provide mugs with its logo, to 
thank the nurses for their cooperation, and pens as gifts to the families who participated, 
which were given with the questionnaire. 
When families brought their children to the health revision at age fifteen months, 
as established in the Healthy Child Program (a set of activities carried out along the 
paediatric ages, aimed to the promotion of health and prevention of diseases), paediatric 
nurses gave them a covering letter explaining the study, and their collaboration was 
requested. 
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If families agreed to participate, after signing a full-informed written consent, 
instructions to complete the questionnaire were given. It was estimated a time between 
fifteen to twenty minutes to fill the questionnaire. 
Families filled it at home, without the assistance of any health care professional, 
and could either hand it to the nurse in the same healthcare centre on the next visit, or 
mail it to the Public University of Navarre. 
All questionnaires were kept by paediatric professionals and collected periodically 
or sent by mail to the Public University of Navarre (Table 1). In those healthcare centres 
with small infant population, questionnaires were sent to the Nursing Primary Care 
Department every month. 
This study was approved by the Management of Primary Care of Navarre’s Health 
Service and by the Scientific Ethic Committee of University of Murcia. 
Table 1. Healthcare centres and questionnaires collection. 
Healthcare centre  
(sample size) 
Collection Dates 
Huarte (164) Mail - 
Villava/Atarrabia (130) Mail - 
Burlada (190) Mail - 
Berriozar (196) Mail/Collected in the centre 15/01/2007 
Orcoyen (59) Mail - 
San Jorge (218) Mail/Collected in the centre 20/12/2006; 28/02/2007; 18/04/2007 
Rochapea (389) Mail - 
Chantrea (146) Mail - 
Casco viejo (119) Mail - 
II Ensanche (128) Mail/Collected in the centre 19/01/2007; 12/04/2007 
Iturrama (68) Mail/Collected in the centre 10/01/2007; 7/03/2007; 15/05/2007 
San Juan (151) Mail/Collected in the centre 15/01/2007; 7/03/2007; 15/05/2007 
Barañáin (195) Mail - 
Zizur-Echavacoiz (291) Mail/Collected in the centre 1/03/2007 
Noáin (122) Mail - 
Azpilagaña (63) Mail - 
Mendillorri (251) Mail - 
Ansoáin (185) Mail/Collected in the centre 9/01/2007; 8/03/2007; 16/05/2007 
Milagrosa (120) Mail/Collected in the centre 12/04/2007; 20/04/2007 
Ermitagaña (99) Mail - 
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3.4 Flow chart of the study 
 
 
 
 
 
 
  
Project presentation to the        
Primary Care Management of 
Navarre’s Health Service Meeting 
Authorisation 
Pilot study in San Jorge and 
Noáin healthcare centres 
Meetings in the healthcare centres 
 
Material delivery in participating centres 
Database creation 
 
Explanation of the project 
Collaboration request 
Doubt solving 
Questionnaire collection 
Questionnaire delivery  
to the families 
Study report 
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3.5 International Study of Wheezing in Infants timeline 
In Figure 3, the steps followed in the International Study of Wheezing in Infants 
in the region of Pamplona between 2006 and 2008 are shown graphically. 
May 2006 
A report was sent to the Primary Care Management of Navarre’s Health Service, 
and a meeting was scheduled to explain the project that would be carried out in the region. 
July-August 2006 
After obtaining the approval, a pilot study was conducted for two months in two 
healthcare centres (San Jorge and Noain), using the same methodology that would be 
followed in the subsequent months. These two healthcare centres continued in the study 
after this period. 
October-November 2006 
Once obtained satisfactory results in the pilot study, meetings with the paediatric 
nurses of the healthcare centres were scheduled to explain the project, request their 
collaboration and resolve doubts. 
December 2006-June 2008 
Once obtained the support of healthcare centres, materials (questionnaires and 
gifts) were delivered. Along a year and a half, questionnaires were given to the families 
who agreed to participate, and were collected by mail or in the centre, as previously 
explained. 
September 2008 
When all questionnaires were collected, they were read and a database was created 
in IBM SPSS v12 and STATA v7. 
3.6 Questionnaires 
The questionnaire used was the standard model of the International Study of 
Wheezing in Infants. As the region of Pamplona is a mixed language area, and most 
people speak both Spanish and Basque, it was decided to provide two models of the 
questionnaire in both languages. 
The Spanish version was back translated to Basque by the Department of Euskera 
of the Public University of Navarre. Both questionnaire models are presented in Appendix 
1. The questionnaire consisted of seventy-seven items with closed answer format, in four 
pages. The questions were dichotomous, categorized or numerical.
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Figure 3. International Study of Wheezing in Infants timeline in the region of Pamplona. 
Year 2006 2007 2008 
Months* Ma J Jl A S O N D 
 
J F M A Ma J Jl A  S 
Meeting with the Management of 
Primary Care 
                  
Pilot study in San Jorge and 
Noáin healthcare centres 
                  
Meeting with paediatric nurses in 
healthcare centres 
                  
Delivery and collection of 
questionnaires 
                  
Database creation                   
*J: January; F: February; M: March; A: April; Ma: May; J: June; Jl: July; A: August; S: September; O: October; N: November; D: December.
Material and methods 
 
28 
 
The questionnaire gathered information about the infant (demographic and 
anthropometric data, respiratory/allergy symptoms, and treatment), wheezing (number of 
episodes, age of the first episode, characteristics and severity), family background 
(exposure to tobacco smoke, history of asthma or allergies, socioeconomic information), 
environmental factors (nursery attendance, household characteristics, feeding), and 
exposures throughout pregnancy (maternal diet, use of paracetamol, complications). 
The questionnaire has been previously validated. It showed a high sensitivity and 
specificity, 86% and 91.8%, respectively, a predictive positive value of 76.8%, and a 
predictive negative value of 95.4% (Chong Neto et al., 2007), and was considered a valid 
tool to detect children with wheezing in the first year of life (Mallol et al., 2007). 
Definitions 
The dependent variable of the study was the presence or absence of wheezing in 
the first year of life. Wheeze ever was defined as a positive answer to the question: “Has 
your child had wheezing or whistling in the chest in the first 12 months of life?”. 
Recurrent wheeze was defined as three or more episodes of wheezing in the first 
year of life. Severe wheeze was defined as a positive answer to the question: “In the first 
12 months of life, has your child experienced wheezing or whistling sounds in the chest 
that were so intense that he/she choked and had breathing difficulties?”. 
Infant eczema was defined as a positive response to the question: “Has your child 
had in the first 12 months of life red spots in the skin that itch and appear and disappear 
anywhere on the body, except around the mouth and nose, and in the area of the nappy?”. 
Colds were recorded when parents answered with a positive numerical response 
to the question: “How many colds (sneezing, cough, runny nose) has your child had in 
the first 12 months of life?” 
Presence of mould/damp stains at home was assessed with a positive answer to 
the question: “Is there mould (fungi) or damp stains in the house where the child live?”. 
Air pollution was ascertained with an affirmative answer to the question: “Do you 
consider your child live in an air polluted area?” 
Mediterranean diet is characterised by frequent consumption of plant foods (fresh 
fruit, vegetables, legumes and nuts), low to moderate consumption of dairy products, fish 
and poultry, low consumption of red meats and sweets, low to moderate consumption of 
red wine (usually accompanying meals), and olive oil as the principal source of fat 
(Willett et al., 1995). 
To assess the adherence to the Mediterranean diet during pregnancy, a score 
previously applied by Garcia-Marcos et al. (2007), based on the score used by 
Psaltopoulou et al. (2004), was developed. 
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As pro-Mediterranean diet components, white and oily fish, fruit, salads, fresh and 
cooked vegetables, legumes, cereals, pasta, rice, potatoes and nuts were included. Dairy 
products (milk and yogurt) were also presumed to be beneficial components as the 
involved population were pregnant women. Their consumption was scored with zero 
points in mothers who never consumed them during pregnancy, one point for those who 
occasionally consumed them (one-two times per week), and two points for those mothers 
who reported a usual consumption (three or more times a week). 
Conversely, consumption of presumed non-Mediterranean diet components, as 
meat, fast food, high-fat dairy products (butter and margarine), snacks and pastries, was 
scored inversely, from two points if never consumed them during pregnancy, to zero 
points if was reported a usual consumption (three or more times a week). Alcohol 
consumption was excluded from the score. Therefore, a higher score indicated a better 
adherence to the Mediterranean dietary pattern. 
In addition, as olive oil was not included in the food-frequency questionnaire, its 
consumption was ascertained by the question “Which is predominantly used to fry in the 
household where the infant lives?”. 
3.7 Database creation and statistical analysis 
Questionnaires, both Spanish and Basque version, were designed by the Teleform 
Designer program. They were read with a Canon scanner DR30202, and the form 
processing application Teleform Reader 6.1 (Cardiff Software, USA). To avoid issues 
with processing personal data, according to the Organic Law 5/1992, regulating the 
automatic processing of personal data, no personal data were collected. Database was 
corrected removing abnormal values, and exported to a format compatible with IBM 
SPSS and STATA software. Analyses were performed with STATA version 13.0 
(StataCorp, College Station, TX, USA). 
Those infants with no information to the question “Has your child had wheezing 
or whistling in the chest in the first 12 months of life?” (eighteen subjects) were excluded 
from the analyses. Also, infants aged less than eleven months (five subjects), or those 
who had their first wheezing episode after twenty-four months of age (fifty-five subjects) 
were excluded. In those cases when parents did not answer the question about number of 
wheezing episodes, it was assumed they had healthy infants. Separate analyses were 
conducted for wheeze ever, recurrent wheeze and severe wheeze. 
To allow detecting an estimated prevalence of wheezing of 34%, with an error of 
2.5%, conducting a correction for a finite population of 3,284 newborns, a sample size of 
972 subjects would be necessary. 
To allow detecting prevalence odds ratios over two, with a 95% confidence, and 
a statistical power of 80%, assuming that prevalence of the exposition in healthy subjects 
was 10%, it would be necessary a sample size of 568 subjects. Calculations were 
conducted with OpenEpi program (Dean et al., 2013).  
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A descriptive analysis was performed, computing frequencies and percentages for 
categorical variables, and mean and standard deviation (±SD) for quantitative variables. 
Bivariate analyses were performed using the chi-squared test, or the Student’s t-test, as 
appropriate, to study associations between factors and wheeze ever, recurrent wheeze and 
severe wheeze, calculating odds ratio (OR) with 95% confidence intervals (95% CI). In 
all analyses, a p value lower than 0.05 was regarded as statistically significant. 
For each outcome of interest, multivariate models were used to adjust for 
confounding variables to obtain adjusted odds ratios (aOR). All the variables related to 
the outcome (p value<0.1) in the bivariate analysis were included in the model, and only 
retained if showed a statistically significant association (p value<0.05) or modified the 
association of interest by 15-20%.  
This process resulted in the inclusion of the following covariates used for 
adjusting wheeze ever: sex, pneumonia, number of colds, maternal history of asthma, 
paternal history of atopic dermatitis, nursery attendance, number of siblings, and months 
of exclusive breastfeeding. Recurrent wheeze was adjusted by pneumonia, infant eczema, 
number of colds, smoking father, smoking during pregnancy, nursery attendance, 
hypertension during pregnancy, and prematurity at birth. Severe wheeze was adjusted by 
sex, number of colds, age of the first cold, colds in the first three months of life, history 
of atopic dermatitis in siblings, and months of exclusive breastfeeding. 
The Hosmer-Lemeshow test for goodness of fit for logistic regression models was 
performed, being all models well calibrated (p value>0.1). 
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The study sample size in Pamplona was 3,284 infants. During the study 1,065 
questionnaires were collected (participation rate: 32.4%). After exclusions, information 
from 987 infants was available for analysis. 
4.1 Descriptive analysis 
Demographic factors 
Most questionnaires (80.1%) were filled by mothers, and 4.3% by fathers, while 
both parents completed the questionnaire in the 15.6% of cases. 
Half of the sample, 50.8% of infants, were boys, and the mean age was 12.1 (±0.7) 
months. 
The most common weight at birth (59.5% of infants) was between 2,500 and 3,499 
grams and the mean height was 49.6 (±2.7) centimetres. When questionnaire was filled, 
mean weight and height were 9.5 (±1.2) kilograms, and 75.6 (±3.1) centimetres, 
respectively. 
Almost every infant (97.0%) was white race and was born in Spain (99.7%). 
Likewise, most of fathers (91.1%) and mothers (91.9%) were also Spanish. (Table 2) 
Table 2. Demographic and anthropometric factors. 
 N (%) ±SD 
Sex   
Boys 486 (50.8) 
 
Girls 470 (49.2) 
 
Age 969 12.1±0.7 
Weight at birth   
Less than 1,500 grams 5 (0.5) 
 
1,500-1,999 grams 17 (1.7) 
 
2,000-2,499 grams 57 (5.8) 
 
2,499-3,499 grams 582 (59.5) 
 
More than 3,500 grams 318 (32.5) 
 
Weight (current) 951 9.5±1.2 
Height at birth 939 49.6±2.7 
Height (current) 925 75.6±3.1 
Race   
White 951 (97.0)  
Gipsy 3 (0.3)  
Latin American 7 (0.7)  
Others (African, Asian,...) 19 (1.9)  
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Wheezing, treatment and respiratory/allergy symptoms 
Of the total of infants in the study, 32.5% wheezed in the first year of life, 10.6% 
developed recurrent wheeze, and 9.6% suffered from severe wheeze. Figure 4 shows the 
number of episodes in the first year of life. The mean number of episodes was 2.7 (±3.9), 
and the mean age of the first episode was 6.5 (±3.0) months. 
Figure 4. Number of wheezing episodes in the first year of life. 
 
In the 32.5% of infants, wheezing began with a cold, and for the 9.9% worsened 
when they moved, or got angry, or laughed. Almost one fifth of parents reported that 
wheezing affected infant’s feeding, and more than 10% had their daily activities limited. 
Family life was modified for this cause in the 9.8% of cases. (Figure 5) 
Figure 5. Characteristics of wheezing in the infant. 
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A 22.1% of infants had received treatment with inhaled drugs, and 10.2% with 
inhaled corticosteroids. Frequencies of children treated with antileukotrienes or ketotifen 
were lower, the 3.6% and 0.6%, respectively, whereas the treatment with both drugs only 
was administered to one child (0.1%). 
Parents were occasionally awakened by infant wheezing in the 15.2% of cases, 
and 4.2% were often awakened. A 13.8% of infants went to the Emergency Department 
due to the severity of wheezing. Hospitalisation was necessary once in twenty-six cases 
(2.8%), and three infants (0.3%) were hospitalised twice. 
Only the 1.1% of infants were diagnosed with asthma by a physician, and a 4.1% 
had pneumonia or bronchopneumonia in the first year of life, being necessary the 
hospitalisation for this cause in 1.0% of the cases. The 13.9% of infants suffered from 
infant eczema. Mean number of colds in the first year of life was 3.5 (±3.7), and mean 
age of the first cold was 5.2 (±4.5) months. Two hundred forty infants (27.5%) had their 
first cold in the first three months of life. (Table 3) 
Table 3. Wheezing, treatment and respiratory/allergy symptoms in the first year.  
 N (%) ±SD 
Wheezing   
Wheeze ever 321 (32.5)  
Recurrent wheeze  105 (10.6)  
Severe wheeze 95 (9.6)  
Wheezing episodes 305 2.7±3.9 
Age of the first episode 320 6.5±3.0 
Treatment   
Inhaled drugs 192 (22.1)  
Inhaled corticosteroids 85 (10.2)  
Awakened due to wheezing   
Never 535 (57.4)  
Rarely 216 (23.2)  
Occasionally 142 (15.2)  
Often 39 (4.2)  
Emergency Department 118 (13.8)  
Hospitalization due to wheezing   
Once 26 (2.8)  
Twice 3 (0.3)  
Diseases   
Asthma 10 (1.1)  
Pneumonia 38 (4.1)  
Hospitalization due to pneumonia 9 (1.0)  
Eczema 131 (13.9)  
Number of colds 983 3.5±3.7 
Age of the first cold 976 5.2±4.5 
First cold ≤ 3 months 240 (27.5)  
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Family background 
Two hundred and one mothers (20.7%) were smokers, and reported smoking a 
daily mean of 10.7 (±8.6) cigarettes. On the other hand, two hundred eighty-five fathers 
(29.9%) also smoked, a mean of 12.2 (±8.3) cigarettes per day. Furthermore, one hundred 
sixty-two mothers (16.7%) smoked during pregnancy. In the household, the mean number 
of smokers was 0.5 (±0.8) persons. 
Forty-two fathers (4.3%), and fifty-two mothers (5.6%) were asthmatics, while 
only a 2.7% of siblings had asthma. One hundred and twenty-four fathers (13.0%), and 
one hundred thirty-two mothers (13.6%) had allergic rhinitis, whilst only the 2.1% of 
siblings were allergic. Thirty-seven fathers (3.9%), and fifty-seven mothers (6.0%) 
suffered from atopic dermatitis, as well as the 5.2% of siblings. 
One hundred sixty-five fathers (17.4%) showed allergy in an allergy test, whereas 
the 5.9% had negative results. Similarly, one hundred sixty-eight mothers (17.7%) had 
positive allergy test results, against the 8.6% who did not show allergy. Among siblings, 
frequencies were lower, only twenty-five (2.8%) had allergy, whilst the 4.2% showed 
negative results in the allergy test. 
Most mothers had a university degree (51.4%), or completed secondary education 
(40.1%). On the other hand, the 3.0% of mothers only had a basic school degree. One 
hundred eighty-nine fathers (19.9%) belonged to the professional social class, and three 
hundred sixty-four (38.4%) to skilled manual workers. Most of mothers (26.7%) were 
unemployed when the questionnaire was filled. Among those who worked, the 35.5% 
belonged to the managerial social class, and 16.0% to the professional. (Figure 6)  
Mean age of mothers was 33.8 (±3.9) years. In Table 4 family background 
descriptive analysis results are summarized. 
Figure 6. Frequencies of parental occupations. 
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Table 4. Family background. 
 N (%) ±SD 
Smoking   
Smoking mother 201 (20.7) 
 
Daily smoked cigarettes 204 10.7±8.6 
Smoking father 285 (29.9) 
 
Daily smoked cigarettes 283 12.2±8.3 
Smoking during pregnancy 162 (16.7)  
First trimester 6 (14.0)  
Second trimester 1 (2.3)  
Third trimester 1 (2.3)  
Two trimesters 7 (16.3) 
 
Throughout pregnancy 28 (65.1) 
 
Number of smokers in the household 956 0.5±0.7 
Asthma   
Father 42 (4.3)  
Mother 52 (5.6)  
Siblings 25 (2.7)  
Allergic rhinitis   
Father 124 (13.0)  
Mother 132 (13.6)  
Siblings 19 (2.1)  
Atopic dermatitis   
Father 37 (3.9)  
Mother 57 (6.0)  
Siblings 48 (5.2)  
Positive allergy test   
Father 165 (17.4)  
Mother 168 (17.7)  
Siblings 25 (2.8)  
Maternal education   
Basic school (≤8 years) 29 (3.0)  
Incomplete Secondary (9-11 years) 54 (5.5)  
Complete Secondary (≥12 years) 391 (40.1)  
University 502 (51.4)  
Mean age of mothers 983 33.8±3.9 
Household and environmental factors 
One third of infants (33.9%) attended to nursery in the first year of life. Children 
began attending to nursery at a mean age of 7.5 (±2.6) months. 
When the baby was born, in most households (83.8%) there were no pets. Those 
families who had pets, usually had dogs (5.3%) and cats (3.0%). Likewise, when the 
questionnaire was filled, in most households there were no pets (82.9%), and those 
families who reported the presence of pets usually had dogs (4.7%), cats (3.2%) and other 
pets (3.5%). 
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The most common fuel used for heating was gas, in the 79.6% of households, and 
electricity was used for cooking by most families (90.4%). 
Only fifty-eight dwellings (6.0%) had an air conditioning unit, and seventeen 
(1.8%) were carpeted. Almost every dwelling had a bathroom and kitchen inside the 
house, and phone at home (frequencies over 99% in all cases). Forty-one families (4.2%) 
reported the presence of mould or damp stains. 
Over the 25% of families considered living in an air polluted area. Among them, 
more than a half (59.6%) reported a medium level of pollution, and only the 6.9% a high 
level. 
Almost every child (98.6%) had complete immunisation schedule according to 
their age. Mean number of siblings was 0.6 (±0.8), and mean number of people living in 
the household was 3.4 (±1.0) persons. 
Almost half of infants (43.2%) consumed industrial infant food every day over the 
first year of life, and 23.2% were fed with them once a week. On the contrary, the 22.7% 
of infants were not feed with industrial infant food in the first year of life. 
Mean duration of exclusive breastfeeding was 4.2 (±3.1) months. Three hundred 
thirty-two mothers (34.0%) exclusively breastfed their infant six or more months. 
Duration of exclusive breastfeeding is shown in Figure 7. 
Olive oil was the most frequent food used for frying (93.0%), while other oils 
were used by the 6.7% of families. In Table 5, household and environmental factors 
descriptive analysis results are presented. 
Figure 7. Duration of exclusive breastfeeding (in months). 
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Table 5. Household and environmental factors. 
 N (%) ±SD 
Nursery   
Nursery attendance 330 (33.9) 
 
Age nursery attendance 352 7.5±2.6 
Pets (birth)   
None 813 (83.8)  
Dog 51 (5.3)  
Cat 29 (3.0)  
Bird 21 (2.2)  
Rabbit/hamster 3 (0.3)  
Other pets 22 (2.3)  
More than one pet 31 (3.2)  
Pets (current)   
None 800 (82.9)  
Dog 45 (4.7)  
Cat 31 (3.2)  
Bird 22 (2.3)  
Rabbit/hamster 4 (0.4)  
Other pets 34 (3.5)  
More than one pet 29 (3.0)  
Household   
Air conditioning unit 58 (6.0)  
Carpet 17 (1.8)  
Bathroom inside the house 971 (99.2)  
Kitchen inside the house 961 (99.3)  
Telephone 967 (99.3)  
Mould or damp stains 41 (4.2)  
Air pollution 252 (25.6)  
High level 18 (6.9)  
Medium level 155 (59.6)  
Low level 87 (33.5)  
Complete immunisation schedule 952 (98.6)  
Number of siblings 986 0.6±0.8 
Number of people at home 970 3.4±1.0 
Industrial infant food   
Never 212 (22.7)  
Once a month 102 (10.9)  
Once a week 217 (23.2)  
Everyday 404 (43.2)  
Exclusive breastfeeding 976 4.2 ±3.1 
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Exposures during pregnancy and birth 
The mean Mediterranean diet adherence score was 28.2 (±3.1) points, ranging 
between 17 and 36 points. Most women reported a frequent consumption of meat, fresh 
fruit and juices, fresh and cooked vegetables, salads, cereals, milk and yoghurt, and an 
occasional consumption of white and oily fish, legumes, pasta and rice, cooked potatoes, 
eggs, and industrial pastry. On the other hand, most pregnant women never consumed 
home-made hamburgers, fast food (precooked meals, fry-up), butter and margarine, nuts, 
snacks, or alcoholic beverages and soft drinks throughout pregnancy. (Figure 8) 
Over half of mothers (55.4%) never took oral contraceptives, whilst 15.8% did it 
between one and three years, and 13.4% more than six years. On the other hand, most 
women (82.7%) never or less than once a month took paracetamol during pregnancy, and 
14.1% took it one to four times per month. The main causes for taking paracetamol were 
headaches (58.2%) and fever (14.5%). 
The most frequent complications during pregnancy and birth were the use of 
forceps (21.5%), and caesarean section (17.5%). Other common complications were 
infections (13.7%) and nuchal cord (11.9%). (Table 6) 
Table 6. Exposures during pregnancy and birth. 
 N (%) ±SD 
Mediterranean diet 668 32.3±3.4 
Oral contraceptives   
Never 538 (55.4)  
Less than a year 59 (6.1)  
Between one to three years 154 (15.8)  
Between four to six years 91 (9.4)  
More than six years 130 (13.4)  
Paracetamol   
Never or less than once per month 805 (82.7)  
One to four times per month 137 (14.1)  
More than once per week 32 (3.3)  
Complication during pregnancy and birth   
Hypertension 77 (8.7)  
Threatened miscarriage 103 (11.6)  
Infections 122 (13.7)  
Gestational diabetes mellitus 66 (7.4)  
Malposition of the foetus 31 (3.6)  
Premature rupture of membranes 63 (7.2)  
Placenta problems 50 (5.7)  
Hypoxia 50 (5.8)  
Prematurity 78 (8.9)  
Nuchal cord or knots in umbilical cord 104 (11.9)  
Obstetric trauma 4 (0.5)  
Forceps/suction cup 191 (21.5)  
Caesarean section 158 (17.5)  
Results 
 
40 
 
 
 
Figure 8. Frequencies of consumption of food groups during pregnancy. 
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After the descriptive analysis, we conducted bivariate and multivariate analyses 
to study the relation between factors and wheeze phenotypes. In the following sections, 
results from these analyses are shown. 
4.2 Demographic factors 
Wheeze ever 
Of the total of infants who wheezed, 39.1% were boys, and 26.0% were girls, 
finding a significant association between infant gender and wheeze ever (p<0.001). Male 
gender was found positively associated with wheeze ever in the first year of life 
(aOR=1.82; 95% CI 1.33-2.51). 
Mean age in children who wheezed was 12.2 (±0.9) months, while in healthy 
infants was 12.1 (±0.5) months, also showing statistical differences (p=0.020). However, 
non-significant higher odds for wheeze at older ages were observed (aOR=1.15; 95% CI 
0.92-1.44). 
The 39.2% of infants with low birth weight wheezed, compared to 31.9% with 
normal birth weight, not finding any significant association (p=0.181). In addition, no 
statistical differences were found when current weight (when the questionnaire was filled) 
was studied (p=0.153). 
On the contrary, statistical differences were observed in height at birth (p=0.037). 
Mean height in wheezing infants was 49.4 (±2.5) centimetres, whilst healthy infants were 
taller, 49.8 (±2.8) centimetres. Although in the statistical limit, higher height at birth was 
found as a protective factor for wheeze ever (aOR=0.94; 95% CI 0.87-1.00).  
Mean current height (when the questionnaire was filled) in wheezing infants was 
75.4 (±3.0) centimetres, while healthy children were 75.7 (±3.1) centimetres tall. No 
statistical differences were observed (p=0.178), although higher height was also in the 
statistical borderline to be considered a protective factor (aOR=0.94; 95% CI 0.89-1.00). 
No significant relations were detected between infant’s race (p=0.547), nor place 
of birth (p=1.000) and wheeze ever. Moreover, no statistical relations were found between 
parental (father and mother) place of birth and wheeze in the offspring in the first year of 
life (p=0.361 and 0.841, respectively). (Table 7) 
Recurrent wheeze 
Of the 105 infants who wheezed repeatedly, 13.0% were boys and 8.7% were girls, 
detecting a significant association between infant gender and recurrent wheeze (p=0.035). 
Marginally significant increased odds for development of recurrent wheeze in male 
infants were found (aOR=1.62; 95% CI 0.98-2.68). 
Mean age of recurrent wheezers was 12.1 (±0.5) months, whilst in healthy infants 
mean age was 12.1 (SD=±0.7) months, not observing statistical differences (p=0.756). 
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Table 7. Associations between demographic factors and wheeze ever.  
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR 
(95% CI) 
Sex  <0.001   
Boys 190 (39.1)  1.83 (1.39-2.41) 1.82 (1.33-2.51) 
Girls 122 (26.0)  1 (reference) 1 (reference) 
Age  0.020   
Wheezers 12.2±0.9  1.27 (1.02-1.57) 1.15 (0.92-1.44) 
Non-wheezers 12.1±0.5  1 (reference) 1 (reference) 
Low weight at birth  0.181   
Low birth 31 (39.2)  1.38 (0.86-2.21) 1.37 (0.77-2.41) 
Normal weight 287 (31.9)  1 (reference) 1 (reference) 
Weight (current)  0.153   
Wheezers 9.6±1.2  1.09 (0.97-1.21) 1.03 (0.90-1.19) 
Non-wheezers 9.5±1.2  1 (reference) 1 (reference) 
Height at birth  0.037   
Wheezers 49.4±2.5  1 (reference) 1 (reference) 
Non-wheezers 49.8±2.8  0.95 (0.90-1.00) 0.94 (0.87-1.00) 
Height (current)  0.178   
Wheezers 75.4±3.0  1 (reference) 1 (reference) 
Non-wheezers 75.7±3.1  0.97 (0.93-1.01) 0.94 (0.89-1.00) 
Born in Spain  1.000   
Yes 316 (32.7)  1.03 (0.09-11.40) 2.62 (0.13-54.35) 
No 1 (33.3)  1 (reference) 1 (reference) 
The 13.9% of infants with low weight at birth, and 10.3% with normal weight, 
developed recurrent wheeze, not showing evidence of statistical differences (p=0.321). 
Also, no statistical differences in current weight were observed (p=0.161). Wheezing 
infants weighed 9.7 (±1.3) kilograms, against 9.5 (±1.2) kilograms in healthy infants. 
When height at birth was studied, statistical differences were found (p=0.020). 
Wheezing infants were 49.0 (±3.3) centimetres tall, in contrast to 49.7 (±2.6) centimetres 
tall in healthy infants. However, higher height at birth was not inversely related to the 
development of recurrent wheeze (aOR=0.94; 95% CI 0.85-1.05). 
Also, healthy infants were taller when current height (when the questionnaire was 
filled) was studied (75.6±3.1, against 75.3±2.9 in wheezing infants), but no statistical 
differences were observed (p=0.392).  
No significant relations were observed between suffering from recurrent wheeze 
and infant’s race (p=0.401), nor place of birth (p=1.000). In addition, neither father’s 
(p=0.482) nor mother’s place of birth (p=0.230) were significantly related to recurrent 
wheeze in the offspring. (Table 8) 
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Table 8. Associations between demographic factors and recurrent wheeze.  
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR 
(95% CI) 
Sex  0.035   
Boys 63 (13.0)  1.56 (1.03-2.36) 1.62 (0.98-2.68) 
Girls 41 (8.7)  1 (reference) 1 (reference) 
Age  0.756   
Wheezers 12.1±0.5  0.96 (0.69-1.34) 0.94 (0.62-1.41) 
Non-wheezers 12.1±0.7  1 (reference) 1 (reference) 
Low weight at birth  0.321   
Low birth 11 (13.9)  1.40 (0.72-2.75) 0.99 (0.40-2.45) 
Normal weight 93 (10.3)  1 (reference) 1 (reference) 
Weight (current)  0.161   
Wheezers 9.7±1.3  1.13 (0.95-1.33) 1.20 (0.97-1.49) 
Non-wheezers 9.5±1.2  1 (reference) 1 (reference) 
Height at birth  0.020   
Wheezers 49.0±3.3  1 (reference) 1 (reference) 
Non-wheezers 49.7±2.6  0.91 (0.84-0.98) 0.94 (0.85-1.05) 
Height (current)  0.392   
Wheezers 75.3±2.9  1 (reference) 1 (reference) 
Non-wheezers 75.6±3.1  0.97 (0.91-1.04) 1.01 (0.93-1.10) 
Born in Spain  1.000   
Yes 102 (10.6)  - - 
No 0 (0.0)  - - 
Severe wheeze 
Among infants who suffered from severe wheeze, 12.8% were boys, and 6.6% 
were girls, observing a significant association between severe wheeze and infant gender 
(p=0.001), and finding male gender as risk factor for severe wheeze (aOR=1.90; 95% CI 
1.16-3.11). 
Mean age in wheezing infants was 12.2 (±0.8) months, while in healthy infants 
was 12.1 (±0.7) months, not showing evidence of statistical differences (p=0.442). 
The 8.9% of infants with low weight at birth, and 9.6% with normal weight, 
wheezed severely in the first year of life, not detecting a statistical relation (p=0.840). 
Conversely, statistical differences in infant’s current weight (when the questionnaire was 
filled) were found (p=0.038). Mean weight in wheezing infants was 9.8 (±1.2) kilograms, 
compared to 9.5 (±1.2) kilograms in healthy infants. When weight rose, a non-significant 
increased risk for severe wheeze was observed (aOR=1.11; 95% CI 0.91-1.35). 
On the other hand, no statistical differences were found when height at birth 
(p=0.172) nor current height (p=0.786) were studied. Infants who wheezed severely were 
smaller at birth than healthy infants (49.3±2.8 against 49.7±2.7), but were taller when the 
questionnaire was filled (75.6±3.1 and 75.5±3.0, respectively). 
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Neither children’s race (p=0.254) nor place of birth (p=1.000) were significantly 
related to the development of severe wheeze in the first year of life. Moreover, no 
significant associations were found between severe wheeze in the offspring and parental 
(father and mother) place of birth (p=0.763 and p=0.521, respectively). (Table 9) 
Table 9. Associations between demographic factors and severe wheeze.  
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR  
(95% CI) 
Sex  0.001   
Boys 62 (12.8)  2.07 (1.32-3.25) 1.90 (1.16-3.11) 
Girls 31 (6.6)  1 (reference) 1 (reference) 
Age  0.442   
Wheezers 12.2±0.8  1.10 (0.85-1.43) 0.95 (0.61-1.48) 
Non-wheezers 12.1±0.7  1 (reference) 1 (reference) 
Low weight at birth  0.840   
Low birth 7 (8.9)  0.92 (0.41-2.06) 0.73 (0.29-1.81) 
Normal weight 86 (9.6)  1 (reference) 1 (reference) 
Weight (current)  0.038   
Wheezers 9.8±1.2  1.21 (1.01-1.44) 1.11 (0.91-1.35) 
Non-wheezers 9.5±1.2  1 (reference) 1 (reference) 
Height at birth  0.172   
Wheezers 49.3±2.8  1 (reference) 1 (reference) 
Non-wheezers 49.7±2.7  0.94 (0.87-1.02) 0.92 (0.83-1.02) 
Height (current)  0.786   
Wheezers 75.6±3.1  1.01 (0.94-1.08) 0.96 (0.88-1.05) 
Non-wheezers 75.5±3.0  1 (reference) 1 (reference) 
Born in Spain  1.000   
Yes 95 (9.8)  - - 
No 0 (0.0)  - - 
4.3 Treatment and respiratory/allergy symptoms 
Wheeze ever 
Most infants (89.1%) who had received treatment with inhaled drugs wheezed, 
against 20.4% who were not treated. Similarly, almost every child (95.3%) treated with 
inhaled corticosteroids wheezed in the first year of life, compared to 26.9% who did not 
receive treatment. In both cases, significant associations were found (p<0.001), and 
significant increased odds for wheeze ever in children who were treated were observed 
(aOR=35.90; 95% CI 18.75-68.76, and aOR=31.25; 95% CI 11.00-88.81, respectively). 
Every child who had asthma diagnosed by a physician also wheezed in the first 
year of life, compared to 32.7% who were not asthmatic, also observing a significant 
association (p<0.001). 
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Most infants (84.2%) who suffered from pneumonia in the first year of life also 
wheezed, in contrast to 30.9% who did not have pneumonia, detecting a significant 
relation (p<0.001). A more than 8-fold significant higher risk for wheeze ever in children 
who had had pneumonia was shown (aOR=8.83; 95% CI 3.53-22.12). In addition, every 
infant hospitalised for pneumonia also wheezed, against 32.6% who were not hospitalised 
for this cause, also finding a statistically significant association (p<0.001). 
The 43.5% of infants who had infant eczema, and 31.2% who did not, wheezed in 
the first year of life. A significant relation was observed (p=0.005), finding infant eczema 
in the statistical borderline to be considered risk factor for wheeze ever (aOR=1.54; 95% 
CI 0.97-2.43). 
Mean number of colds in the first year of life in wheezing infants was 4.6 (±3.9) 
colds, and 2.9 (±3.5) colds in healthy infants, showing statistical differences (p<0.001). 
A significant higher risk for wheeze ever when number of colds rose was observed 
(aOR=1.17; 95% CI 1.10-1.25). 
On the contrary, no statistical differences were detected when age of the first cold 
was studied (p=0.293). Wheezing infants had their first cold at a mean age of 5.0 (±4.7) 
months, and healthy infants at 5.3 (±4.4) months. 
The 40.8% of children who had a cold in the first three months of life wheezed in 
the first year of life, compared to 32.1% who had their first cold at older ages. Although 
a significant association was found (p=0.015), no significant increased risk for wheeze 
ever in infants who had had a cold in early life was observed (aOR=1.01; 95% CI 0.69-
1.47). (Table 10) 
Recurrent wheeze 
The 37.0% of infants treated with inhaled drugs wheezed repeatedly, compared to 
4.9% who were not treated. On the other hand, 43.5% of children who were treated with 
inhaled corticosteroides developed recurrent wheeze, compared to 7.6% who were not 
treated. In both cases, significant associations between treatment and recurrent wheeze 
were found (p<0.001). Moreover, significant increased odds for recurrent wheeze when 
infants received any treatment were observed (aOR=8.44; 95% CI 4.89-14.58, and 
aOR=9.11; 95% CI 4.76-17.42, respectively). 
Most asthmatic infants (70.0%) suffered from recurrent wheeze, compared to 10.2% 
who did not have asthma, detecting a statistical association (p<0.001). Also, an almost 
20-fold significant increased risk for developing recurrent wheeze in asthmatic infants 
was observed (aOR=18.80; 95% CI 3.21-110.11). 
The 39.5% of children who had pneumonia wheezed repeatedly, in contrast to 9.8% 
who did not suffer from pneumonia, showing evidence of a statistical association 
(p<0.001). Furthermore, a significant higher risk for recurrent wheeze in children who 
suffered from pneumonia was found (aOR=5.81; 95% CI 2.49-13.57).  
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Table 10. Associations between treatment and respiratory/allergy symptoms in the 
first year of life and wheeze ever. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR  
(95% CI) 
Inhaled drugs  <0.001   
Yes 171 (89.1)  31.80 (19.48-51.93) 35.90 (18.75-68.76) 
No 138 (20.4)  1 (reference) 1 (reference) 
Inhaled corticosteroids  <0.001   
Yes 81 (95.3)  55.04 (19.91-152.13) 31.25 (11.00-88.81) 
No 202 (26.9)  1 (reference) 1 (reference) 
Asthma  <0.001   
Yes 10 (100)  - - 
No 308 (32.7)  - - 
Pneumonia  <0.001   
Yes 32 (84.2)  11.90 (4.92-28.80) 8.83 (3.53-22.12) 
No 276 (30.9)  1 (reference) 1 (reference) 
Hospital pneumonia  <0.001   
Yes 9 (100)  - - 
No 303 (32.6)  - - 
Eczema  0.005   
Yes 57 (43.5)  1.70 (1.17-2.48) 1.54 (0.97-2.43) 
No 254 (31.2)  1 (reference) 1 (reference) 
Number of colds  <0.001   
Wheezers 4.6±3.9  1.18 (1.12-1.24) 1.17 (1.10-1.25) 
Non-wheezers 2.9±3.5  1 (reference) 1 (reference) 
Age of the first cold  0.293   
Wheezers 5.0±4.7  1 (reference) 1 (reference) 
Non-wheezers 5.3±4.4  0.98 (0.95-1.02) 1.00 (0.97-1.03) 
Colds ≤ 3 months  0.015   
Yes 98 (40.8)  1.46 (1.08-1.99) 1.01 (0.69-1.47) 
No 203 (32.1)  1 (reference) 1 (reference) 
Most infants (77.8%) hospitalised for pneumonia had recurrent wheeze, against 
10.2% who were not hospitalised for this cause, observing a significant relation (p<0.001). 
In addition, being hospitalised for pneumonia was positively related to the development 
of recurrent wheeze (OR=30.73; 95% CI 6.29-150.03). 
The 19.1% of infants who had eczema, and 9.6% who did not, suffered from 
recurrent wheeze, showing statistical differences (p<0.001). More than twice increased 
odds for the onset of recurrent wheeze in infants who had infant eczema was observed 
(aOR=2.30; 95% CI 1.28-4.15). 
Infants who wheezed repeatedly had a mean of 6.0 (±4.8) colds, whilst healthy 
infants reported a mean of 3.2 (±3.4) colds, detecting statistical differences (p<0.001). 
When number of colds rose, a 18% significant increased risk for recurrent wheeze was 
found (aOR=1.18; 95% CI 1.10-1.27). 
Results 
 
47 
 
Mean age of the first cold in infants who wheezed repeatedly was 4.6 (±4.3) 
months, while healthy children had their first cold at older ages, 5.3 (±4.5) months. 
However, no statistical differences were observed (p=0.121). 
The 14.2% of infants who had their first cold in the first three months of life 
developed recurrent wheeze, compared to 10.1% who had their first cold at older ages, 
not finding any significant relation (p=0.090). (Table 11) 
Table 11. Associations between treatment and respiratory/allergy symptoms in the 
first year of life and recurrent wheeze. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR  
(95% CI) 
Inhaled drugs  <0.001   
Yes 71 (37.0)  11.45 (7.26-18.07) 8.44 (4.89-14.58) 
No 33 (4.9)  1 (reference) 1 (reference) 
Inhaled corticosteroids  <0.001   
Yes 37 (43.5)  9.39 (5.65-15.58) 9.11 (4.76-17.42) 
No 57 (7.6)  1 (reference) 1 (reference) 
Asthma  <0.001   
Yes 7 (70.0)  20.59 (5.24-80.93) 18.80 (3.21-110.11) 
No 96 (10.2)  1 (reference) 1 (reference) 
Pneumonia  <0.001   
Yes 15 (39.5)  6.03 (3.04-12.00) 5.81 (2.49-13.57) 
No 87 (9.8)  1 (reference) 1 (reference) 
Hospital pneumonia  <0.001   
Yes 7 (77.8)  30.73 (6.29-150.03) - 
No 95 (10.2)  1 (reference) - 
Eczema  0.001   
Yes 25 (19.1)  2.23 (1.36-3.65) 2.30 (1.28-4.15) 
No 78 (9.6)  1 (reference) 1 (reference) 
Number of colds  <0.001   
Wheezers 6.0±4.8  1.18 (1.11-1.24) 1.18 (1.10-1.27) 
Non-wheezers 3.2±3.4  1 (reference) 1 (reference) 
Age of the first cold  0.121   
Wheezers 4.6±4.3  1 (reference) 1 (reference) 
Non-wheezers 5.3±4.5  0.95 (0.89-1.01) 0.97 (0.91-1.03) 
Colds ≤ 3 months  0.090   
Yes 34 (14.2)  1.47 (0.94-2.29) 1.22 (0.68-2.20) 
No 64 (10.1)  1 (reference) 1 (reference) 
Severe wheeze 
Many infants who were treated with inhaled drugs (39.1%) or corticosteroids 
(50.6%) wheezed severely in the first year of life, in contrast to those who were not treated 
(2.5% and 5.3%, respectively). In both cases, evidence of a significant relation was shown 
(p<0.001). 
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Furthermore, significant increased odds for severe wheeze in infants who had 
received any treatment were observed (aOR=16.65 95% CI 9.15-30.30, and aOR=13.07; 
95% CI 7.13-23.98, respectively). 
Over half of infants (60.0%) who had asthma diagnosed by a physician suffered 
from severe wheeze, compared to 9.4% who were not asthmatics, detecting a significant 
association (p<0.001). A more than 9-fold significant increased risk for severe wheeze in 
asthmatic infants was observed (aOR=9.29; 95% CI 2.13-40.47). 
Almost half of infants (47.4%) who had pneumonia also suffered from severe 
wheeze, compared to 8.1% who did not have pneumonia, finding a significant relation 
(p<0.001). Moreover, pneumonia in the first year of life was positively related to the 
development of severe wheeze (aOR=6.93; 95% CI 3.11-15.44). 
Similarly, most children (88.9%) who were hospitalised for pneumonia also 
wheezed severely, against 9.2% who were not hospitalised for this cause, finding 
statistical differences (p<0.001), and increased odds for severe wheeze in infants who 
required hospitalisation (OR=79.44; 95% CI 9.82-642.73). 
The 16% of infants who had eczema, and 8.8% who did not report this condition, 
had severe wheeze, finding a statistically significant association (p=0.010). Furthermore, 
a positive relation between infant eczema and suffering from severe wheeze was observed 
(aOR=2.02; 95% CI 1.11-3.68). 
In the first year of life, wheezing infants reported a mean of 5.6 (±5.2) colds, 
against 3.3 (±3.4) colds in healthy infants, showing statistical differences (p<0.001). 
When the number of colds rose, a 10% significant increased risk for the onset of severe 
wheeze was observed (aOR=1.10; 95% CI 1.03-1.18). 
Also, statistical differences were found when studying the age of the first cold 
(p=0.003). Wheezing infants had their first cold at a mean age of 4.3 (±2.7) months, 
compared to 5.3 (±4.6) months in healthy infants. Having the first cold at older ages was 
found in the statistical borderline to be considered as protective factor for severe wheeze 
(aOR=0.86; 95% CI 0.74-1.00). 
A 14.2% of infants who had a cold in the first three months of life suffered from 
severe wheeze, against 8.4% who had their first cold at older ages, detecting a statistical 
association (p=0.011). However, after adjustment, having a cold in the first three months 
of life was no longer found as risk factor for severe wheeze (aOR=0.67; 95% CI 0.30-
1.48). (Table 12) 
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Table 12. Associations between treatment and respiratory/allergy symptoms in the 
first year of life and severe wheeze. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR  
(95% CI) 
Inhaled drugs  <0.001   
Yes 75 (39.1)  24.89 (14.19-43.66) 16.65 (9.15-30.30) 
No 17 (2.5)  1 (reference) 1 (reference) 
Inhaled corticosteroids  <0.001   
Yes 43 (50.6)  18.20 (10.70-30.96) 13.07 (7.13-23.98) 
No 40 (5.3)  1 (reference) 1 (reference) 
Asthma  <0.001   
Yes 6 (60.0)  14.39 (3.99-51.97) 9.29 (2.13-40.47) 
No 89 (9.4)  1 (reference) 1 (reference) 
Pneumonia  <0.001   
Yes 18 (47.4)  10.25 (5.19-20.25) 6.93 (3.11-15.44) 
No 72 (8.1)  1 (reference) 1 (reference) 
Hospital pneumonia  <0.001   
Yes 8 (88.9)  79.44 (9.82-642.73) - 
No 85 (9.2)  1 (reference) - 
Eczema  0.010   
Yes 21 (16.0)  1.97 (1.16-3.33) 2.02 (1.11-3.68) 
No 72 (8.8)  1 (reference) 1 (reference) 
Number of colds  <0.001   
Wheezers 5.6±5.2  1.12 (1.07-1.19) 1.10 (1.03-1.18) 
Non-wheezers 3.3±3.4  1 (reference) 1 (reference) 
Age of the first cold  0.003   
Wheezers 4.3±2.7  1 (reference) 1 (reference) 
Non-wheezers 5.3±4.6  0.92 (0.86-0.99) 0.86 (0.74-1.00) 
Colds ≤ 3 months  0.011   
Yes 34 (14.2)  1.81 (1.14-2.86) 0.67 (0.30-1.48) 
No 53 (8.4)  1 (reference) 1 (reference) 
4.4 Family background 
Wheeze ever 
Among smoking mothers, 33.8% had a child who wheezed in the first year of life, 
against 30.9% who did not smoke, finding a statistically significant association (p=0.046), 
although no significant increased risk for wheeze ever in early life was observed 
(aOR=1.30; 95% CI 0.88-1.92). 
Mothers who had wheezing offspring smoked a daily mean of 2.9 (±6.2) cigarettes, 
against 2.1 (±5.9) cigarettes smoked by mothers with healthy children. Statistical 
differences (p=0.046), and marginally significant higher odds for wheeze ever in infants 
when number of cigarettes smoked rose, were found (aOR=1.01; 95% CI 0.99-1.04). 
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On the other hand, among smoking fathers, 34.0% had a child who wheezed, 
compared to 31.8% who were non-smokers. No statistically significant association 
between paternal smoking status and wheeze in the first year of life was shown (p=0.497). 
Fathers of wheezing children reported smoking a daily mean of 3.8 (±6.8) 
cigarettes, against 3.7 (±7.5) cigarettes smoked by fathers of healthy children, also not 
observing statistical differences (p=0.813). 
Among smoking mothers during pregnancy, 40.1% had offspring who wheezed, 
in contrast to 31.2% who were non-smokers, detecting a significant association (p=0.028). 
Furthermore, prenatal exposure to tobacco smoke showed a marginally significant higher 
risk for wheeze ever in the offspring (aOR=1.43; 95% CI 0.95-2.15). 
Wheezing infants lived with a mean of 0.6 (±0.9) smokers, while healthy children 
lived with 0.5 (±0.7) smokers, not finding statistical differences (p=0.144). 
Almost half of asthmatic fathers (47.6%) had offspring who wheezed in the first 
year of life, compared to 31.7% who were not asthmatic, detecting a significant 
association (p=0.031). A non-significant increased risk for wheeze ever was observed in 
those infants with paternal history of asthma (aOR=1.70; 95% CI 0.83-3.48). 
Also, a statistically significant relation was found when maternal history of asthma 
was assessed (p=0.019). Almost half of mothers with asthma (48.1%) had offspring who 
wheezed, compared to 32.3% who were not asthmatic. A marginally significant increased 
risk for wheeze ever in infants with positive history of maternal asthma was found 
(aOR=1.81; 95% CI 0.96-3.43). 
Among allergic fathers, 29.8% had infants who wheezed, against 33.1% who did 
not report allergies. In addition, the 38.6% of allergic mothers had wheezing offspring, 
against 31.5% who were not allergic. In both cases, no significant relations between 
parental history of allergy and wheeze ever in the offspring were found (p=0.471 and 
p=0.104, respectively). 
Over half of fathers (51.4%) who suffered from atopic dermatitis had wheezing 
children, against 32.0% who did not have eczema, finding statistical differences 
(p=0.014). Furthermore, paternal history of dermatitis was positively related to the onset 
of wheeze ever in the offspring (aOR=2.85; 95% CI 1.31-6.20). 
On the contrary, 33.3% of mothers who suffered from atopic dermatitis had a child 
who wheezed, compared to 32.7% who did not report the condition, not detecting a 
statistically significant association (p=0.926). 
Neither having asthmatic siblings (p=0.323), nor allergic (p=0.899), nor siblings 
with atopic dermatitis (p=0.522) was significantly related to the onset of wheeze in the 
first year of life. 
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When socioeconomic variables were studied, no statistically significant 
associations between maternal education (p=0.104), nor parental (father and mother) 
occupations (p=0.882 and p=0.110, respectively) and wheeze ever in the first year of life 
were observed.  
Mean age of mothers who had a child who wheezed was 33.8 (±3.9) years, while 
mothers with healthy children had a mean age of 33.8 (±3.9) years, not detecting statistical 
differences (p=0.912). (Table 13) 
Recurrent wheeze 
Among smoking mothers, 13.4% had children who wheezed repeatedly, 
compared to 10.0% who were non-smokers, not finding a statistically significant 
association (p=0.161). In addition, no statistical differences were observed between daily 
number of cigarettes smoked and recurrent wheeze in the offspring (p=0.240). 
On the other hand, among smoking fathers, 14.4% had offspring who developed 
recurrent wheeze, against 9.5% of non-smoking fathers, finding a significant relation 
(p=0.025). Moreover, having a smoking father significantly increased the risk of recurrent 
wheeze in the offspring (aOR=1.96; 95% CI 1.13-3.38). Conversely, no statistical 
differences were observed in the daily number of cigarettes smoked (p=0.104).  
Among smoking mothers during pregnancy, 15.4% had a child who suffered from 
recurrent wheeze, in contrast to 9.6% who did not smoke, showing statistical differences 
(p=0.028), although a non-significant increased risk for recurrent wheeze in infancy was 
observed (aOR=1.28; 95% CI 0.68-2.40). 
Infants who wheezed repeatedly lived with a mean of 0.6 (±0.8) smokers, whilst 
healthy infants lived with 0.5 (±0.8) smokers, not finding statistical differences (p=0.063). 
The 16.7% of asthmatic fathers had a child who wheezed repeatedly, in contrast 
to 10.4% of non-asthmatic fathers, not finding a statistically significant association 
(p=0.194). Conversely, a significant association was found between positive maternal 
history of asthma and the development of recurrent wheeze in the offspring (p=0.013). 
Among asthmatic mothers, 21.2% had a child who wheezed repeatedly, compared to 10.2% 
of non-asthmatic mothers. However, after adjustment, having an asthmatic mother not 
significantly increased the risk of recurrent wheeze in the offspring (aOR=1.25; 95% CI 
0.50-3.11). 
A 10.5% of allergic fathers had offspring who wheezed repeatedly, compared to 
10.8% of non-allergic fathers, not detecting a significant relation (p=0.929). On the other 
hand, among allergic mothers, 18.2% had wheezing offspring, compared to 9.6% who 
were not allergic, showing evidence of a statistically significant association (p=0.003). 
Non-significant increased odds for recurrent wheeze in those infants with allergic mothers 
were observed. (aOR=1.45; 95% CI 0.76-2.78). 
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Table 13. Associations between family background and wheeze ever. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR 
(95% CI) 
Smoking mother  0.046   
Yes 77 (38.3)  1.39 (1.01-1.92) 1.30 (0.88-1.92) 
No 238 (30.9)  1 (reference) 1 (reference) 
Smoking father  0.497   
Yes 97 (34.0)  1.11 (0.83-1.49) 1.07 (0.75-1.51) 
No 212 (31.8)  1 (reference) 1 (reference) 
Smoking during pregnancy  0.028   
Yes 65 (40.1)  1.48 (1.04-2.09) 1.43 (0.95-2.15) 
No 253 (31.2)  1 (reference) 1 (reference) 
Smokers in the household  0.144   
Wheezers 0.6±0.9  1.14 (0.96-1.36) 1.13 (0.93-1.38) 
Non-wheezers 0.5±0.7  1 (reference) 1 (reference) 
Asthma     
Father  0.031   
Yes 20 (47.6)  1.96 (1.05-3.64) 1.70 (0.83-3.48) 
No 294 (31.7)  1 (reference) 1 (reference) 
Mother  0.019   
Yes 25 (48.1)  1.94 (1.11-3.40) 1.81 (0.96-3.43) 
No 282 (32.3)  1 (reference) 1 (reference) 
Allergic rhinitis     
Father  0.471   
Yes 37 (29.8)  0.86 (0.57-1.30) 0.74 (0.45-1.21) 
No 274 (33.1)  1 (reference) 1 (reference) 
Mother  0.104   
Yes 51 (38.6)  1.37 (0.94-2.00) 1.10 (0.67-1.81) 
No 264 (31.5)  1 (reference) 1 (reference) 
Atopic dermatitis     
Father  0.014   
Yes 19 (51.4)  2.24 (1.16-4.33) 2.85 (1.31-6.20) 
No 294 (32.0)  1 (reference) 1 (reference) 
Mother  0.926   
Yes 19 (33.3)  1.03 (0.58-1.81) 1.15 (0.58-2.26) 
No 295 (32.7)  1 (reference) 1 (reference) 
Maternal education  0.104   
Basic school 12 (41.4)  1 (reference) 1 (reference) 
Incomplete Secondary 23 (42.6)  1.05 (0.42-2.62) 0.52 (0.16-1.64) 
Complete Secondary 113 (28.9)  0.58 (0.27-1.24) 0.31 (0.12-0.85) 
University 169 (33.7)  0.72 (0.34-1.54) 0.40 (0.15-1.05) 
Mother’s age  0.912   
Wheezers 33.8±3.9  1.00 (0.97-1.04) 1.01 (0.97-1.05) 
Non-wheezers 33.8±3.9  1 (reference) 1 (reference) 
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The 16.2% of fathers with atopic dermatitis had wheezing offspring, in contrast to 
10.4% who did not report the condition, not finding a statistically significant relation 
(p=0.255). Also, no significant association was found between maternal history of 
dermatitis and infant recurrent wheeze (p=0.955). The 10.5% of mothers who suffered 
from dermatitis had a child who wheezed repeatedly, compared to 10.7% of mothers who 
did not have eczema. 
Neither having an asthmatic sibling (p=1.000), nor allergic siblings (p=0.440) nor 
siblings with atopic dermatitis (p=0.656) was significantly associated with recurrent 
wheeze in infants in the first year of life. 
In addition, neither maternal education (p=0.305), nor parental (father and mother) 
occupations (p=0.806 and p=0.575, respectively) showed statistically significant 
associations with the development of recurrent wheeze. 
Mean age of mothers whose offspring wheezed repeatedly was 33.8 (±3.4) years, 
whilst in mothers with healthy infants mean age was 33.8 (±4.0) years, not detecting 
statistical differences (p=0.829). (Table 14) 
Severe wheeze 
A 10.0% of smoking mothers had a child who suffered from severe wheeze, 
compared to 9.6% of mothers who did not smoke, not finding any statistically significant 
association (p=0.885). In addition, mothers who had wheezing offspring smoked a daily 
mean of 2.6±5.4 cigarettes, while mothers with healthy children smoked a daily mean of 
2.3±6.1, also not showing statistical differences (p=0.653). 
Among smoking fathers, 9.5% had a child who wheezed, against 9.6% who were 
not smokers, not finding a significant relation between paternal smoking status and severe 
wheeze in the offspring (p=0.953). Moreover, no statistical differences (p=0.722) were 
found between daily mean of cigarettes smoked by fathers whose offspring wheezed or 
was healthy (4.0±7.1 and 3.7±7.3, respectively). 
Among smoking mothers during pregnancy, 13.6% had a child who wheezed 
severely, against 8.8% of mothers who did not smoke, nearly showing evidence of a 
statistically significant association between prenatal exposure to tobacco smoke and the 
onset of severe wheeze in the offspring (p=0.057). Furthermore, a non-significant 
increased risk for severe wheeze was shown (aOR=1.52; 95% 0.84-2.78)  
Infants who wheezed severely lived with a mean of 0.6 (±0.9) smoking persons, 
in contrast to 0.5 (±0.8) smokers living with healthy children, not detecting statistical 
differences (p=0.354). 
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Table 14. Associations between family background and recurrent wheeze. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR 
(95% CI) 
Smoking mother  0.161   
Yes 27 (13.4)  1.40 (0.87-2.23) 0.77 (0.33-1.82) 
No 77 (10.0)  1 (reference) 1 (reference) 
Smoking father  0.025   
Yes 41 (14.4)  1.61 (1.06-2.45) 1.96 (1.13-3.38) 
No 63 (9.5)  1 (reference) 1 (reference) 
Smoking during pregnancy  0.028   
Yes 25 (15.4)  1.71 (1.05-2.78) 1.28 (0.68-2.40) 
No 78 (9.6)  1 (reference) 1 (reference) 
Smokers in the household  0.063   
Wheezers 0.6±0.8  1.26 (0.99-1.60) 0.90 (0.54-1.51) 
Non-wheezers 0.5±0.8  1 (reference) 1 (reference) 
Asthma     
Father  0.194   
Yes 7 (16.7)  1.73 (0.75-4.00) 1.59 (0.54-4.70) 
No 96 (10.4)  1 (reference) 1 (reference) 
Mother  0.013   
Yes 11 (21.2)  2.36 (1.17-4.76) 1.25 (0.50-3.11) 
No 89 (10.2)  1 (reference) 1 (reference) 
Allergic rhinitis     
Father  0.929   
Yes 13 (10.5)  0.97 (0.53-1.80) 1.22 (0.60-2.47) 
No 89 (10.8)  1 (reference) 1 (reference) 
Mother  0.003   
Yes 24 (18.2)  2.11 (1.28-3.47) 1.45 (0.76-2.78) 
No 80 (9.6)  1 (reference) 1 (reference) 
Atopic dermatitis     
Father  0.255   
Yes 6 (16.2)  1.68 (0.68-4.12) 0.62 (0.16-2.48) 
No 95 (10.4)  1 (reference) 1 (reference) 
Mother  0.955   
Yes 6 (10.5)  0.98 (0.41-2.33) 0.68 (0.20-2.31) 
No 97 (10.8)  1 (reference) 1 (reference) 
Maternal education  0.305   
Basic school 5 (17.2)  1 (reference) 1 (reference) 
Incomplete Secondary 7 (13.0)  0.71 (0.21-2.49) 0.66 (0.13-3.31) 
Complete Secondary 34 (8.7)  0.46 (0.16-1.28) 0.52 (0.14-1.98) 
University 58 (11.6)  0.63 (0.23-1.71) 0.67 (0.18-2.52) 
Mother’s age  0.829   
Wheezers 33.8±3.4  1.01 (0.95-1.06) 1.01 (0.94-1.08) 
Non-wheezers 33.8±4.0  1 (reference) 1 (reference) 
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The 9.5% of asthmatic fathers had offspring who wheezed severely, in contrast to 
9.4% of non-asthmatic, not observing any statistically significant association between 
paternal history of asthma and severe wheeze in the offspring (p=1.000).  
In contrast, among asthmatic mothers, 19.2% had wheezing offspring, compared 
to 9.1% of non-asthmatic mothers, finding a significant relation (p=0.016), and a non-
significant higher risk for severe wheeze in infants with a positive maternal history of 
asthma (aOR=1.79; 95% CI 0.71-4.52). 
No statistical differences were found between paternal history of allergy and 
severe wheeze in the offspring (p=0.937). 9.7% of allergic fathers had a child who 
wheezed severely, compared to 9.9% of non-allergic fathers. 
Among allergic mothers, 14.4% had a child who suffered from severe wheeze, 
against 9.0% of non-allergic mothers, finding a marginally significant association 
(p=0.049). However, non-significant increased odds for severe wheeze in infants with 
positive history of maternal allergy were found (aOR=1.37; 95% CI 0.73-2.59). 
The 8.1% of fathers who had eczema also had wheezing offspring, against 9.9% 
who did not suffer from dermatitis. No statistically significant association between 
paternal history of atopic dermatitis and severe wheeze in the offspring was observed 
(p=1.000). 
On the other hand, a significant relation between maternal history of dermatitis 
and severe wheeze in the offspring was detected (p=0.036). Among atopic mothers, 17.5% 
had a child who wheezed severely, compared to 9.1% of mothers who did not suffer from 
eczema. However, a non-significant increased risk for severe wheeze in infants with 
positive history of maternal dermatitis was found (aOR=1.38; 95% CI 0.57-3.32). 
Neither having asthmatic (p=1.000), nor allergic siblings (p=0.105) was 
significantly related to the development of infant severe wheeze. However, infants whose 
siblings had eczema showed a more than 2-fold significantly increased risk for severe 
wheeze in the first year of life (aOR=2.57; 95% CI 1.14-5.80). 
Maternal education was marginally associated with severe wheeze in the offspring 
(p=0.056). 8.8% of mothers with a University degree, and 9.2% with complete Secondary 
education, had a child who wheezed severely, compared to 20.7% who only attended to 
basic school. Higher maternal educational level was (although not reaching statistical 
significance) inversely related to suffer from severe wheeze. 
Conversely, no significant associations were found between parental (father and 
mother) occupation and severe wheeze in the offspring in the first year of life (p=0.932 
and p=0.076, respectively). 
Mean age of mothers whose offspring had severe wheeze was 33.5 (±4.0) years, 
while mothers with healthy children had a mean age of 33.8 (±3.9) years, not showing 
statistical differences (p=0.458). (Table 15) 
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Table 15. Associations between family background and severe wheeze. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR  
(95% CI) 
Smoking mother  0.885   
Yes 20 (10.0)  1.04 (0.62-1.75) 0.75 (0.40-1.41) 
No 74 (9.6)  1 (reference) 1 (reference) 
Smoking father  0.953   
Yes 27 (9.5)  0.99 (0.61-1.58) 0.86 (0.50-1.48) 
No 64 (9.6)  1 (reference) 1 (reference) 
Smoking during pregnancy  0.057   
Yes 22 (13.6)  1.64 (0.98-2.73) 1.52 (0.84-2.78) 
No 71 (8.8)  1 (reference) 1 (reference) 
Smokers in the household  0.354   
Wheezers 0.6±0.9  1.13 (0.87-1.48) 1.04 (0.75-1.42) 
Non-wheezers 0.5±0.8  1 (reference) 1 (reference) 
Asthma     
Father  1.000   
Yes 4 (9.5)  1.02 (0.35-2.91) 1.04 (0.30-3.55) 
No 87 (9.4)  1 (reference) 1 (reference) 
Mother  0.016   
Yes 10 (19.2)  2.39 (1.16-4.95) 1.79 (0.71-4.52) 
No 79 (9.1)  1 (reference) 1 (reference) 
Allergic rhinitis     
Father  0.937   
Yes 12 (9.7)  0.97 (0.52-1.84) 0.89 (0.43-1.83) 
No 82 (9.9)  1 (reference) 1 (reference) 
Mother  0.049   
Yes 19 (14.4)  1.71 (1.00-2.94) 1.37 (0.73-2.59) 
No 75 (9.0)  1 (reference) 1 (reference) 
Atopic dermatitis     
Father  1.000   
Yes 3 (8.1)  0.80 (0.24-2.66) 0.51 (0.11-2.34) 
No 91 (9.9)  1 (reference) 1 (reference) 
Mother  0.036   
Yes 10 (17.5)  2.13 (1.04-4.36) 1.38 (0.57-3.32) 
No 82 (9.1)  1 (reference) 1 (reference) 
Maternal education  0.056   
Basic school 6 (20.7)  1 (reference) 1 (reference) 
Incomplete Secondary 9 (16.7)  0.77 (0.24-2.42) 2.02 (0.36-11.33) 
Complete Secondary 36 (9.2)  0.39 (0.15-1.02) 0.85 (0.18-4.13) 
University 44 (8.8)  0.37 (0.14-0.95) 0.75 (0.16-3.59) 
Mother’s age  0.458   
Wheezers 33.5±4.0  1 (reference) 1 (reference) 
Non-wheezers 33.8±3.9  0.98 (0.93-1.03) 0.97 (0.91-1.04) 
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4.5 Household and environmental factors 
Wheeze ever 
Among infants who attended nursery, 41.8% wheezed, in contrast to 27.8% who 
did not attend, finding a significant association (p<0.001). Moreover, nursery attendance 
in the first year of life was positively related to wheeze ever in infants (aOR=1.39; 95% 
CI 0.99-1.95). 
Infants who wheezed started attending nursery at a mean age of 3.5 (±5.9) months, 
whereas healthy infants began at 2.8 (±6.3) months, not detecting statistical differences 
(p=0.132). 
In 40.1% of households with pets during pregnancy, infants wheezed in the first 
year of life, in contrast to 31.5% without pets. Similarly, when the questionnaire was 
filled, in 40.0% of households with pets, infants also wheezed, against 31.6% with no 
pets. In both cases, significant associations were observed (p=0.035 and p=0.037, 
respectively), although only those infants who currently lived with pets presented a 
marginally significant higher risk for wheeze ever in the first year of life (aOR=1.44; 95% 
CI 0.96-2.15). 
No significant relations were found between fuel used for heating (p=0.474) nor 
for cooking (p=0.402) and wheeze ever. Also, no associations were detected between 
dwellings with an air conditioning unit or carpeted and wheeze ever (p=0.835 and 
p=0.768, respectively). 
The 43.9% of families who reported presence of mould or damp stains in the walls 
had a child who wheezed, in contrast to 32.0% who did not report this issue in their 
dwellings, not finding a statistically significant association (p=0.110). 
A 31.4% of families who considered living in a polluted area had wheezing 
offspring, against 32.7% who did not report this environmental issue, not finding a 
significant relation between air pollution and the onset of wheeze in infants (p=0.697). 
Also, no significant association was observed when immunisation status was 
studied (p=0.567). Only three children (21.4%) who had a complete immunisation 
schedule wheezed, against 32.7% who did not complete the immunisation schedule. 
The mean number of siblings of infants who wheezed was 0.7±0.7, whilst healthy 
children had a mean of 0.6 (±0.8) siblings, detecting statistical differences (p=0.048). 
When number of siblings rose, a 21% significant increased risk for wheeze ever was 
found (aOR=1.21; 95% CI 0.99-1.49). 
Infants who wheezed lived with a mean of 3.5 (±1.0) persons, and healthy children 
lived with 3.3 (±1.1) persons, also showing statistical differences (p=0.035). When 
number of people in the same household rose, a non-significant higher risk for wheeze 
ever was observed (aOR=1.10; 95% CI 0.90-1.34). 
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The 34.9% of infants who consumed industrial infant food every day wheezed, 
compared to 31.3% who were fed with them once a week, and 30.2% who were not fed 
with industrial infant food in the first year of life, not detecting any significant relation 
(p=0.623). 
Infants who wheezed were exclusively breastfed during a mean of 3.8 (±3.0) 
months, while healthy infants were breastfed for a longer period, 4.5 (±3.1) months, 
finding statistical differences (p=0.002). In addition, an exclusively longer breastfeeding 
was found as protective factor for wheeze ever (aOR=0.94; 95% CI 0.89-0.99). 
No significant relation was detected between the food used for frying and the onset 
of wheezing in the first year of life (p=0.839). Table 16 summarizes the main associations 
between household and environmental factors and wheeze ever. 
Recurrent wheeze 
The 16.7% of infants who attended nursery in the first year of life developed 
recurrent wheeze, in contrast to 7.4% of children who did not attend, detecting a 
significant association (p<0.001). An almost 2-fold significant increased risk for recurrent 
wheeze in infants who attended nursery school was found (aOR=1.89; 95% CI 1.15-3.12). 
Furthermore, statistical differences were also found in the age at which children 
began attending nursery school (p=0.039). Healthy infants attended at earlier ages than 
those who wheezed (2.9±6.1 and 4.2±6.6, respectively). However, after adjustment, no 
significant increased odds for recurrent wheeze were found (aOR=1.01; 95% CI 0.97-
1.05). 
In 14.7% of households where presence of pets during pregnancy was reported, 
infants wheezed repeatedly, against 10% of households with no pets, not detecting a 
significant association (p=0.082). Likewise, when the questionnaire was filled, in 14.6% 
of households with pets, children suffered from recurrent wheeze, compared to 10.0% of 
infants who lived in households with no pets, also not finding a significant relation 
(p=0.086). 
Also, no statistically significant associations were found between fuel used for 
heating (p=0.933), nor for cooking (p=0.813), and the development of recurrent wheeze 
in the first year of life.  
Only seven children (12.1%) who suffered from recurrent wheeze lived in 
dwellings with an air conditioning unit, and just one infant (5.9%) in a carpeted house, 
not detecting any significant association in either cases (p=0.664 and p=1.000, 
respectively). 
Among families who had mould or damp stains at home, 9.8% had an infant who 
wheezed repeatedly, compared to 10.7% of families who did not report this issue in the 
dwelling, not finding a statistically significant relation between dampness and infant 
recurrent wheezing (p=1.000).  
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Table 16. Associations between household and environmental factors and wheeze 
ever. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
 Adjusted OR 
(95% CI) 
Nursery attendance  <0.001   
Yes 138 (41.8)  1.87 (1.42-2.47) 1.39 (0.99-1.95) 
No 179 (27.8)  1 (reference) 1 (reference) 
Age nursery attendance  0.132   
Wheezers 3.5±5.9  1.02 (0.99-1.04) 1.01 (0.98-1.04) 
Non-wheezers 2.8±6.3  1 (reference) 1 (reference) 
Presence of pets (birth)  0.035   
Yes 63 (40.1)  1.46 (1.03-2.07) 1.37 (0.91-2.06) 
No 256 (31.5)  1 (reference) 1 (reference) 
     
None   1 (reference) 1 (reference) 
Dog   1.29 (0.72-2.32) 1.29 (0.66-2.54) 
Cat   1.33 (0.62-2.86) 0.96 (0.38-2.47) 
Others   1.83 (1.00-3.33) 1.94 (0.96-3.93) 
More than one   1.37 (0.66-2.87) 1.23 (0.55-2.76) 
Presence of pets (current)  0.037   
Yes 66 (40.0)  1.44 (1.02-2.04) 1.44 (0.96-2.15) 
No 253 (31.6)  1 (reference) 1 (reference) 
     
None   1 (reference) 1 (reference) 
Dogs   1.44 (0.78-2.67) 1.58 (0.78-3.20) 
Cats   0.75 (0.33-1.70) 0.50 (0.17-1.44) 
Others   1.89 (1.12-3.21) 1.86 (1.00-3.45) 
More than one   1.53 (0.72-3.24) 1.80 (0.79-4.11) 
Mould or damp stains  0.110   
Yes 18 (43.9)  1.67 (0.89-3.13) 1.55 (0.74-3.23) 
No 296 (32.0)  1 (reference) 1 (reference) 
Air pollution  0.697   
Yes 79 (31.4)  0.94 (0.69-1.28) 0.82 (0.57-1.18) 
No 235 (32.7)  1 (reference) 1 (reference) 
Number of siblings  0.048   
Wheezers 0.7±0.7  1.17 (0.99-1.38) 1.21 (0.99-1.49) 
Non-wheezers 0.6±0.8  1 (reference) 1 (reference) 
Number of people at home  0.035   
Wheezers 3.5±1.0  1.14 (1.01-1.29) 1.10 (0.90-1.34) 
Non-wheezers 3.3±1.1  1 (reference) 1 (reference) 
Exclusive breastfeeding  0.002   
Wheezers 3.8±3.0  1 (reference) 1 (reference) 
Non-wheezers 4.5±3.1  0.93 (0.89-0.97) 0.94 (0.89-0.99) 
<6 months   1 (reference) 1 (reference) 
≥6 months   0.84 (0.63-1.12) 0.97 (0.69-1.36) 
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A 10.7% of families who considered living in an air polluted area had wheezing 
offspring, compared to 10.3% of families who did not report this issue, not finding any 
significant association (p=0.850). 
Also, no statistical relation was shown between a complete immunization 
schedule and the onset of recurrent wheeze in the infant (p=0.384). Every child who 
wheezed repeatedly in the first year of life had been adequately vaccinated. 
Infants who suffered from recurrent wheeze had a mean of 0.7 (±0.8) siblings, 
while healthy infants had 0.6 (±0.8) siblings, not showing statistical differences (p=0.340). 
Also, no statistical differences were found between the number of people who lived with 
the wheezing or healthy infants (3.5±1.0, and 3.4±1.1, respectively) and the development 
of recurrent wheeze in the first year of life (p=0.268). 
The 13.1% of infants who wheezed repeatedly usually consumed industrial infant 
food, compared to 8.8% who consumed them once a week, and 10.9% who never were 
fed with industrial infant food, not finding a significant association (p=0.188). 
Infants who suffered from recurrent wheeze exclusively breastfed for a mean of 
3.9 (±3.1) months, in contrast to healthy children, who breastfed for a longer period, 4.3 
(±3.1) months, although no statistical differences were observed (p=0.185). 
Also, the food used for frying was not significantly related to the development of 
recurrent wheeze in infants in the first year of life (p=0.668). (Table 17) 
Severe wheeze 
Among infants who attended nursery in the first year of life, 10.3% suffered from 
severe wheeze, against 9.3% of infants who did not attend, not detecting any significant 
relation (p=0.616). 
Furthermore, no statistical differences were observed between age of attendance 
to nursery school and infant severe wheeze (p=0.219). Wheezing infants began at a mean 
age of 2.6 (±3.6) months, while healthy children attended to nursery for the first time at 
older ages, 3.1 (±6.4) months. 
Among families who reported presence of pets during pregnancy, 16.6% had a 
child who wheezed severely, compared to 8.5% who did have any pets, finding a 
statistically significant association (p=0.002). A 75% significant increased risk for severe 
wheeze in those infants whose families had contact with pets throughout pregnancy was 
observed (aOR=1.75; 95% CI 0.99-3.08).  
Also, when the questionnaire was filled, a significant association was observed 
between the onset of severe wheeze and presence of pets (p=0.002). In 16.4% of 
households with pets, infants wheezed severely, in contrast to 8.5% who did not have any 
pets. Thus, presence of pets at home significantly increased the odds for suffering from 
severe wheeze (aOR=1.75; 95% CI 1.01-3.06). 
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Table 17. Associations between household and environmental factors and recurrent 
wheeze. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR 
(95% CI) 
Nursery attendance  <0.001   
Yes 55 (16.7)  2.49 (1.65-3.76) 1.89 (1.15-3.12) 
No 48 (7.4)  1 (reference) 1 (reference) 
Age nursery attendance  0.039   
Wheezers 4.2±6.6  1.02 (1.00-1.05) 1.01 (0.97-1.05) 
Non-wheezers 2.9±6.1  1 (reference) 1 (reference) 
Presence of pets (birth)  0.082   
Yes 23 (14.7)  1.55 (0.94-2.55) 1.59 (0.86-2.93) 
No 81 (10.0)  1 (reference) 1 (reference) 
     
None   1 (reference) 1 (reference) 
Dog   1.68 (0.76-3.70) 1.31 (0.50-3.41) 
Cat   1.04 (0.31-3.52) 0.69 (0.13-3.63) 
Others   1.62 (0.70-3.74) 1.77 (0.59-5.29) 
More than one   1.74 (0.65-4.65) 3.44 (1.12-10.57) 
Presence of pets (current)  0.086   
Yes 24 (14.6)  1.53 (0.94-2.50) 1.57 (0.86-2.86) 
No 80 (10.0)  1 (reference) 1 (reference) 
     
None   1 (reference) 1 (reference) 
Dogs   1.66 (0.72-3.83) 1.43 (0.51-4.05) 
Cats   0.96 (0.29-3.24) 1.15 (0.31-4.30) 
Others   1.59 (0.75-3.35) 1.28 (0.46-3.51) 
More than one   1.88 (0.70-5.05) 3.27 (1.07-9.99) 
Mould or damp stains  1.000   
Yes 4 (9.8)  0.90 (0.32-2.59) 0.49 (0.12-2.03) 
No 99 (10.7)  1 (reference) 1 (reference) 
Air pollution  0.850   
Yes 27 (10.7)  1.05 (0.66-1.67) 1.24 (0.72-2.14) 
No 74 (10.3)  1 (reference) 1 (reference) 
Number of siblings  0.340   
Wheezers 0.7±0.8  1.12 (0.89-1.41) 1.10 (0.81-1.50) 
Non-wheezers 0.6±0.8  1 (reference) 1 (reference) 
Number of people at home  0.268   
Wheezers 3.5±1.0  1.11 (0.93-1.32) 1.06 (0.82-1.37) 
Non-wheezers 3.4±1.1  1 (reference) 1 (reference) 
Exclusive breastfeeding  0.185   
Wheezers 3.9±3.1  1 (reference) 1 (reference) 
Non-wheezers 4.3±3.1  0.96 (0.89-1.02) 0.98 (0.90-1.07) 
<6 months   1 (reference) 1 (reference) 
≥6 months   0.74 (0.47-1.16) 0.73 (0.41-1.28) 
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Neither fuel used for heating nor for cooking were significantly related to severe 
wheeze in the first year of life (p=0.162 and p=0.731, respectively). In addition, neither 
having an air conditioning unit nor living in a carpeted house were significantly associated 
with infant severe wheeze (p=1.000 and p=0.396, respectively). 
Only five families (12.2%) who reported having mould or damp stains at home 
had wheezing offspring, in contrast to 9.6% of families who did not report dampness in 
the dwelling, not finding any significant association (p=0.587). 
Among families who reported living in an air polluted area, 9.9% had offspring 
who wheezed severely, compared to 9.0% who did not consider living in a polluted area, 
not detecting statistical differences (p=0.678). 
Every child who wheezed severely in the first year of life had complete 
immunization schedule, not finding any statistically significant association between the 
immunisation status and the condition (p=0.219). 
Wheezing infants had a mean of 0.8 (±0.7) siblings, whilst healthy children had 
0.6 (±0.8) siblings, showing statistical differences (p=0.018). When number of siblings 
rose, a non-significant increased risk for severe wheeze was observed (aOR=1.15; 95% 
CI 0.86-1.53).  
In contrast, no statistical differences were detected between the number of people 
in the household and infant severe wheeze (p=0.180). Wheezing infants lived with a mean 
of 3.5 (±1.0) persons, while healthy children lived with 3.4 (±1.1) persons. 
The 12.6% of infants who consumed industrial infant food every day had severe 
wheezing, against only two children (2.0%) who were fed with them once a month, and 
8.5% who never consumed industrial infant food in the first year of life, detecting 
statistical differences (p=0.004). Furthermore, a significant lower risk for severe wheeze 
in those infants who once a month were fed with industrial food was found (aOR=0.20; 
95% CI 0.04-0.94). 
Wheezing infants exclusively breastfed for a mean of 3.3 (±2.8) months, whereas 
healthy children breastfed for a longer period, 4.3 (±3.1) months, detecting statistical 
differences (p=0.001). In addition, a longer exclusively breastfeeding was inversely 
related to the onset of severe wheeze (aOR=0.90; 95% CI 0.82-0.98). 
No statistically significant relation was found between food used for frying and 
suffering from severe wheeze in the first year of life (p=0.468). In Table 18, the 
associations between household and environmental factors and severe wheeze are 
summarized.  
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Table 18. Associations between household and environmental factors and severe 
wheeze. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR 
(95% CI) 
Nursery attendance  0.616   
Yes 34 (10.3)  1.12 (0.72-1.74) 0.86 (0.51-1.44) 
No 60 (9.3)  1 (reference) 1 (reference) 
Age nursery attendance  0.219   
Wheezers 2.6±3.6  1 (reference) 1 (reference) 
Non-wheezers 3.1±6.4  0.98 (0.94-1.03) 0.97 (0.92-1.03) 
Presence of pets (birth)  0.002   
Yes 26 (16.6)  2.14 (1.31-3.49) 1.75 (0.99-3.08) 
No 69 (8.5)  1 (reference) 1 (reference) 
     
None   1 (reference) 1 (reference) 
Dog   2.31 (1.08-4.95) 2.02 (0.87-4.72) 
Cat   0.80 (0.19-3.43) 0.46 (0.06-3.55) 
Other   3.00 (1.43-6.30) 2.11 (0.81-5.52) 
More than one   2.07 (0.77-5.57) 2.06 (0.72-5.91) 
Presence of pets (current)  0.002   
Yes 27 (16.4)  2.11 (1.30-3.41) 1.75 (1.01-3.06) 
No 68 (8.5)  1 (reference) 1 (reference) 
     
None   1 (reference) 1 (reference) 
Dog   1.98 (0.85-4.61) 1.37 (0.54-3.51) 
Cat   1.15 (0.34-3.89) 1.52 (0.43-5.39) 
Other   2.69 (1.36-5.31) 1.82 (0.75-4.40) 
More than one   2.24 (0.83-6.07) 2.80 (0.96-8.18) 
Mould or damp stains  0.587   
Yes 5 (12.2)  1.31 (0.50-3.41) 1.17 (0.42-3.23) 
No 89 (9.6)  1 (reference) 1 (reference) 
Air pollution  0.678   
Yes 25 (9.9)  1.11 (0.68-1.80) 1.28 (0.75-2.18) 
No 65 (9.0)  1 (reference) 1 (reference) 
Number of siblings  0.018   
Wheezers 0.8±0.7  1.30 (1.04-1.62) 1.15 (0.86-1.53) 
Non-wheezers 0.6±0.8  1 (reference) 1 (reference) 
Number of people at home  0.180   
Wheezers 3.5±1.0  1.13 (0.94-1.36) 1.05 (0.83-1.32) 
Non-wheezers 3.4±1.1  1 (reference) 1 (reference) 
Exclusive breastfeeding  0.001   
Wheezers 3.3±2.8  1 (reference) 1 (reference) 
Non-wheezers 4.3±3.1  0.89 (0.82-0.95) 0.90 (0.82-0.98) 
<6 months   1 (reference) 1 (reference) 
≥6 months   0.64 (0.39-1.04) 0.67 (0.39-1.15) 
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4.6 Exposures during pregnancy and birth 
Wheeze ever 
When maternal diet during pregnancy and its relation with wheeze ever was 
studied, only fresh fruit and cooked potatoes showed significant associations (p=0.039 
and p=0.035, respectively). 
However, neither usual (aOR=0.45; 95% CI 0.17-1.16) nor occasional 
consumption (aOR=0.45; 95% CI 0.16-1.24) of fresh fruit and natural juices during 
pregnancy were found inversely related to wheeze ever in the offspring. 
Conversely, only those mothers who occasionally consumed cooked potatoes 
during pregnancy presented marginally higher odds for wheeze ever in the offspring 
(aOR=1.57; 95% 1.05-2.36). 
No statistical differences were found between adherence to the Mediterranean diet 
during pregnancy and wheeze ever in the offspring (p=0.830). Mothers who had a child 
who wheezed scored a mean of 28.2 (±3.2) points, whereas in mothers with healthy 
infants the mean score was 28.2 (±3.0) points. 
A 33.6% of mothers who never took oral contraceptives had a child who wheezed, 
compared to 31.2% and 30.8% who took them between one to three years, and four to six 
years, respectively, not finding any statistically significant association (p=0.395). 
Among mothers who occasionally took paracetamol during pregnancy, 42.3% had 
wheezing offspring, in contrast to 31.1% who never or less than once a month took it, 
showing evidence of a statistically significant association (p=0.033). A 60% significant 
increased risk for wheeze ever in the offspring whose mothers reported an occasional 
consumption of paracetamol was observed (aOR=1.60; 95% CI 1.04-2.47). 
When complications during pregnancy and birth were studied, gestational 
diabetes, malposition of the foetus and prematurity showed the highest, although non-
significant, risks for wheeze ever in the offspring. (Table 19) 
Recurrent wheeze 
No significant associations were found between frequency of consumption of 
different food groups during pregnancy and development of recurrent wheeze in the 
offspring in the first year of life.  
Furthermore, no statistical differences (p=0.598) were found between adherence 
to the Mediterranean dietary pattern during pregnancy and recurrent wheeze in the 
offspring. Mothers whose offspring wheezed repeatedly scored a mean of 28.0 (±3.2) 
points, whereas mothers with healthy children scored 28.2 (±3.1) points. 
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Table 19. Associations between exposures during pregnancy and birth and wheeze 
ever. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR  
(95% CI) 
Mediterranean diet  0.897   
Wheezers 32.4±3.4  1.00 (0.96-1.05) 1.02 (0.97-1.08) 
Non-wheezers 32.3±3.3  1 (reference) 1 (reference) 
Oral contraceptives  0.395   
Never 181 (33.6)  1 (reference) 1 (reference) 
Less than a year 23 (39.0)  1.26 (0.72-2.19) 1.39 (0.70-2.75) 
One to three years 48 (31.2)  0.89 (0.61-1.31) 0.85 (0.54-1.34) 
Four to six years 28 (30.8)  0.88 (0.54-1.42) 0.80 (0.45-1.44) 
More than six years 34 (26.2)  0.70 (0.45-1.07) 0.66 (0.40-1.09) 
Paracetamol  0.033   
Never/less than once a month 250 (31.1)  1 (reference) 1 (reference) 
1-4 times a month 58 (42.3)  1.63 (1.13-2.36) 1.60 (1.04-2.47) 
More than once a week 11 (34.4)  1.16 (0.55-2.45) 1.14 (0.46-2.81) 
Complications     
None - - 1 (reference) 1 (reference) 
Hypertension 28 (36.4) 0.427 1.22 (0.75-1.98) 1.22 (0.69-2.15) 
Threatened miscarriage 38 (36.9) 0.304 1.25 (0.82-1.92) 1.31 (0.79-2.18) 
Infections 40 (32.8) 0.875 1.03 (0.69-1.55) 0.88 (0.55-1.42) 
Gestational diabetes 28 (42.4) 0.069 1.60 (0.96-2.66) 1.69 (0.90-3.14) 
Malposition of the foetus 13 (41.9) 0.247 1.53 (0.74-3.18) 1.83 (0.79-4.28) 
Premature rupture of membranes 19 (30.2) 0.745 0.91 (0.52-1.59) 1.19 (0.62-2.29) 
Placenta problems 19 (38.0) 0.359 1.32 (0.73-2.37) 1.10 (0.54-2.22) 
Hypoxia 18 (36.0) 0.551 1.20 (0.66-2.18) 1.03 (0.50-2.11) 
Prematurity 32 (41.0) 0.091 1.50 (0.94-2.42) 1.47 (0.82-2.63) 
Knots in umbilical cord 35 (33.7) 0.733 1.08 (0.70-1.66) 1.13 (0.69-1.85) 
Obstetric trauma 1 (25.0) 1,000 0.70 (0.07-6.72) - 
Forceps/suction cup 53 (27.8) 0.100 0.74 (0.52-1.06) 0.81 (0.54-1.22) 
Caesarean section 47 (29.8) 0.469 0.87 (0.60-1.27) 0.78 (0.50-1.23) 
The 11.0% of mothers who never took oral contraceptives had a child with 
recurrent wheezing, in contrast to 9.1% of mothers who took them between one to three 
years, and 12.3% who took oral contraceptives for more than six years, not finding any 
significant relation between oral contraceptives use and recurrent wheeze in the offspring 
(p=0.873). 
Also, no statistically significant association was found between paracetamol 
consumption during pregnancy and infant recurrent wheeze (p=0.110). The 16.1% of 
mothers who occasionally took paracetamol throughout pregnancy had wheezing 
offspring, in contrast to 9.9% who never or less than once a month took it.  
When complications during pregnancy and birth were studied, only hypertension 
disorders during pregnancy and prematurity at birth were positively related to recurrent 
wheeze in the offspring. 
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Among mothers who reported hypertension during pregnancy, 16.7% had a child 
who wheezed repeatedly in the first year of life, compared to 10.3% who did not suffer 
from hypertension disorders, finding a more than 2-fold significant higher risk for 
recurrent wheeze in their children (aOR=2.18; 95% CI 1.04-4.55). 
On the other hand, 21.8% of premature infants wheezed repeatedly, compared to 
9.7% of infants born full term, finding an almost 3-fold significant increased risk for 
recurrent wheeze in premature infants (aOR=2.69; 95% CI 1.34-5.40). (Table 20) 
Table 20. Associations between exposures during pregnancy and birth and recurrent 
wheeze. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR 
(95% CI) 
Mediterranean diet  0.285   
Wheezers 31.9±3.5  1 (reference) 1 (reference) 
Non-wheezers 32.4±3.4  0.96 (0.89-1.03) 0.99 (0.91-1.09) 
Oral contraceptives  0.873   
Never 59 (11.0)  1 (reference) 1 (reference) 
Less than a year 5 (8.5)  0.75 (0.29-1.95) 0.55 (0.15-1.96) 
One to three years 14 (9.1)  0.81 (0.44-1.50) 0.92 (0.46-1.84) 
Four to six years 8 (8.8)  0.78 (0.36-1.70) 0.94 (0.37-2.36) 
More than six years 16 (12.3)  1.14 (0.63-2.05) 1.29 (0.63-2.62) 
Paracetamol  0.110   
Never/less than once a month 80 (9.9)  1 (reference) 1 (reference) 
1-4 times a month 22 (16.1)  1.73 (1.04-2.89) 1.56 (0.84-2.90) 
More than once a week 3 (9.4)  0.94 (0.28-3.15) 0.49 (0.08-2.92) 
Complications     
None - - 1 (reference) 1 (reference) 
Hypertension 13 (16.9) 0.075 1.77 (0.94-3.36) 2.18 (1.04-4.55) 
Threatened miscarriage 7 (6.8) 0.195 0.59 (0.27-1.32) 0.49 (0.19-1.22) 
Infections 16 (13.1) 0.375 1.30 (0.73-2.30) 1.21 (0.61-2.39) 
Gestational diabetes 10 (15.2) 0.239 1.53 (0.75-3.10) 0.81 (0.31-2.15) 
Malposition of the foetus 6 (19.4) 0.134 1.99 (0.80-4.99) 2.24 (0.71-7.02) 
Premature rupture of membranes 9 (14.3) 0.401 1.37 (0.65-2.87) 0.66 (0.24-1.85) 
Placenta problems 7 (14.0) 0.450 1.37 (0.60-3.15) 1.26 (0.46-3.40) 
Hypoxia 5 (10.0) 1.000 0.93 (0.36-2.40) 0.56 (0.16-1.91) 
Prematurity 17 (21.8) 0.001 2.59 (1.44-4.65) 2.69 (1.34-5.40) 
Knots in umbilical cord 7 (6.7) 0.178 0.58 (0.26-1.29) 0.63 (0.26-1.55) 
Obstetric trauma 0 (0.0) 1,000 - - 
Forceps/suction cup 18 (9.4) 0.493 0.83 (0.48-1.42) 0.77 (0.41-1.44) 
Caesarean section 18 (11.4) 0.767 1.09 (0.63-1.87) 0.63 (0.30-1.33) 
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Severe wheeze 
Statistical differences were found in several food groups when their consumption 
during pregnancy was studied. 
The 20.0% of mothers who usually consumed snacks during pregnancy had a child 
who wheezed severely, compared to 12.3% who reported an occasional consumption, and 
7.8% of mothers who never consumed them throughout pregnancy (p=0.005). Non-
significant increased risks for severe wheeze in the offspring in those mothers who 
occasionally or frequently consumed snacks were observed (aOR=1.40; 95% CI 0.80-
2.44, and aOR=2.17; 95% CI 0.86-5.49, respectively). 
Moreover, although eggs consumption did not show statistical differences 
(p=0.081), both occasional and usual eggs consumption during pregnancy were found 
inversely related to infant severe wheeze (aOR=0.16; 95% CI 0.03-0.73, and aOR=0.11; 
95% CI 0.02-0.52, respectively). 
Adherence to the Mediterranean diet during pregnancy did not show statistical 
differences (p=0.208). Mothers who had children who wheezed severely scored a mean 
of 27.8 (±3.5) points, whereas those with healthy children scored 28.3 (±3.0) points. 
The 8.9% of mothers who never took oral contraceptives had a child who wheezed 
severely, compared to 9.7% of mothers who took them between one to three years, and 
7.7% who took them more than 6 years, not showing evidence of any statistically 
significant relation between oral contraceptives use and infant severe wheeze (p=0.555). 
On the contrary, a significant association was detected between paracetamol 
consumption during pregnancy and severe wheeze in the offspring (p=0.011). The 8.5% 
of mothers who never (or less than once a month) took paracetamol had a child who 
wheezed severely, against 16.8% who occasionally took it, and three mothers (9.4%) who 
took paracetamol more than once a week. Marginally significant increased odds for severe 
wheeze in those infants whose mothers occasionally had paracetamol during pregnancy 
were observed (aOR=1.78; 95% CI 0.99-3.22). 
When complications during pregnancy and birth were studied, no statistically 
significant associations were detected between any of the complications during pregnancy 
and birth and the onset of severe wheeze in the first year of life. Gestational diabetes, 
malposition of the foetus and prematurity showed the highest (although non-significant) 
odds for the onset of severe wheeze in the offspring. 
In Table 21, the associations between exposures during pregnancy and birth and 
severe wheeze in the infant are shown. 
  
Results 
 
68 
 
Table 21. Associations between exposures during pregnancy and birth and severe 
wheeze. 
 N (%) 
±SD 
p value Crude OR  
(95% CI) 
Adjusted OR  
(95% CI) 
Mediterranean diet  0.027   
Wheezers 31.4±4.0  1 (reference) 1 (reference) 
Non-wheezers 32.4±3.3  0.92 (0.86-0.99) 0.99 (0.91-1.08) 
Oral contraceptives  0.555   
Never 48 (8.9)  1 (reference) 1 (reference) 
Less than a year 9 (15.3)  1.84 (0.85-3.97) 2.06 (0.90-4.71) 
One to three years 15 (9.7)  1.10 (0.60-2.03) 0.97 (0.49-1.92) 
Four to six years 9 (9.9)  1.12 (0.53-2.37) 1.40 (0.60-3.28) 
More than six years 10 (7.7)  0.85 (0.42-1.73) 0.69 (0.30-1.62) 
Paracetamol  0.011   
Never/less than once a month 68 (8.5)  1 (reference) 1 (reference) 
One to four times a month 23 (16.8)  2.19 (1.31-3.65) 1.78 (0.99-3.22) 
More than once a week 3 (9.4)  1.12 (0.33-3.78) 0.92 (0.22-3.76) 
Complications     
None - - 1 (reference) 1 (reference) 
Hypertension 8 (10.4) 0.807 1.10 (0.51-2.37) 1.04 (0.44-2.44) 
Threatened miscarriage 10 (9.7) 0.960 1.02 (0.51-2.04) 1.16 (0.55-2.42) 
Infections 13 (10.7) 0.693 1.13 (0.61-2.12) 1.04 (0.52-2.07) 
Gestational diabetes 10 (15.2) 0.119 1.75 (0.86-3.57) 1.78 (0.78-4.10) 
Malposition of the foetus 4 (12.9) 0.525 1.44 (0.49-4.23) 1.53 (0.46-5.06) 
Premature rupture of membranes 6 (9.5) 0.991 1.00 (0.42-2.41) 0.98 (0.36-2.63) 
Placenta problems 3 (6.0) 0.617 0.59 (0.18-1.94) 0.59 (0.16-2.09) 
Hypoxia 2 (4.0) 0.218 0.37 (0.09-1.56) 0.38 (0.08-1.71) 
Prematurity 11 (14.1) 0.163 1.62 (0.82-3.20) 1.52 (0.70-3.28) 
Knots in umbilical cord 8 (7.7) 0.526 0.78 (0.37-1.67) 0.83 (0.37-1.87) 
Obstetric trauma 0 (0.0) 1.000 - - 
Forceps/suction cup 12 (6.3) 0.083 0.57 (0.31-1.08) 0.60 (0.29-1.24) 
Caesarean section 11 (7.0) 0.267 0.69 (0.36-1.33) 0.70 (0.34-1.46) 
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The present study aimed to study the epidemiology of wheezing in infants in the 
region of Pamplona, a Spanish Northern city. Almost one third of infants in the sample 
wheezed in the first year of life, and nearly 10% wheezed repeatedly or suffered from 
severe wheeze. Male gender, pneumonia in the first year of life, infant eczema, higher 
number of colds, prenatal and postnatal exposure to tobacco smoke, presence of pets in 
the household, or nursery attendance, have been found as main risk factors for these 
wheeze phenotypes. 
Prevalence 
Prevalences of wheeze ever and recurrent wheeze in infants in the first year of life 
in the region of Pamplona were 32.5% and 10.6%, respectively. These figures are similar 
to others found in EISL Spanish centres. In Salamanca, the prevalence of wheeze ever 
was 32.3%, and 11.9% for recurrent wheeze (Pellegrini-Belinchon et al., 2012). In 
Cantabria, also a Northern region, 32.7% of infants wheezed in the first year of life, and 
14.3% developed recurrent wheeze (Bercedo-Sanz et al., 2015). 
In Northern coastal cities, as La Coruña or Bilbao, prevalences of wheeze ever 
were higher, 34.8% and 38.9%, respectively, while in Southern cities, the prevalence 
ranged from 28.7% in Valencia to 39.1% in Cartagena (Mallol et al., 2010b). These results, 
except for Valencia, are in line with a study that found outdoor relative humidity as risk 
factor in coastal cities (Garcia-Marcos et al., 2009). 
Prevalence of severe wheeze in the region of Pamplona was 9.6%, lower than in 
Cartagena (16.2%), but similar to other centres, e.g., Cantabria (9.8%), Bilbao (10.3%) 
or La Coruña (11.3%) (Mallol et al., 2010b; Bercedo-Sanz et al., 2015). 
The other European EISL centre, in Netherlands, found prevalences of wheeze 
ever and recurrent wheeze of 28.5% and 14.5%, respectively, also comparable with ours. 
However, prevalence of severe wheeze (15.4%) was higher than what was found in the 
region of Pamplona (Visser et al., 2010). 
In Latin America, past studies found that 47.3% of infants had wheezed in the first 
year of life, 21.4% wheezed repeatedly, and 23.6% suffered severe wheezing episodes 
(Mallol et al., 2010b). More recently, a pooled analysis showed that the prevalence of 
wheezing in the first year of life in Latin American countries was 39.9%, with 16.6% of 
infants who wheezed repeatedly, and 17.6% suffering severe wheezing episodes (Mallol 
et al., 2016). In Argentina, 39% of infants had at least one wheezing episode in the first 
year of life, and of these, 33.0% were classified as recurrent wheezers (Teijeiro et al., 
2016). 
The above-cited evidence shows that prevalence of the disease in Latin America 
is higher than in Europe, and this could be due to several factors. One of the causes 
hypothesised to explain these differences were the multifactorial environment-gene 
interactions, distinctive in each region, which modulate airway responses from early life 
(Mallol et al., 2010b). 
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Also, differences in the prevalences could be attributed to socioeconomic factors. 
Garcia-Marcos et al. (2010) observed that low socioeconomic conditions had an 
important role in the higher prevalence of recurrent wheeze found in Latin America 
compared to Europe. In the same line, several studies showed evidence that children in 
low-income households had a higher risk for suffering from wheezing (Hafkamp-de 
Groen et al., 2013b), or a 2-fold increased risk of asthma in childhood (Kozyrskyj et al., 
2010).  
Other authors also found a relation between poverty and dirt, as household rodent 
infestation and infrequent cleaning of the house, and exposure to community violence, 
and an increased risk for wheezing (Barreto et al., 2010; Alves et al, 2012), sustaining the 
hypothesis that worse socioeconomic conditions might be one of the causes explaining 
the higher prevalence observed in Latin American countries. 
Another possible reason could be the parasitic infection, which was positively 
related to the onset of wheeze in Brazilian children (Alcântara-Neves et al., 2010). 
Nevertheless, results are conflictive (Leonardi-Bee et al., 2006), and further studies are 
necessary to confirm this hypothesis. 
Male gender 
Our results showed significant differences in the prevalence of wheeze between 
boys and girls, showing evidence that male gender was a risk factor for all wheeze 
phenotypes. These findings agree with other studies in preschool populations, which also 
found male gender as a risk factor for wheeze in infants (Chong Neto et al., 2008; Venero-
Fernandez et al., 2013). In a Dutch study, van Merode et al. (2007) observed gender 
differences, finding that boys significantly suffered more wheezing episodes, and more 
often presented for medical consultations. 
One possible explanation for these gender differences could be genetic factors. 
Previous studies have described interactions between male sex and heredity of a family 
allergic disease, influencing in the appearance of wheezing at early ages (Melén et al., 
2004). In addition, another study identified polymorphisms in the IFGN gene, which 
increased the risk of asthma in children, especially in those who had suffered from 
wheezing, while it was a protective factor in girls (Loisel et al., 2011). 
Another reason for the higher prevalence of wheeze in boys could be the 
physiological differences in airways. Young et al. (2000) found in a healthy cohort that, 
in the first years of life, boys had lower airway flows than girls, with a significant gender 
influence. These findings are consistent with previous investigations finding differences 
in the lung function between boys and girls, with the latter having larger airways relative 
to their lungs than boys (Tepper et al., 1986). 
  
Discussion 
 
72 
 
Weight and height 
In this study, low birth weight did not show any significant association with any 
wheeze outcome, in contrast to findings from several previous investigations. One of 
them described the relationship between low birth weight and wheezing, cough and 
respiratory infections, being significant between ages two and five, and showing the 
highest risk at four years old (Caudri et al., 2007). 
A meta-analysis conducted by Mebrathu et al. (2015) also found low birth weight 
as a risk factor for wheeze, although no significant relation between the disease and high 
birth weight was detected. 
The foetal origin hypothesis postulated that inadequate nutrition of the foetus 
determined the predisposition to suffer diseases in the future (Barker, 1990). In the same 
way, lung function in infants with low birth weight was significantly lower compared to 
infants with normal birth weight (Dezateux et al., 2004). It could be speculated that low 
weight at birth was related to an incorrect lung development, with consequences in the 
childhood. 
When high weight at birth (infants who weighed more than 3,500 grams) was 
considered, no significant associations with any wheeze phenotypes were observed (data 
not shown), differing from the findings of a meta-analysis which found high birth weight 
as risk factor of asthma in infants (Flasherman and Rutherford, 2006). However, results 
are conflicting, with other studies describing a weak decrease in the risk of asthma and 
wheeze in children who weighed more than four kilograms at birth (Mebrathu et al., 
2015b). 
When weight gain (assessed as current weight) was studied, only statistical 
differences, but a non-significant increased risk for severe wheeze, were observed, 
contrasting to previous literature. 
Results from a meta-analysis showed evidence that a major gain of weight was 
related to the onset of wheezing in preschool age, and with asthma in subsequent ages 
(Sonnenschein-van der Voort et al., 2014). Also, van der Gugten et al. (2012) found that 
a higher gain of weight in the first three months of life was associated with wheezing and 
worse lung function in childhood, independently of weight at birth. In a longitudinal study, 
a positive relation between weight and adiposity gain in the first year of life and wheeze 
in the first years of life was also observed (Pike et al., 2010).  
Several studies have described higher adiposity, overweight and obesity in the 
first year of life as a risk factor for wheeze and recurrent wheeze (Taveras et al., 2008; 
Mebrathu et al., 2015c). According to child growth standards proposed by the World 
Health Organization, infant’s weight in our sample was near the median, which might 
explain why overweight was not found associated with any wheeze disorders. 
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Higher height at birth and when the questionnaire was filled were in the statistical 
borderline to be considered as protective factors for wheeze ever. These findings seem to 
be in line with other studies describing a lower risk of wheeze at age three years in 
children with higher height growth rates (de Korte-de Boer et al., 2015), suggesting a 
relation between infant height and lung development. 
Race 
Neither race or ethnic group, nor offspring’s or parental place of birth, were 
significantly associated with any wheeze phenotype. The lack of significant relations 
contrasts with previous findings. Panico and colleagues (2007) detected differences in a 
cohort study conducted in the United Kingdom. In their study, black race was found as 
risk factor for asthma and wheeze, while Bangladeshi children were less prone to these 
conditions than white race children at age three years. 
Another English study found a significant lower prevalence and risk for wheeze 
in south Asian children in the first year of life compared to white race children, although 
between age two to four, the risk for wheeze was inverted (Kuehni et al., 2007). In the 
United States, differences were also observed in prevalence and severity of wheeze in 
black and Hispanics children and adolescents, as well as hospitalizations for this cause, 
higher in these ethnic groups compared to white children (Jones et al., 2008). 
These differences could be attributed to several factors. Some studies have 
suggested a genetic role in racial differences, especially in people with African ancestry 
(Flores et al., 2012), whilst other authors pointed to an adverse socioeconomic 
environment as the main reason for the disparities (Smith et al., 2005; Cope et al., 2008; 
Beck et al., 2014). 
When we analysed parental occupation and place of birth, statistical differences 
were detected. Most of foreign parents had low qualified jobs, with presumably lower 
salaries, which could lead to socioeconomic differences between Spanish and immigrant 
families (data not shown). Nonetheless, in this study, low participation of immigrant 
population could have biased our results. Therefore, it could be thought that higher 
number of participating immigrant families may had helped to minimize the probable 
existing sampling bias. 
Quality of life 
Our results showed that wheeze affected not only infant’s, but also parental quality 
of life. Several studies agree with these observations. In the Generation R study, lower 
scores for quality of life in infants aged twelve months with asthma-like symptoms and 
their families were observed, especially if these were severe, concluding that infants with 
severe symptoms had a higher risk for low quality of life (Mohangoo et al., 2012). 
Furthermore, Hafkamp-de Groen et al. (2013) also found lower quality of life at four 
years old in children who reported wheeze, especially those who had persistent wheeze.  
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In schoolchildren, asthma severity was also related to lower quality of life, 
affecting both emotional function and activity limitation (Halterman et al., 2004). These 
findings support the hypothesis that wheeze and asthma not only were associated with 
lower quality of life, but also suggested that severity play a main role in children’s and 
parental conditions of life. 
Treatment 
Although treatment with inhaled drugs and corticosteroids was strongly associated 
with every wheeze disorders, these results should be interpreted carefully. It could be 
thought that reverse causation led to these findings. Although the study’s cross-sectional 
design not allow to confirm this hypothesis, it seem plausible to think that infants were 
treated because of their condition, and not that treatment led to the onset of wheeze. 
Past studies have described the prevalence of use and effects of treatment in 
infancy. In two Brazilian EISL centres, the prevalences of use of inhaled corticosteroids 
were 18.5% and 24.3% (Alvim et al., 2011; Chong Neto et al., 2007b), higher than what 
was found in our study, possibly due to the higher prevalence of the disease in Latin 
American infants. 
The use and efficacy of corticosteroids in the treatment of wheezing is still 
controversial. Some studies described a beneficial effect in children with asthma 
symptoms, with an increase of days with no symptoms (Roorda et al., 2001), and 
reduction in wheezing and asthma exacerbations, especially in asthmatic children 
(Castro-Rodriguez and Rodrigo, 2009).  
Conversely, other studies did not found any effect in the progression from episodic 
to persistent wheezing, or in the natural course of asthma in children at high risk (Bisgaard 
et al., 2006; Guilbert et al., 2006), and a recent meta-analysis showed evidence that 
corticosteroids administration did not lead to lower hospital admissions, less need for 
additional systemic corticoids courses, shorter hospital length of stay, nor less 
unscheduled emergency department visits for asthma symptoms (Castro-Rodriguez et al., 
2016). 
On the other hand, although the questionnaire did not address antibiotic treatment, 
several authors have described a significant association between antibiotic treatment and 
risk for wheeze (Alm et al., 2008; Verhulst et al., 2008). Changes in the intestinal 
microflora due to antibiotics use could be the underlying cause of this increased risk 
(Verhulst et al., 2008). 
Respiratory/allergy symptoms in the first year of life 
Our findings showed that every asthmatic child had wheezed in the first year of 
life. Moreover, most of the children who were diagnosed with asthma by a physician had 
wheezed repeatedly or severely. 
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Wheeze is one of the manifestations of asthma. Thus, although a significant 
association have been detected, reverse causation should not be discarded. Asthma would 
not be a risk factor for wheeze, but the onset of wheeze would increase the risk of 
developing asthma. 
Prior studies have assessed the association between wheezing and asthma. Among 
children with a parental history of asthma or allergy, frequent early wheezing (before 
three years) was strongly associated with asthma at age seven years (Ly et al., 2006). 
Kappelle and Brand (2012) found a higher risk for childhood asthma in children with 
severe episodic viral wheeze who needed hospitalization and had a family history of 
asthma. 
Martinez et al. (1995) also suggested a relation between early wheezing episodes 
and predisposition to asthma in childhood. In the same Tucson Children’s Respiratory 
Study, suffering from wheeze at six years of age (late onset wheezing and persistent 
wheezing) was found related to asthma in adolescence and early adulthood (Morgan et 
al., 2005; Stern et al., 2008). 
Two factors were proposed to explain the connection between infant wheeze and 
asthma: viral respiratory tract infections and allergic sensitisation. The inflammatory 
responses to these agents may alter the structure and function of lung and airway tissues, 
leading to asthma (Holt and Sly, 2002; Holt et al., 2004). 
Viral respiratory tract infections have been described as one of the major risk 
factors for wheeze in infants and preschool children, with convincing evidence supporting 
this relation (Busse et al., 2010). 
Kusel et al. (2006) found rhinovirus as the most common respiratory pathogen, 
describing a higher risk for both upper and lower respiratory tract infections than RSV. 
In a Japanese study in children aged up to three years old hospitalised with lower 
respiratory tract infections, RSV and rhinovirus were detected in a higher percentage in 
patients who wheezed than in those without the condition, concluding these viruses were 
associated with wheeze in infants (Takeyama et al., 2014). Moreover, another prospective 
study described rhinovirus infection as the most important risk factor for recurrent wheeze 
among infants who had been hospitalised for bronchiolitis (Midulla et al., 2012). 
 Mommers et al. (2010), in the KOALA study, observed that infection-like 
symptoms in the first three months of life, including having a cold episode in early life, 
were related to wheezing in the first two years of life. Further evidence also described a 
higher risk of asthma at school ages in those children who suffered from virus-induced 
wheezing in infancy (Kotaniemi-Syrjänen et al., 2003; Puig et al., 2010). 
In this study, pneumonia and higher number of colds were significantly related to 
the onset of wheeze ever, recurrent and severe wheeze, in line with the above-mentioned 
findings. 
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Some of the mechanisms suggested to explain the relationship between viral 
infections and the onset of wheeze and asthma were genetic factors (Caliskan et al., 2013), 
diminished neonatal lung function (van der Zalm et al., 2011), or immunologic factors, 
as imbalanced Th1/2 responses (Message et al., 2008).  
In addition, a review by Gern and coworkers (2005) concluded that viral infections, 
due to viral damage and pro inflammatory responses, led to impairment in lung function, 
which could play causative role in the onset of wheeze. 
On the other hand, only in those children who reported severe wheeze episodes, 
an older age of the first cold episode was found as protective factor. Previous studies 
described an age-dependent adaptive immune response, biased to Th2 response in 
children aged up to three months (Kristjansson et al., 2005). Thus, changes in the immune 
response at older ages seem to be a reasonable explanation to this finding. 
Infant eczema was also found positively associated with every wheeze phenotype, 
being our findings consistent with previous literature. Several investigations have 
described a higher risk for wheeze, and 2-fold increased risk of asthma at school age, in 
infants who suffered from atopic dermatitis in the first months of life (Sangsupawanich 
et al., 2007; Saunes et al., 2012; Neuman et al., 2014). 
Venero-Fernandez and coworkers (2013) found infant eczema as the largest risk 
factor for wheezing in a cohort of Cuban infants. Moreover, eczema was recently found 
in European EISL centres, but not in Latin American, related to a shorter period to the 
first wheeze episode (Pacheco-Gonzalez et al., 2016). 
Several explanations could be proposed. Past studies showed evidence of higher 
IgE levels in children with atopic dermatitis (Perkin et al., 2004), strongly associated with 
airway responsiveness (Sears et al., 1991). Therefore, an IgE-mediated mechanism could 
be involved in the increased risk of wheeze in children who had eczema.  
Other possible explanation could be the role of the atopic march, defined as the 
progression from atopic dermatitis to other allergic diseases, such as asthma (Zheng et al., 
2011; Dharmage et al., 2014). In this progression, the occurrence of wheezing could be 
considered as the onset of early asthmatic symptoms. Nevertheless, in a study conducted 
by Illi et al. (2004), the atopic march was discarded when a co manifestation of early 
atopic dermatitis and wheezing, instead of the above-cited progression, was observed. 
Exposure to tobacco smoke 
Exposure to tobacco smoke has been described as a major risk factor for wheeze 
by many studies. Murray et al. (2004) found that both maternal smoking during pregnancy 
and postnatal exposure to tobacco smoke, increased the risk of wheezing in the first year 
of life. In the same line, in the Generation R study, conducted in Dutch children aged up 
to four years, Duijts and colleagues (2012) described a higher risk for wheeze in preschool 
ages in children exposed to tobacco smoke during pregnancy. 
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Also, a recent meta-analysis showed that prenatal maternal smoking was 
associated with a 40% significant increased risk of wheeze in the first two years of life, 
and postnatal maternal smoking, but not paternal, was significantly related to the onset of 
wheeze in early life (Burke et al., 2012). 
In our study, smoking throughout pregnancy was marginally associated with 
wheeze ever, in accordance with previous findings, and non-significant higher risks were 
observed for recurrent and severe wheeze. In contrast, maternal postnatal smoking was 
not significantly associated with any wheeze outcome. 
Several studies have found that in utero exposure to tobacco smoke affects lung 
growth and development, and is associated with reduced lung function (Gilliland et al., 
2000; Wang et al., 2008). The greatest effect of smoking during pregnancy could 
therefore minimise the effect of postnatal maternal smoking, explaining the non-
significant higher risk for wheeze in children whose mothers continued smoking after 
giving birth. 
On the other hand, paternal smoking only showed a statistically significant 
association with the development of recurrent wheeze. This finding contrasts to other 
Spanish study underlining the influence of maternal postnatal smoking compared to 
paternal smoking on the development of respiratory symptoms (wheezing, cough) in 
children aged three to six years (Jurado et al., 2005). 
Higher number of smokers in the household showed non-significant increased 
risks for both wheeze ever and severe wheeze, in contrast to other studies in which 
household environmental tobacco smoke was described as risk factor for wheezing (Tsai 
et al., 2010; Hunt et al., 2011).  
Nonetheless, some inconsistencies in the data that may altered our results should 
be noted. Fifty parents (twenty mothers and thirty fathers) who reported being current 
smokers did not account themselves as smokers in the household. Although it might be a 
possible scenario, it could be thought that inconsistencies removal would reinforce the 
association between number of smokers in the household and the outcomes of interest. 
Furthermore, although similar estimates in the assessment of environmental 
tobacco smoke risk for recurrent wheezing either using biomarkers or questionnaires were 
observed (Carlsten et al., 2012), it is worth mentioning that our data source were written 
questionnaires, and no biomarkers, as cotinine (Benowitz, 1999), were used to ascertain 
the exposure to environmental tobacco smoke, which could have provided more reliable 
information.  
Family history of asthma and allergies 
Many authors have described the link between parental history of asthma and 
allergies and the onset of wheeze and asthma in the offspring. In a prospective study in 
infants aged up to eighteen months, a parental history of asthma was positively associated 
with the incidence of lower respiratory tract illnesses with wheezing (Bosken et al., 2000). 
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In the same line, Pérez-Yarza et al. (2015), in a Spanish cohort of moderate-to-
late preterm infants, also showed evidence that history of asthma in either parent was a 
risk factor for developing recurrent wheeze in the first year of life.  
These findings contrast with ours, where only maternal history of asthma was 
found positively related to wheeze ever, and neither maternal nor paternal history of 
asthma were significantly associated with the development of recurrent nor severe 
wheeze, although non-significant increased risks were observed. 
In a Swedish study conducted in schoolchildren, Bjerg et al. (2007) observed that 
both maternal and paternal history of asthma showed an increased risk for wheeze in 
childhood, and the greatest risk if both parents were asthmatics. Unfortunately, in our 
study only two infants had a parental history of asthma, and joint effect (maternal and 
paternal) could not be studied.  
On the other hand, paternal and siblings’ history of dermatitis were found as risks 
factor for wheeze ever and severe wheeze, respectively. Results from other EISL studies 
seem to be, at least partially, in line with our findings. Bessa et al. (2014) found a parental 
history of asthma as risk factor for occasional and recurrent wheezing, and history of 
dermatitis only for occasional wheezing. However, they evaluated the joint effect of 
parental history of atopy, whilst we studied maternal and paternal relations individually. 
In this study, maternal history of asthma seemed to show a greater effect in the 
onset of wheeze ever and severe wheeze than paternal history. Prior studies also described 
a stronger association between maternal asthma and childhood asthma, especially in 
preschool children (Litonjua et al., 1998). More recently, a meta-analysis confirmed these 
findings, asserting that maternal asthma was a greater contributor for risk of asthma in 
the offspring than paternal asthma (Lim et al., 2010). 
The results presented suggest the existence of a hereditary mechanism in the onset 
of wheeze and asthma in the offspring, corroborated by other investigations (Willemsen 
et al., 2008; Cantani and Micera, 2011). Further, several mechanisms have been proposed 
to explain the role of family history of asthma in the development of the disease in the 
offspring.  
A review concluded that the influence of an allergic mother in the transition from 
a Th2 skewed immune response in the offspring during pregnancy to a non-allergic Th1 
response after birth might play an important role, apart from other factors, such as 
environmental stimuli or breast milk factors, which also might contribute to the shaping 
of the newborn immune response (Barrett, 2008). Another described mechanism were 
epigenetic alterations due to maternal asthma, as DNA methylations of certain genes with 
potential importance in the development of asthma in the infant (Gunawardhana et al., 
2014). 
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It is worth noting that in this study prevalences of asthma and rhinitis among 
parents were nearly 6% and 15%, respectively. These figures were lower than others 
observed in Spanish EISL centres, where asthma and rhinitis prevalences were above 
10%, and nearly or over 20%, respectively (Garcia-Marcos et al., 2010). Although our 
findings showed a tendency towards significant increased risks, especially in the parental 
history of asthma, lower prevalences may suggest that these results underestimate the 
effect of family history of allergic diseases, and therefore should be interpreted with 
caution. 
Socioeconomic factors 
Socioeconomic determinants have a proven influence in the onset and evolution 
of diseases (Marmot, 2005). In this study, factors considered to be indicators of the 
socioeconomic background were maternal educational level and parental occupation, 
which showed a major impact in children’s health related quality of life and risk of 
developing asthma in childhood (von Rueden et al., 2006; Kozyrskyj et al., 2010). 
Conflictive results have been found in previous studies assessing the relationship 
between educational level and the onset of wheezing. On one hand, several authors have 
described a significant protective effect against wheeze and recurrent wheeze in infants 
and schoolchildren whose parents had a higher educational level (Dom et al., 2009; de 
Meer et al., 2010). In the UK Millenium Cohort Study, Taylor-Robinson et al. (2016) 
observed that lower maternal educational level was positively related to early and 
persistent wheeze in the crude analyses, but after adjustment, statistical significance was 
not reached. 
On the contrary, Miyake and coworkers (2012) described a 2.4-fold increased risk 
for wheeze in Japanese schoolchildren whose mothers had fifteen or more years of 
education compared with those whose mothers studied for less than thirteen years. 
In this study, only infants whose mothers studied twelve or more years but did not 
have a University degree showed lower risk for wheeze ever. Although declining trends 
were observed when maternal education level was higher, we could not detect the 
protective effects of maternal education described in other studies. 
Nonetheless, when we recategorised maternal education level into two categories 
(low: <12 years; high: ≥12 years), significantly lower risk for wheeze ever and severe 
wheeze were observed when higher maternal educational level was reported (data not 
shown), in line with the positive role previously mentioned. 
Our results did not show any significant association between parental occupation 
and any of the outcomes of interest. Moreover, when we recategorised occupations into 
three categories (white collar worker: executive, graduate, administrative assistant; blue 
collar worker: manual skilled, semi-skilled, non-skilled workers; others: other cases, not 
working), non-significant relations were also found (data not shown). 
Discussion 
 
80 
 
These findings contrast with other studies describing a significant association 
between parental occupations and (increased or decreased) risk of diagnosis of asthma in 
childhood (Li et al., 2009).  
Other authors remarked the role of prenatal and/or postnatal maternal exposure to 
sensitisers, as latex, biocides or fungicides, which increased the likelihood of suffering 
from wheeze and asthma in childhood (Tagiyeva et al., 2010). Unfortunately, in the 
questionnaire, occupational categories were not accurate enough to determine parental 
jobs, therefore not enabling to evaluate possible exposures or risks which might be related 
to the development of infant wheeze. 
It also could be thought that the lack of significant associations observed could be 
due to the existence of a universal access to medical care in those years, which could have 
attenuated the presumed negative effect in low income families. 
Furthermore, none of the outcomes were significantly related to maternal age, in 
contrast to other studies, which described the protective role of having an older mother 
against the onset of asthma symptoms in the offspring (Ruijsbroek et al., 2011), whereas 
another Spanish study found in a cohort of newborns that younger maternal age was 
inversely associated with wheeze in the offspring in the first six months of age (Pérez-
Tarazona et al., 2010). 
In this sample, over 90% of mothers were older than twenty-eight years old. 
Although younger maternal age is likely to be associated with worse lifestyle habits 
associated with wheeze disorders in the offspring, the fact that most of the women were 
near or in their thirties could explain why maternal age showed a diminished role. 
Nursery attendance 
Nursery attendance was found as risk factor for both wheeze ever and recurrent 
wheeze in the first year of life. These findings are supported by some previously published 
investigations, although role of nursery attendance in the onset of the disease is still 
conflictive. 
In a Swedish study in children aged one to six years old, current wheeze was 
significantly related to nursery attendance, especially in the first years of life (Hagerhed-
Engman et al., 2006). Moreover, other prospective longitudinal studies found similar 
results. Celedón et al. (2002) showed evidence of an increased risk for wheeze associated 
with nursery attendance only in the first year of life, which became non-significant in 
subsequent years, while in the PIAMA birth cohort study, early nursery attendance was 
positively associated with wheeze in the first year of life, observing a decreasing risk 
trend with age (Caudri et al., 2009). 
Conversely, in the Tucson Children’s Respiratory Study, Ball et al. (2000) only 
found attending nursery during the first six months of life positively related to the 
development of frequent wheeze at two years of age, whereas in older ages it was a 
protective factor for the onset of asthma. 
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In the same line, more recent research has also shown evidence that nursery 
attendance was associated with a reduced risk of current wheeze at age five years among 
British children (Nicolau et al., 2008). 
The exposure to an infectious environment and the contact with other children 
could be the reasons of the increased risk observed in our study. Several investigations 
have found that children attending to nursery were at high risk for suffering from 
respiratory tract infections (Marbury et al., 1997; Sun and Sundell, 2011), previously 
stated as a main risk factor for wheeze. This assertion contrast with the “hygiene 
hypothesis”, which stated that early life infections might confer protection against 
allergies (Strachan, 1989). 
Only among those infants who developed recurrent wheeze, age of entry to 
nursery showed statistical differences, observing a non-significant increased risk in those 
children who started attending nursery at older ages. These findings seem to be in line 
with other investigation which found older age at entry to nursery as risk factor for atopic 
outcomes during childhood (Krämer et al., 1999), due to protection conferred by early 
infections against allergies in older ages. 
However, in this latter study, the reference age of entry was 6 to 11 months, and 
was compared to children who began attending at ages 12-23 months and 24 months and 
older, differing substantially from our study, where mean age for both wheezing and 
healthy infants was below six months of age, thus a hypothetical harmful effect of older 
age of entry may have been diminished. 
Pet ownership 
Overall, our findings seem to show higher odds for the onset of wheeze disorders 
when families reported presence of pets in the household, both during pregnancy and 
when the questionnaire was filled, although significant associations were only detected 
for wheeze ever and severe wheeze. Presence of dogs or cats, the most common pets, 
were not significantly related to the development of any wheeze phenotype. Unexpectedly, 
despite the lack of significant associations, having more than one pet showed more than 
3-fold increased risk for recurrent wheeze. 
When the literature was revised, inconsistencies when assessing the effect of pets 
keeping in wheeze and asthma outcomes in childhood were observed. In Mexican 
American children, in utero exposure to cats, dogs and birds was found positively related 
to wheeze and asthma in infancy and adolescence (Eldeirawi et al., 2016). 
On the other hand, in a systematic review conducted by Apelberg and colleagues 
(2001), they concluded that exposure to pets showed a non-significant protective effect 
for wheeze and asthma at younger ages, but increased risk in older children. More recently, 
another meta-analysis did not find any significant association between any type of pet 
ownership during the first two years of life and asthma in schoolchildren (Lodrup Carlsen 
et al., 2012). 
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In a Canadian prospective study, Carlsten et al. (2011) showed evidence that early 
exposure to dog, along with elevated indoor pollution or exposure to tobacco smoke, also 
increased the risk for asthma in infancy in a high-risk birth cohort. 
Presence of dogs, rabbits or birds during pregnancy and any pet ownership in early 
life was found positively associated with wheeze only in the first months of life, but not 
at subsequent ages, in an UK birth cohort (Collin et al., 2015).  
In this latter study, rabbit and rodent ownership showed an overall higher risk for 
wheeze, whereas presence of cats was a protective factor, in line with other studies 
(Celedón et al., 2002b). On the other hand, in the Tucson Chidren’s Respiratory Study, 
Remes et al. (2001) found an inverse association between dog exposure in infancy, but 
not cat, and risk of suffering from frequent wheeze. 
This great inconsistency was attributed to the questions used to assess self-
reported pet exposure in questionnaires, which showed a great variation across studies 
(Apfelbacher et al., 2016). 
As stated before, overall, our findings suggest a higher risk for wheeze in those 
children exposed to pets. Sensitisation to animal allergens has been described by several 
studies as one major risk factor for asthma (Rönmark et al., 2003; Korppi et al., 2008; 
Uddenfeldt et al., 2013; Bjerg et al., 2015). Therefore, one reasonable explanation could 
be that presence of pets in the household increased indoor pet allergens, leading to infant’s 
sensitisation to those allergens, who consequently showed an increased risk for 
developing wheeze disorders. 
It also should be noted the probable existence of bias resultant of avoidance of pet 
ownership in families with history of asthma or allergies, or whose children wheezed in 
the first months of life, which might have underestimated the effects of presence of pets. 
Household environmental conditions 
To assess the effect of household indoor air quality, fuel used for heating and 
cooking were studied. The exposure to fume emitting heaters in the first year of life has 
been found consistently associated with wheeze and asthma in schoolchildren (Phoa et 
al., 2004). In addition, improving home heating (to non-polluting heating) led to a 
reduction of asthma symptoms and was associated with improved children wellbeing 
(Howden-Chapman et al., 2008). These findings contrast with ours, which did not show 
any significant relation between any wheeze outcome and domestic heating. 
On the other hand, some investigations showed evidence that use of gas and a gas 
hob for cooking was positively related to an increased risk for childhood wheeze (de 
Bilderling et al., 2005), whilst others did not find any association neither with wheeze nor 
asthma (Willers et al., 2006). More recently, in a meta-analysis, Lin et al. (2013) 
concluded that only increased indoor dioxide of nitrogen levels was associated with 
higher risk for wheeze, but no increased risk in children who had been exposed to gas 
cooking was observed. 
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In our study, no statistical associations were detected, in line with these latter 
findings. The fact that most of the families in our sample had central heating in their 
dwellings, and used electricity for cooking, could be the reason of the lack of statistical 
associations found. 
The presence of infants in dwellings with carpeted floor was very limited in our 
study sample. In contrast to our findings, where no significant relation was detected, other 
authors described an almost 40% increased risk for wheeze and severe wheeze in infants 
living in dwellings with carpet covered floor, due to higher exposure to house-dust mites 
or chemical-mediated mechanisms (Herr et al., 2012). 
Likewise, dampness and mould stains did not show significant associations with 
any wheeze phenotype, contrasting with previous findings. A meta-analysis including 
eight European birth cohorts concluded that infants exposed to mould and/or dampness 
were at significant increased risk of asthma at preschool ages (Tischer et al., 2011). In the 
CCHH study conducted in Shanghai (China), a positive relation between wheeze and 
dampness exposure was also observed, showing a clear dose-response relationship 
between dampness indicators and airway symptoms (Hu et al., 2014).  
Furthermore, Visser et al. (2010), in the European EISL study conducted in 
Netherlands also found a strong association between damp housing and each wheeze 
phenotype, especially severe wheeze (defined in that study as wheezing which needed 
hospitalization). Nevertheless, the lower number of families reporting damp or mould 
stains in our sample compared to these studies could have masked a significant 
association with the outcomes of interest. 
Air pollution has also been described as risk factor for wheeze in the preschool 
ages. Oxidative stress or the promotion of inflammatory responses were some of the 
mechanisms proposed as causes of the adverse health effects (Bernstein et al., 2004). 
In a prospective birth cohort study, infants exposed to either moving or stop-and-
go traffic showed an increased risk for wheeze in the first year of life compared to those 
unexposed (Ryan et al., 2007). In the same study, higher risk persisted at three years of 
age, and accentuation of the effect of exposure to traffic-related particles in children 
coexposed to high levels of endotoxin in the home, was observed (Ryan et al., 2009). 
Also, Sonnenschein-van der Voort and colleagues (2012) described a significant 
relation between exposure to higher traffic-related air pollutants and wheeze in the first 
years of life, although only in those children exposed to tobacco smoke during fetal and 
infant life.  
In contrast with previously published, in this study no significant associations 
between air pollution and any wheeze phenotype have been observed. However, in the 
questionnaire, families were asked for their personal perception of living in an air polluted 
area, and no objective measurements were conducted. 
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Therefore, it is plausible to think that the lack of mechanisms to measure air 
quality might have led to reporting bias, thus our results should be interpreted carefully. 
Presence of older siblings was significantly related to the onset of wheeze ever 
and severe wheeze, although only the first showed a marginally increased risk. These 
findings contrast with previous investigations which did not show evidence of any 
relation between sibship size or birth order and asthma, although this condition seemed 
to be less prevalent in families with more children (Bernsen et al., 2003). Recently, Wu 
et al. (2016) also found a 15% significant decrease in risk for asthma in preschool children 
with every additional sibling at home. These investigations considered the hygiene 
hypothesis (Strachan, 1989) explained the lower risk observed. Conversely, in a French 
birth cohort study, presence of siblings was significantly associated with an increased risk 
for mild and severe wheeze (Herr et al., 2012). 
The contradictions among previous findings could be due to differences in the 
outcome studied and the age of the sample. Presence of siblings could be related to higher 
odds for suffering respiratory infections, triggering wheeze in the first months of life. 
However, in most children, wheezing at early ages is a transient condition, and in 
subsequent ages, this exposure to pathogens might confer protection against asthma. 
On the other hand, only wheeze ever was found significantly associated with 
living in a crowded household, although non-significant increased risk after adjustment 
was observed. In contrast to our findings, Cardoso et al. (2004) described a strong 
reduction in the incidence of asthma in crowded houses, in line with the above-mentioned 
hygiene hypothesis.  
Nonetheless, some facts should be considered. In our study, less than 10% of 
infants lived with five or more people, and only ten families could be considered as living 
in crowded households (seven or more people), which may have led to underestimate the 
effect of crowding. 
Breastfeeding 
The role of breastfeeding in relation to wheeze and asthma-related symptoms has 
not been completely elucidated. While some authors reported an increased risk in those 
children who were longer breastfed (Wright et al., 2001), others did not find any relation 
between breastfeeding duration and onset of wheeze or asthma or being hospitalised for 
these conditions (Miyake et al., 2008; Leung et al., 2016). 
Nonetheless, there is sufficient evidence supporting the protective effects of 
longer breastfeeding in wheeze disorders. Compared to longer exclusive breastfeeding or 
breastfeeding for more than six months, shorter periods of exclusive breastfeeding and 
never breastfeeding were positively associated with risk of asthma symptoms 
(Sonnenschein-van der Voort et al., 2012b). More recently, Dogaru et al. (2014) 
conducted a meta-analysis including one hundred thirteen studies, concluding that 
breastfeeding was strongly associated with lower risk of developing asthma. 
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In this line, our findings also showed a decreased risk for both wheeze ever and 
severe wheeze, and a non-significant lower risk for recurrent wheeze. When we 
dichotomised the variable into breastfeeding at least six months or less than six months, 
infants who were breastfed for a longer period showed a decreased risk, although did not 
reach statistical significance for any wheeze outcome. 
Discrepancies found in the literature may be related to a widely proven protective 
effect of longer breastfeeding in early childhood, which gradually disappear in subsequent 
years. Supporting this statement, Guibas et al. (2013), in two studies with preschoolers 
and preadolescents, only observed a protective effect in younger children. 
Several investigations described a protective role of breast milk against the 
development of respiratory tract infections (Duijts et al., 2010; Tarrant et al., 2010; 
Yamakawa et al., 2015), a well-established risk factor for wheeze in early life, possibly 
via its antimicrobial properties and promoting infant’s immune system development and 
maturation (Hanson et al., 2002; Field, 2005), which could explain the lower risk 
observed in infants who breastfed for a longer period. 
Further, when industrial infant food consumption frequency was studied, 
interpreting it as a weaning assessment, only a significant relation with severe wheeze 
was observed, although the lower risk observed in those infants who consumed industrial 
infant food once a month seem to be related to the small number of subjects in this group, 
thus this finding should be interpreted carefully. When consumption frequencies were 
dichotomised (never and once a month versus once a week and everyday), a non-
significant increased risk in those children who often consumed industrial infant foods in 
the first year of life was observed (data not shown). Overall, these findings stressed the 
importance of longer breastfeeding. 
Diet and adherence to the Mediterranean diet during pregnancy 
When dietary components were studied individually, statistical differences in fruit, 
potatoes, snacks and eggs intake were observed. Frequent consumption of fruit was 
related to non-significant decreased risks for wheeze ever and recurrent wheeze, whilst 
higher intake of eggs during pregnancy was inversely associated with severe wheeze. 
Conversely, both frequent intake of potatoes and snacks were related to higher, although 
non-significant, risks for wheeze ever and severe wheeze, respectively. 
Several past studies have assessed the role of maternal diet during pregnancy in 
offspring respiratory outcomes. Miyake et al. (2010) did not find a protective role for 
infant wheeze in higher intake of fruit and vegetables, in agreement with our findings, 
although an inverse relationship with vitamin E intake was described. Oily fish, especially 
in non-breastfed children, have been inversely associated with atopic and persistent 
wheeze in childhood (Romieu et al., 2007), whereas in another Spanish EISL centre, 
occasional meat consumption and avoiding eating pasta during pregnancy were also 
protective factors for wheeze in the first years of life (Castro-Rodriguez et al., 2016b). 
However, none of these latter findings were shown in our study. 
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In this questionnaire, potatoes food group also included chips (French fries), 
which could be considered as an unhealthy dietary component (as well as the snacks 
group), explaining the increased risks observed. 
On the other hand, frequent eggs intake during pregnancy was associated with 
decreased risk for severe wheeze in the offspring. This finding, due to be a well-known 
allergenic food, seems contradictory, and thus this result should be interpreted with 
caution. 
The health benefits of the Mediterranean dietary pattern have been widely studied, 
reporting a nearly 50% decreased risk for wheeze in preschool children who greatly 
adhered to the Mediterranean diet (Castro-Rodriguez et al., 2008). However, better 
adherence to this diet in pregnant women showed non-conclusive findings. While some 
studies found higher adherence to the Mediterranean diet not significantly associated with 
wheeze in the first year of life (Chatzi et al., 2013), supporting our findings, others showed 
evidence of a protective effect against persistent wheeze in childhood (Chatzi et al., 2008). 
In contrast to previous research finding olive oil use for cooking or dressing salads 
during pregnancy as protective factor (Castro-Rodriguez et al., 2010b), in this study no 
statistical relation was observed, even when the variable was recategorised into olive oil 
as main source versus other oils and butter/margarine (data not shown). 
Assessment of the adherence to the Mediterranean diet had some limitations, and 
in this regard, some facts should be noted. First, recall bias should not be excluded. 
Secondly, the food-frequency questionnaire used only allowed a gross estimation, as only 
the frequency, but not the portion sizes, were ascertained, and no further adjustments (e.g., 
energy intake) were conducted. Thirdly, the variability in scores used to measure 
adherence could be another reason of the differences observed with other studies (Milà-
Villaroel et al., 2011). 
Moreover, in this study sample, maternal education, occupation and maternal age 
were found as factors which influence the adherence to the Mediterranean diet during 
pregnancy (Álvarez-Álvarez et al., 2015).  However, no significant differences in these 
factors were observed, explaining the lack of statistical differences in the adherence to 
the Mediterranean dietary pattern. 
Oral contraceptives and paracetamol 
When oral contraceptive pills use before pregnancy was examined, no significant 
associations were observed for any wheeze phenotype. In line with these findings, in a 
large Norwegian pregnant cohort, Hancock et al. (2011) neither found statistical 
associations between oral contraceptive pills use and respiratory outcomes, including 
lower tract respiratory infections, wheezing, or asthma. 
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In the same line, inconclusive findings were shown in another study describing a 
slightly higher risk for asthma if oral contraceptives were used within six months before 
pregnancy, but non-significant risk if use was within the two years before conception 
(Osman et al., 2009). 
On the contrary, recently, in a Japanese study, maternal use of oral contraceptive 
pills, especially for more than three months, was positively associated with infant wheeze 
(Yamamoto-Hanada et al., 2016). Therefore, the role of oral contraceptives during 
pregnancy and its relation with wheeze outcomes remains controversial. 
Further, underlying mechanisms remain unclear. Some authors hypothesised that 
predisposition to asthma in the offspring could be due to immunomodulatory mechanisms 
during pregnancy (Wjst and Dold, 1997), whereas epigenetic causes, via DNA 
methylation of specific genes, were recently proposed as a plausible cause (Guthikonda 
et al., 2014). 
The effect of prenatal paracetamol exposure and wheeze in early life has also been 
studied by several studies. Shaheen et al. (2002), in the ALSPAC study, reported an 
increased risk of persistent wheezing when paracetamol use during early pregnancy was 
frequent. Also, prenatal exposure to paracetamol was found positively associated with 
infant wheeze in other European cohorts in more recent studies (Rebordosa et al., 2008; 
Goksör et al., 2011). 
Interestingly, Garcia-Marcos et al. (2009b), when investigated the effect of 
paracetamol during pregnancy stratifying for maternal asthma, only found a significant 
increased risk of wheezing in offspring of non-asthmatic mothers. Overall, our findings, 
showing an increased risk for wheeze and severe wheeze in infants whose mothers 
occasionally took paracetamol during pregnancy, seem to be in line with the literature. 
The harmful effect of paracetamol use could be mediated by oxidative damage 
due to the impairment of respiratory antioxidant defences (reduced gutathione) (Nuttall 
et al., 2003), or by modulating glutathione levels on Th1-Th2 cytokine response patterns 
(Dimova et al., 2005). Other studies have proposed confounding as an explanation of the 
association between paracetamol use in pregnancy and wheezing in infants (Migliore et 
al., 2015). Nevertheless, in this study we adjusted for a wide range of confounders, thus, 
although it should not be discarded, this latter hypothesis does not seem very plausible. 
Complications during pregnancy 
Gestational diabetes, maternal hypertension, malposition of the foetus and 
prematurity were the complications throughout pregnancy which showed the highest odds 
for wheeze disorders in infants. 
In agreement with our findings, Zugna and colleagues (2015), in a pooled analysis 
of fourteen birth cohorts, showed that hypertensive disorders, and particularly 
preeclampsia, were related to an increased risk of developing recurrent wheeze, while 
diabetes showed a non-significant increased risk.  
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Hypertension was also related to transient, late-onset and persistent wheezing in 
childhood in an Italian study, whereas diabetes showed a marginally increased risk for 
persistent wheezing, and urinary tract infections during pregnancy were positively 
associated with transient wheezing, differing these latter findings with ours (Rusconi et 
al., 2007). In the ALSPAC study, gestational hypertension was not related to wheeze at 
eighteen months of life, whilst preeclampsia showed a weak association with early 
wheezing (Shaheen et al., 2016). 
It should be mentioned that, in the questionnaire, it was not specified if 
hypertension term included other related disorders, as preeclampsia, and this fact should 
be considered when interpreting the results. 
In our study, prematurity showed increased risks for all wheeze disorders, 
although only reached statistical significance for recurrent wheeze. Previous evidence 
seems to be in line with these findings (Kumar et al., 2008; Robison et al., 2012). 
Abnormalities of the small airways in prematurely born infants may explain the link with 
the onset of wheeze in the first months of life (Broughton et al., 2007). 
In a longitudinal prospective study, Annesi-Maesano et al. (2001) showed 
evidence of the relation between malpresentation of the foetus at birth and a significant 
increase of asthma in the child. Although in this study malposition showed higher odds 
for both wheeze ever and recurrent wheeze, no statistical significance was reached, and 
wide confidence intervals were shown, probably due to the small number of mothers who 
reported this complication. 
Delivery via caesarean section showed a non-significant decreased risk for all 
wheeze phenotypes, contrasting to prior evidence. Caesarean delivery was found 
positively associated with development of asthma in the first years of life (Davidson et 
al., 2010; Magnus et al., 2011). 
Some studies have proposed that exposure to vaginal bacteria lead to colonization 
by bacteria from the mother’s birth canal and perianal region, instead of bacteria from 
hospital environment, conducting to different immune system maturation (Huurre et 
al.,2008; Cho and Norman, 2013), explaining the higher risk observed in children 
delivered by cesarean section, although it was not reflected in our results. 
Strengths and limitations 
One of the strengths of this study was the large number of variables studied 
(demographic, environmental or family background, among others), which guarantee a 
wide focus on studying wheeze disorders. In addition, a validated questionnaire, a well-
recognised tool, was used. 
Another strength was the fact that, as part of the EISL multicentre project, the 
results obtained enable to make national and international comparisons with other 
European and Latin American centres, providing a framework for future research. 
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However, several limitations should be addressed. The main limitation of the 
study is its low participation rate. Nearly one third of the families participated in the study 
(32.4%). Compared to other EISL centres, in Zwolle (Netherlands) the participation rate 
was 81% (Visser et al., 2010), and in most Spanish centres was over 70% (Garcia-Marcos 
et al., 2010). This low participation rate may have led to a sampling bias, and its 
consequences should be acknowledged. 
One of the possible reasons of this participation rate could be the low participation 
of foreign population. More than 90% of parents had born in Spain. However, according 
to the data from the Navarre Statistical Office (Navarre Statistical Office webpage), 
between 2006 and 2008, about 20% of births in Navarre were from foreign mothers, thus 
their low participation had a notable effect.  
Another possible cause was the inability to make phone calls or send reminder 
letters to participants, to obey the data protection law and authorizations, which could 
have helped increasing the participation rate. 
In this study, self-reported information was used, although is prone to reporting 
bias. Nevertheless, questionnaires were filled when infants aged 12-15 months, and a 
diminished impact of reporting bias should be expected. Finally, the cross-sectional study 
design not allowed studying causality, and should also be pointed out as a weakness. 
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1. Prevalence of wheeze ever in infants in the region of Pamplona was 32.5%. 
Prevalences of recurrent wheeze and severe wheeze in the first year of life were 10.6% 
and 9.6%, respectively. 
2. Prevalences found in this study were comparable to those in other EISL European 
centres, but were lower than those observed in Latin American centres. 
3. Male gender, pneumonia, infant eczema, higher number of colds, smoking during 
pregnancy, maternal history of asthma, or paternal history of dermatitis, were identified 
as risk factors for wheeze ever in the first year of life. 
4. Also, nursery attendance, presence of pets in the household when the questionnaire 
was filled, higher number of siblings, and paracetamol consumption during pregnancy 
were found as risk factors for wheeze ever in infants.  
5. Male gender, pneumonia, infant eczema, higher number of colds, smoking father, 
nursery attendance, hypertension during pregnancy and prematurity were risk factors for 
recurrent wheeze in infants. 
6. Male gender, pneumonia, infant eczema, higher number of colds, history of dermatitis 
in siblings, presence of pets during pregnancy and when the questionnaire was filled, and 
paracetamol consumption during pregnancy were risk factors for severe wheeze. 
7. Higher height at birth, and longer exclusive breastfeeding were identified as protective 
factors for wheeze ever. Older age when suffering the first cold, and longer exclusive 
breastfeeding were protective factors for severe wheeze. No protective factors were found 
for recurrent wheeze. 
8. This study reflects that wheezing in infants is a common disease which affects both 
infant and parental quality of life, and can lead to asthma in subsequent ages. Several 
preventable risk factors, such as household and environmental factors, have been 
identified. 
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Appendix 1 
International Study of Wheezing in 
Infants questionnaire 
Proyecto  Salud Respiratoria durante el primer año de vida
3. Persona que rellena la encuesta Madre Padre Otra Padre y Madre
4.  Sexo de su hijo/a niño niña
5. Edad de su hijo/a (en meses)
6. ¿Cuánto pesó su hijo/a al nacer?
menos de 1500 gramos 1500 a 1999 gr 2000 a 2499 gr 2500 a 3499 gr más de 3500 gr no lo recuerdo
7. ¿Cuánto pesa su hijo/a actualmente? (en kilos) 8.  ¿Cuánto midió su hijo/a al nacer? (en centímetros,)
9. ¿Cuánto mide su hijo/a actualmente?(en centímetros)
10. Raza o etnia de su hijo/a
blanca gitana norteafricana subsahariana india hispanoamericana asiática otra
11. ¿Nació su hijo/a en España? Si No
11.1. Si ha respondido "NO", ¿en qué país nació su hijo/a?
13. Lugar de nacimiento de la madre
España Europa excepto España África Norteamerica Sudamerica y  CentroA Asia Australia
14. ¿Ha tenido su hijo/a silbidos o pitos en el pecho en sus primeros 12 meses de vida? Si No
17. Cuando su hijo/a tiene pitos en el pecho ¿Suele comenzar por un resfriado normal? Si No nunca ha tenido pitos
dia mes año
2. Fecha de nacimiento
del niño/a
1. Fecha de hoy
añomesdia
Oceanía
12. Lugar de nacimiento del padre
España Europa excepto España África Norteamerica Sudamerica y  CentroA Asia Australia
16. ¿A qué edad tuvo su hijo/a el primer episodio de silbidos o pitos en el pecho? meses
15. ¿Cuantos episodios de silbidos o pitos en el pecho ha tenido su hijo en sus primeros12 meses de vida?
19. Los pitos en el pecho de su hijo/a ¿afectan a la alimentación del niño/a? Si No nunca ha tenido pitos
20. Los pitos en el pecho de su hijo ¿limitan las actividades diarias de los padres del niño Si No nunca ha tenido pitos
21. Los pitos en el pecho de su hijo/a ¿han modificado la vida familiar? Si No nunca ha tenido pitos
22. ¿Ha recibido su hijo/a tratamiento con medicamentos inhalados para dilatarle los bronquios Si No Ns/NC
23. ¿Ha recibido su hijo/a tratamiento con corticoides inhalados? Ejemplo: Flixotide, Becloasma, Si No Ns/NC
Pulmicort, Fluinol, Inhalacor, Budesonida, Becotide, Pulmictan, Ribujet, etc.
24. ¿Ha recibido su hijo/a tratamiento con otros medicamentos como antileucotrienos (Singulair)o ketotifeno (Zasten, Ketasma)?
sí, tomó antileucotrienos sí, tomó ketotifeno sí, tomó ambos medicamentos no no sabe
25. En los primeros 12 meses de vida ¿cuántas veces se ha despertado usted por la noche debido a la tos con ahogos o silbidos/pitos
nunca raras veces algunas veces (algunas semanas en algunos meses) frecuentemente
(menos 1 vez /mes) (2 o más noches / semana, casi todos los meses)
en el pecho de su hijo/a?
que llevarlo a un Servicio de Urgencias?
26. En los primeros 12 meses de vida, ¿han sido las sibilancias o silbidos/pitos en el pecho tan importantes como para tener
Si No
18. ¿Se le han desencadenado o empeorado a su hijo/a los pitos en el pecho al moverse más
Si No nunca ha tenido pitos(gatear, correr..) o al enfadarse o reir?
su hijo/a tenía mucha dificultad para respirar y se ahogaba?
27. En los primeros 12 meses de vida, ¿han sido las sibilancias o silbidos/pitos en el pecho tan importantes que usted notara que
Si No
46266
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28. ¿Ha estado su hijo/a hospitalizado por pitos, silbidos o ahogos en el pecho en sus primeros 12 meses de vida?
no 1 vez 2 veces 3 veces 4 veces 5 veces 6 veces 7 veces 8 veces 9 o más veces
29. ¿Le ha dicho un médico alguna vez que su hijo/a tiene asma ? Si No
30. ¿Ha tenido su hijo/a neumonía o bronconeumonía en sus primeros 12 meses de vida? Si No
31. ¿Ha estado su hijo/a hospitalizado por neumonía o bronconeumonía en sus primeros Si No
en cualquier parte del cuerpo, excepto alrededor de la boca y la nariz y excepto en el área del pañal?
32. ¿Ha tenido su hijo/a, en sus primeros 12 meses de vida, manchas rojas en la piel que pican y que aparecen y desaparecen
Si No
33. ¿Fuma la madre (o tutora) del niño/a actualmente? Si No
 33.1. ¿Cuántos cigarrillos al día fuma la madre (o tutora) del niño/a? (Si no fuma marque "00")
34. ¿Fuma el padre (o tutor) del niño/a actualmente? Si No
 34.1. ¿Cuántos cigarrillos al día fuma el padre (o tutor) del niño/a? (Si no fuma marque "00")
35 ¿Fumó la madre del niño durante el embarazo del niño/a? Si No
35.1. Si responde "SÍ" marque en qué trimestre, puede marcar varias respuestas
1º trimestre 2º trimestre 3º trimestre
36. ¿Cuántos de los que viven en la casa fuman cigarrillos, incluyendo a los padres?
37 ¿Tiene asma el padre del niño/a? Si No 38. ¿Tiene asma la madre del niño/a? Si No
39. ¿Tiene asma algún hermano/a del niño/a? Si No
40. ¿Tiene alergia nasal (rinitis alérgica, fiebre del heno) el padre del niño/a? Si No
41. ¿Tiene alergia nasal (rinitis alérgica, fiebre del heno) la madre del niño/a? Si No
42. ¿Tiene alergia nasal (rinitis alérgica, fiebre del heno) algún hermano/a del niño/a? Si No
43. ¿Tiene alergia en la piel (dermatitis alérgica) el padre del niño/a, excluyendo dermatitis alérgica de contacto? Si No
44. ¿Tiene alergia en la piel (dermatitis alérgica) la madre del niño/a, excluyendo dermatitis alérgica de contacto? Si No
45. ¿Tiene alergia en la piel (dermatitis alérgica) algún hermano  del niño/a, excluyendo dermatitis alérgica de contacto? Si No
46. ¿Se le han realizado al padre del niño/a, alguna vez, pruebas de alergia en piel o en sangre?
no sí, y mostró alergia sí, pero no mostró alergia
47. ¿Se le han realizado a la madre del niño/a, alguna vez, pruebas de alergia en piel o en sangre?
no sí, y mostró alergia sí, pero no mostró alergia
48. ¿Se le han realizado algún hermano/a del niño/a, alguna vez, pruebas de alergia en piel o en sangre?
no sí, y mostró alergia sí, pero no mostró alergia
49. ¿Ha ido su hijo/a a la guardería en sus primeros 12 meses de vida? Si No
50. ¿A qué edad comenzó su hijo/a a ir a la guardería? (en meses,Si no ha ido todavía a una guardería marque "00")
52. En la casa que vive el niño/a, ¿qué tipo de combustible se usa, predominantemente, para la calefacción?
electricidad gas central estufa de gas queroseno carbón madera otra
53.  En la casa que vive el niño/a, ¿qué tipo de combustible se usa, predominantemente, para  cocinar?
electricidad gas queroseno carbón madera otra
m
51. ¿Con qué frecuencia ha ingerido su hijo/a cualquiera de los siguientes productos (NO elaborados en casa) durante sus primeros
nunca una vez al mes una vez por semana todos los días de la semana
12 meses de vida?: yogur, flan, natillas, petit suisse, patatas fritas envasadas, mermeladas, chocolate, refrescos, zumos de sobre, en
sobre, en brick o botella, néctar, etc..
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54. ¿Tiene aire acondicionado en la casa que vive el niño/a? Si No
55. De las siguientes mascotas, marque las que tenía en su casa cuando nació su hijo/a
no tenía mascotas perro gato aves conejo/hamster otra
56. De las siguientes mascotas, marque las que tiene actualmente en la casa que vive el niño/a
no tenía mascotas perro gato aves conejo/hamster otra
57. La casa en la que vive el niño/a, ¿está enmoquetada? Si No
58. La casa en la que vive el niño/a, ¿tiene baño completo (lavabo, inodoro, ducha/bañera) en el interior? Si No
59. La cocina de la casa en la que vive el niño/a (el lugar dónde se prepara la comida)¿está dentro de la casa? Si No
60. ¿Tiene teléfono (fijo o móvil) en la casa en la que vive el niño/a? Si No
61. Marque, por favor, el nivel de educación alcanzado por la madre del niño/a
educación básica, primaria o ninguna (8 años o menos)
educación media o secundaria incompleta (9-11 años)
educación media o secundaria completa y superior (12 y más años)
educación   universitaria
62. ¿Cuántos meses alimentó a su hijo/a exclusivamente con leche materna (sin leches adaptadas, cereales, zumos
zumos de frutas u otros alimentos como papillas, etc.. ?(en meses, Si no le dió leche materna marque "00")
63. ¿Cuántos resfriados (estornudos, tos, moquillo nasal como agua, con o sin fiebre) ha tenido su hijo/a
en sus primeros 12 meses de vida? (Si no ha tenido resfriados marque "00")
r
64 ¿Cuántos meses tenía su hijo/a cuando se resfrió por primera vez? Si no ha tenido resfriados marque "00"
(humos de fábricas, tráfico intenso de vehículos, etc..)
65 ¿Considera usted que su hijo/a vive en una zona con contaminación atmosférica? Si No
65.1 Si ha respondido "SI", marque lo que considere oportuno mucho moderado poco
66. ¿Hay moho (hongos) o manchas de humedad en la casa que vive el niño/a? Si No
67. ¿Tiene su hijo/a las vacunas correspondientes a su edad completas? Si No
668. Número de hermanos/as que tiene su hijo/a Si no tiene hermanos marque "00"
69. ¿Cuántas personas, adultos y niños, viven en total en la casa en la que vive el niño/a actualmente ?
70. Ocupación del padre
directivos, administradores, licenciados
otros  directivos  téc.  medios, diplomados
cuadros intermedios, administrativos
trabajadores manuales cualificados
trabajadores manuales semicualificados
trabajadores no cualificados
otros casos,mal especificados
actualmente no trabaja
71. Ocupación de la madre
directivos, administradores, licenciados
otros directivos téc. medios, diplomados
cuadros intermedios, administrativos
trabajadores manuales cualificados
trabajadores manuales semicualificados
trabajadores no cualificados
otros casos,mal especificados
actualmente no trabaja
72. Edad de la madre del niño (en años)
73. ¿Qué se utiliza, predominantemente, en la cocina de la casa en la que vive el niño/a para freir?
aceite de oliva mantequilla margarina otro tipo de aceite
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74. Durante el embarazo de su hijo/a, ¿con qué frecuencia comió o bebió lo siguiente?
(nunca u ocasionalmente, una o dos veces por semana , tres o más veces por semana,
no lo comió por intolerancia o alergia, no sabe)
Hamburguesas cocinadas en casa nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
 Carne (ternera, pollo, cordero, conejo, cerdo, ...) nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Pescado    blanco nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Pescado azul nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Fruta fresca/zumo natural nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Verdura fresca nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Ensaladas nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Verdura  cocinada nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Legumbres nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Cereales, incluido pan nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Pasta nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Arroz nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Mantequilla nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Margarina nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Frutos secos, o mantequilla de cacahuete/avellana nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Patatas cocinadas en casa (incluidas patatas fritas) nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Patatas fritas de bolsa y snacks (gusanitos, fritos, etc...) nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Leche nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Yogur nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Huevos nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Bollería industrial, galletas nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Bebidas con alcohol nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Bebidas     gaseosas nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
75. ¿Durante cuánto tiempo en total tomó la madre del niño/a anticonceptivos orales antes de quedarse embarazada del niño/a al
nunca menos de 1 año de 1 a 3 años de 4 a 6 años más de 6 añosque se refiere este cuestionario?
(termalgin, gelocatil, etc..)?
76. Durante el embarazo del niño/a al que se refiere esta encuesta, ¿con qué frecuencia tomó la madre del niño paracetamol
nunca o menos de 1 vez al mes de 1 a 4 veces al mes más de 1 vez a la semana
Si tomó alguna vez paracetamol durante el embarazo ¿porqué causa lo hizo?
cefalea/migraña fiebre dolor muscular otra causa
77. Durante el embarazo y parto del niño/a al que se refiere esta encuesta, ¿tuvo alguna de las siguientes complicaciones?
Sufrimiento fetal, hipoxia.. Si No
Prematuridad ..................... Si No
Vueltas de cordón .............. Si No
el  niño .............................. Si No
Forceps, ventosa ................ Si No
Cesárea ............................... Si No
Hipertensión ......................... Si No
Amenaza de aborto ............... Si No
Infecciones ............................ Si No
Diabetes gestacional ............. Si No
Mala presentación ................ Si No
Rotura prematura de aguas. Si No
Problemas de la placenta .... Si No
Trauma obstétrico en
Pizzas precocinadas, platos precocinados nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Hamburguesas  en  burgers,  perritos,  etc.. nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Frituras: croquetas, palitos merluza, etc.. nunca Ocasion 1-2  veces sem 3 ó mas Alergia NS
Comida
rápida:
46266
IKERKETA, BIZITZAKO LEHEN URTEKO ARNAS OSASUNARI
BURUZ
3. Inkesta betetzen ari den pertsona
ama aita beste bat gurasoak
4. Semearen/alabaren sexua mutikoa neskatoa
6. Zenbat pisatu zuen jaoitzean?
menos  1500 gr 1500 a 1999 gr 2000 a 2499 gr 2500 a 3499 gr 3500 gramo baino gehiago ez dut gogoan
7. Zenbat pisatzen du zure haurrak orain? (kg) 8. Zer neurri izan zuen jaoitzean?  (cm)
9 Zer neurri du zure haurrak orain? (cm)Zure semearen arraza edo etnia
zuria ijitoa iparafrikarra azpisahararra hispanoamerikar indiarra asiarra besteren bat
11. Zure semea/alaba Espainian jaio al zen? Bai ez
11.1. "EZ" erantzun baduzu, zein herrialdetan jaio zen zure semea/alaba?
14. Izan al du zure semeak/alabak txistu-hotsa edo soinua bularrean, bere bizitzaren aurreneko 12 hilabeteetan? Bai ez
17. Zure semeak/alabak bularrean txistu-hotsak dituenean, hoztura arrunt batekin hasten dira?
bai No  ez du txistu-hotsik izan inoiz
15. Zenbat alditan izan du txistu-hotsa edo soinua bularrean bere bizitzaren aurreneko 12 hilabeteetan?
19. Zure semearen/alabaren bularreko txistu-hotsek eragiten al diote elikaduran? Bai ez ez du txistu-hotsik izan inoiz
20. Zure semearen/alabaren bularreko txistu-hotsek eragozpenak jartzen dizkizuete gurasoei eguneko jardueretan?
Si ez ez du txistu-hotsik izan inoiz
21. Zure semearen/alabaren bularreko txistu-hotsek aldatu al dute familiaren bizimodua?
ba ez ez du txistu-hotsik izan inoiz
23. Zure semeak/alabak izan al du kortikoide inhalatuen tratamenduren bat? Adibidez: Flixotide, Becloasma, Pulmicort, Fluinol,
bai ez  ez dakit/ez dut erantzungo
Inhalacor, Budesonida, Becotide, Pulmictan, Ribujet, eta abar.
24. Zure semeak/alabak izan al du beste botika batzuen tratamenduren bat, adibidez antileukotrienoena (Singulair)?
bai, antileukotrienoak hartu zituen ketotifenoa hartu zuen bai, bi botika horiek hartu zituen ez ez dakit
12. Aitaren jaioterria
Espainia Europa, Espainia kenduta Afrika Iparramerik Hegoamerika eta ErtA Asia Australia/Ozeania
13  Amaren jaioterria
Espainia Europa, Espainia kenduta Afrika Iparramerik Hegoamerika eta ErtA Asia Australia/Ozeania
(Behin ere ez badu izan txistu-hotsik markatu 00)
hil.16. Zein adinetan izan zuen zure semeak/alabak txistu-hotsa edo soinua bularrean lehen aldiz?
18. ¿Gehiago mugitzean (lau-oinean iblitzean,haserretzean, laster  edo barre egitean) sortu edo okerragotu al
bai No ez du txistu-hotsik izan inoizzaizkio zure semeari/alabari txistu-hotsak?
edo inhalazioetan?Adibidez: Ventolín, Terbasmín, Berodual,Berotec, eta abar.
22. Zure semeak/alabak izan al du bronkioak zabaltzeko botiken (bronkiodilatadoreen) tratamenduren bat nebulizazioetan
bai ez ez dakit/ez dut erantzungo
edo ketotifenoarena (Zasten, Ketasma)?
 txistu-hotsak izan
eraman behar izan baituzue?
26. Haurraren bizitzaren aurreneko 12 hilabeteetan, bularreko txistu-hotsak edo soinuak
bai ez
1. Gaurko eguna
Eguna Hila Urtea
Eguna
2. Haurraren jaoiteguna
Hila Urtea
hilabete5. Haurraren adina
27. Haurraren bizitzaren aurreneko 12 hilabeteetan, bularreko txistu-hotsak edo soinuak hain garrantzitsuak izan dira,
Bai Ez
ezen  zure semeak/alabak zailtasun handia baitzuen arnas hartzeko eta itotzen baitzen?
(bi gauetan edo gehiagotan astean, ia hilero)(hilean behin baino
25. Haurraren bizitzaren aurreneko 12 hilabeteetan zenbat alditan iratzarri zara gauean zure semeak/alabak itolarria edo bularrean
inoiz ez inoiz edo behin noizbait (aste batzuetan hil batzuetan zehar) maiz
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28. Zure semea/alaba ospitalean egon al da, bere bizitzaren aurreneko 12 hilabeteetan, bularreko txistu-hotsak edo soinuak zeuzkalako?
ez behin bi aldiz  3 aldiz 4 5 6 7 8 9 aldiz edo gehiagoz
29. Medikuren batek esan al dizu zure semeak/alabak asma daukala? Bai Ez
30. Izan al du zure semeak/alabak pneumonia edo bronkopneumonia, bere bizitzaren hasierako 12 hilabeteetan? bai ez
31. Zure semea/alaba ospitalean egon al da, bere bizitzaren aurreneko 12 hilabeteetan, pneumonia edo bronkopneumonia zeukalako?
Bai ez
33. Erretzen al du haurraren amak (edo tutoreak) orain? Bai ez
 33.1. Zenbat zigarro erretzen ditu egunean haurraren amak (edo tutoreak)?
34. Erretzen al du haurraren aitak (edo tutoreak) orain? bai ez
35. Erre al zuen haurraren amak haurdunaldian? bai ez
35.1. "Bai" erantzun baduzu, markatu zein hiruhilekotan; erantzun bat baino gehiago marka dezakezu
1. lauhilekoan  2. lauhilekoan 3.lauhilekoan
36. Etxean bizi direnetan zenbatek erretzen ditu zigarroak, gurasoak barne direla?
37. Haurraren aitak asma  dauka? bai ez 38. Haurraren amak asma dauka? bai ez
39. Haurraren anaia , arreba edo ahizparen batek asma  dauka? bai ez
40. Haurraren aitak ba al du sudur alergia (errinitis alergikoa, belar onduaren sukarra? bai ez
41. Haurraren amak a al du sudur alergia (errinitis alergikoa, belar onduaren sukarra? bai ez
42. Haurraren anaia , arreba edo ahizparren+ batek ba al du sudur alergia (errinitis alergikoa, belar onduaren sukarra? bai ez
43. Haurraren aitak ba al du azaleko alergia (dermatitis alergikoa), alde batera utzita kontaktuzko dermatitis alergikoa? bai ez
44. Haurraren amak ba al du azaleko alergia (dermatitis alergikoa), alde batera utzita kontaktuzko dermatitis alergikoa? bai ez
45. Haurraren anaia , arreba edo ahizparen batek ba al du azaleko alergia (dermatitis alergikoa), alde batera utzita kontaktuzko dermatitis alergikoa?
bai ez
46. Haurraren aitari egin al dizkiote alergiaren  probak larruazalean edo odolean?
ez bai eta alergia bazuen bai, baina ez zuen alergiarik
47. Haurraren amari egin al dizkiote alergiaren  probak larruazalean edo odolean?
ez bai eta alergia bazuen  bai, baina ez zuen alergiarik
48. Haurraren anaia , arreba edo ahizparren+ bati egin al dizkiote alergiaren  probak larruazalean edo odolean?
ez bai eta alergia bazuen bai, baina ez zuen alergiarik
49. Joan al da zure semea/alaba haurtzaindegira, bere bizitzaren hasierako 12 hilabeteetan? bai ez
50. Zein adinetan hasi zen zure semea/alaba haurtzaindegian?
52. Haurra bizi den etxean, zein da berokuntzan gehienbat erabiltzen den erregaia?
elektrizitatea gas zentrala gas estufa kerosenoa ikatza  egurra besteren bat
53. Haurra bizi den etxean, zein da sukaldean gehienbat erabiltzen den erregaia?
elektrizitatea gas zentrala gas estufa kerosenoa ikatza egurra besteren bat
hil
ahoaren ingurua, sudurra eta haur-ohialak hartzen duen aldea?
32.  Izan al ditu zure semeak/alabak gorrituak azalean, azkura eman, eta agertu eta desagertzen direnak,gorputzeko edozein ataletan, alde batera utzita
bai ez
zig Erretzen ez badu, markatu "00"
zig Erretzen ez badu, markatu "00"34.1. Zenbat zigarro erretzen ditu egunean haurraren aitak (edo tutoreak)?
. Oraindik joan ez bada, markatu  "00"
51. Zenbatetan hartu ditu zure semeak/alabak produktu hauek (etxean egiten EZ direnak),bere bizitzaren aurreneko 12 hilabeteetan? Jogurta, budina
behin ere ez  hilean behin astean behin asteko egun guztietan
petit suisse, patata frijitu ontziratuak mermeladak, txokolatea, freskagarriak, zukuak hautsetan, brickean edo botilan, nektarra, eta abarrak?
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54. Aire girotua al dago haurra bizi den etxean? Bai ez
55. Hurrengo maskotetatik zein dira haurrak etxean zituenak jaio zenean?
ez zuen maskotarik txakurra katua hegaztiak untxia/hamsterra beste bat
56. Hurrengo maskotetatik zein dira haurrak etxean dituenak?
ez zuen maskotarik txakurra katua hegaztiak untxia/hamsterra beste bat
57. Haurra bizi den etxeak moketa al dauka? bai ez
58. Haurra bizi den etxeak ba al dauka barnean bainugela osoa (konketa, komuna, dutxa/bainu-ontzia)? bai ez
59. Haurra bizi den etxeko sukaldea (janaria prestatzeko tokia) etxearen barnean al dago? Bai ez
60. Haurra bizi den etxean ba al dago telefonoa (finkoa edo sakelakoa)? Bai ez
61. Markatu, mesedez, zein hezkuntza mailatara iritsi den haurraren ama
oinarrizko hezkuntza, lehen hezkuntza edo bat ere ez (8 urtera edo gutxiagora arte)
maila ertaineko hezkuntza, edo bigarren hezkuntza bukatu gabe (9-11 urte bitartean)
maila ertaineko hezkuntza, edo bigarren osoa eta goi mailako hezkuntza (12 urtetik aurrera)
unibertsitate hezkuntza
62. Zenbat hilabetetan zehar eman zenion haurrari ama-esnea bakar-bakarrik (ez esne egokituak, zerealak,
63. Zenbat hoztura (doministikuak, eztula, ura bezalako mukia, sukarrarekin edo gabe) izan du zure semeak/alabak hozt
64. Zenbat hilabete zeuzkan zure semeak/alabak lehenbizikoz hotz hartu zuenean?
65.1 "Bai" erantzun baduzu, markatu egoki iruditzen zaizuna askokoa  neurrikoa gutxikoa
66. Lizuna (onddoak) edo hezetasun orbanak al daude haurra bizi den etxean? Bai Ez
67. Bere adinari dagozkion txerto guztiak dauzka zure semeak/alabak? Bai ez
6
69. Zenbat lagun bizi da, guztira, helduak eta haurrak hartuta, haurra bizi den etxean?
70. Aitaren lana
zuzendaria, administrtzailea, lizentziaduna
bestelako zuzendari tekniko ertaina, diplomaduna
erdiko buruak+, administrariak
esku langile kualifikatuak
esku langile erdikualifikatuak
kualifikaziorik gabeko langileak
gaizki zehaztutako beste kasu batzuk
orain ez dago lanean
71. Amaren lana
zuzendaria, administrtzailea, lizentziaduna
bestelako zuzendari tekniko ertaina, diplomaduna
koadro ertainak, administrariak
esku langile kualifikatuak
esku langile erdikualifikatuak
kualifikaziorik gabeko langileak
gaizki zehaztutako beste kasu batzuk
orain ez dago lanean
73. Zer erabiltzen da gehienbat, haurra bizi den etxeko sukaldean frijitzeko?
oliba olioa gurina margarina beste olio mota bat
hilabete
65 Semea/alaba atmosferaren kutsadura handia duen alderdian bizi al da, zure ustez? bai ez
(fabriketako keak, ibilgailuen trafiko handia, eta abar) )
68. Zenbat anaia-arreba dauzka zure semeak/alabak? anai-arreba
72. Haurraren amaren adina urte
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74. Haurdunaldian, zure semeak/alabak, zenbatetan jan edo edan zituen honako
hauek?noiz edo oso gutxitan  /  astean behin edo bitan  /  astean hirutan edo gehiagotan/,
ez zuen jan intolerantzia edo alergiagatik/  , ez dakit  /
Haragia (txahala, oilaskoa, axuria, untxia, txerria..) inoiz edo oso behin edo bitan hirutan edo gehiagotan alergiagatik ED
75. Zenbat denboran hartu zituen haurraren amak ahozko antisorgailuak galdera-zerrenda honetako haurrarekin haurdun gelditu baino
behin ere ez urte bat baino gutxiago 1etik 3ra urte bitartean 4tik 6ra urte bitartean  6 urte edo gehiagotan
76.1. Haurdunaldian parazetamola hartu bazenuen, zergatik hartu zenuen?
buruko mina/migraña sukarra muskuluetako mina beste zerbaitengatik
77. Galdera-zerrenda honetako haurraren haurdunaldian edo erditzerakoan, izan al zenuen konplikazio hauetakoren bat?
Mesedez, erantzun "Bai" edo "Ez" kasu bakoitzean
Etxean prestatutako hanburgesak inoiz edo oso behin edo bitan hirutan edo gehiagotan alergiagatik ED
Janari lasterra
 Pizza aurrekozinatuak, plater aurrekozinatuak inoiz edo oso behin edo bitan hirutan edo gehiagotan alergiagatik ED
Hanburgesak burgerretan, hot dogak eta abarrak inoiz edo oso behin edo bitan hirutan edo gehiagotan alergiagatik ED
Frijituak: kroketak, legatz-taketak, eta abar. inoiz edo oso behin edo bitan hirutan edo gehiagotan alergiagatik ED
Arrain zuria inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Arrain urdina inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Fruta/zuku naturalak inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Berdura freskoa inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Entsaladak inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Berdura kozinatua inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Lekaleak inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Zerealak, ogia barne inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Pasta inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Arroza inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Gurina inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Margarina inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Fruitu lehorrak edo kakahuete edota hur manteka inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
 Etxean prestatutako  patatak (frijituak barne) inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
 Esnea inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Poltsako patata frijituak eta snackak inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
 (gusanitoak, frijituak eta abarrak)
Jogurta inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
 Arrautzak inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Industria opilak, gailetak inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Edari alkoholdunak inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
Edari gasdunak inoiz edo oso gutxitan behin edo bitan hirutan edo gehiagotan alergiagatik ED
76. Galdera-zerrenda honetako haurraren haurdunaldian, zenbatetan  hartu zituen haurraren amak parazetamola (termalgin, gelocatil, e.a..)?
behin ere ez edo hilean behin baino utxiagotan hilean gutxienez  behin edo gehienez astean behin baino gehiagotan
Hipertentsioa ......................... Bai Ez
Umea galtzeko arriskua............... Bai Ez
 Infektzioak ............................ Bai Ez
Haurdunaldiko diabetesa ............. Bai Ez
Gaizki heldu zela ................ Bai Ez
Garaia baino lehenago urak botatzea Bai Ez
Arazoak plazentarekin .... Bai Ez  Zesarea ............................... Bai Ez
Fortzeps, bentosa................ Bai Ez
haurrarengan............................. Bai Ez
Trauma obstetrikoa
Zilbor-hestearen bueltak .............. Bai Ez
Prematuroa ..................... Bai Ez
Sufrimendu fetala, hipoxia Bai Ez
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Resumen
Introducción: La dieta mediterránea es un estilo de 
vida con efectos beneficiosos contrastados en el embara-
zo, tanto para la madre como para su descendencia. Sin 
embargo, se desconocen los factores que influyen en la 
adhesión a esta dieta.
Objetivo: Investigar los factores (nivel educativo, ocu-
pación, lugar de nacimiento, número de hijos previo y 
edad) que influyen en la adhesión a la dieta mediterránea 
en mujeres embarazadas de la comarca de Pamplona.
Material y métodos: Utilizando los datos del Estudio 
Internacional de Sibilancias en Lactantes (EISL) en la 
comarca de Pamplona, se analizaron las asociaciones en-
tre los alimentos y los factores. Se estableció una puntua-
ción de dieta mediterránea y se estudiaron las puntuacio-
nes de acuerdo a los factores.
Resultados: Se encontraron diferencias significativas 
en la puntuación de dieta mediterránea según el nivel 
de estudios (p=<0,001), la ocupación (p=0,015) y la edad 
(p=<0,001).
Conclusión: Mujeres con mejor nivel educativo, mejor 
ocupación y mayor edad muestran una mayor afinidad a 
la dieta mediterránea durante el embarazo.
(Nutr Hosp. 2015;31:1845-1852)
DOI: 10.3305/nh.2015.31.4.8420
Palabras clave: Embarazo. Dieta mediterránea.
CROSS-SECTIONAL STUDY OF FACTORS 
INFLUENCING ADHERENCE TO THE 
MEDITERRANEAN DIET IN PREGNANCY
Abstract
Introduction: Mediterranean diet is a lifestyle with 
contrasted beneficial effects on pregnancy, for both the 
mother and her offspring. However, factors influencing 
adherence to this diet are unknown.
Objective: To investigate the factors (educational level, 
occupation, place of birth, number of previous children 
and age) that influence adherence to the Mediterranean 
diet in pregnant women in the region of Pamplona.
Material and methods: Using the data from the Estudio 
Internacional de Sibilancias en Lactantes (EISL) in the re-
gion of Pamplona, associations between food and factors 
were analysed. A score of Mediterranean diet was establi-
shed and the scores according to the factors were studied.
Results: Significant differences in the Mediterranean 
diet score by level of education (p=<0,001), occupation 
(p=0,015) and age (p=<0,001) were found.
Conclusion: Women with better education, better oc-
cupation and older show a greater affinity to the Medite-
rranean diet during pregnancy.
(Nutr Hosp. 2015;31:1845-1852)
DOI: 10.3305/nh.2015.31.4.8420
Key words: Pregnancy. Mediterranean Diet.
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Introducción
La alimentación materna durante el embarazo influ-
ye tanto en la madre como en los recién nacidos, con 
efectos tales como riesgo de un parto prematuro1 y pre 
eclampsia2, o el riesgo de padecer enfermedades alér-
gicas en la infancia3.
La dieta mediterránea se caracteriza por el consumo 
abundante de alimentos vegetales (frutas, verduras, 
cereales, legumbres,…), un consumo moderado de 
productos lácteos, pescados y carne de aves, y un bajo 
consumo de carnes rojas, siendo el aceite de oliva la 
principal fuente de grasas4. 
Los beneficios de esta dieta durante el embarazo han 
sido previamente estudiados, tanto para las madres, 
que experimentan un menor incremento de peso du-
rante el embarazo5, como para la descendencia, siendo 
un factor protector de síntomas de asma y atopía6, con 
efectos positivos en la talla y peso al nacer7-9, y dismi-
nuyendo el riesgo de espina bífida10 y gastrosquisis11.
No obstante, a pesar de conocerse los numerosos be-
neficios asociados a una alimentación saludable, no exis-
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ten estudios sobre qué factores influyen en la alimenta-
ción durante el embarazo en las mujeres españolas.
El objetivo de este estudio transversal ha sido in-
vestigar qué factores (nivel de educación, ocupación, 
lugar de nacimiento, número de hijos previos y edad) 
influyen en la adhesión a la dieta mediterránea en mu-
jeres embarazadas en la comarca de Pamplona.
Material y métodos
Población del estudio
La población del estudio son las madres de los lac-
tantes incluidos en el Estudio Internacional de Sibilan-
cias en Lactantes (EISL)12 en la comarca de Pamplona. 
Este estudio observacional transversal multicéntrico se 
llevó a cabo entre los años 2006 y 2008, y en él parti-
ciparon 20 centros de salud.
Las familias participantes eran aquellas que acudían 
con su hijo/a a la revisión de los 15 meses de edad, se-
gún establecía el Programa de Niño Sano, y quisieron 
participar en el estudio.
Recolección de datos
Cuando las familias con su hijo/a acudían al centro 
de salud a la revisión de los 15 meses, una enfermera 
de pediatría les entregaba una carta de presentación del 
estudio, les solicitaba su colaboración y se les indicaba 
las instrucciones para rellenar el cuestionario.
Los cuestionarios se podían entregar en la siguien-
te visita, o remitirlos por correo a la Universidad Pú-
blica de Navarra. La recogida de cuestionarios desde 
los centros de salud se hizo por correo, y en ocasiones 
puntuales se hizo una recogida en el propio centro.
Con el fin de evitar problemas con el tratamiento de 
datos personales derivados de la Ley Orgánica 5/1992, 
de Regulación del Tratamiento Automatizado de los 
Datos de Carácter Personal, no se recogieron datos 
personales.
El cuestionario utilizado fue el modelo estándar 
utilizado en el EISL, utilizando una versión en cas-
tellano y otra en euskera. Este cuestionario ha sido 
validado13.
Se utilizaron preguntas que hacen referencia a la 
madre: “Lugar de nacimiento de la madre”, “Nivel de 
educación alcanzado por la madre del niño/a”, “Ocu-
pación de la madre”, “Edad de la madre”, y al número 
de hijos previos con la pregunta: “Número de herma-
nos que tiene su hijo/a”.
En el cuestionario se incluye un apartado dedicado a la 
alimentación materna en el embarazo, que consta de 26 
ítems que incluyen diferentes grupos de alimentos: car-
ne, comida rápida, pescado, fruta, verduras y ensaladas, 
legumbres, cereales, pasta, arroz, mantequilla y marga-
rina, frutos secos, patatas, snacks, leche, yogur, huevos, 
bollería industrial y bebidas alcohólicas y gaseosas.
Se preguntó la frecuencia con la que se consumieron 
los alimentos, siendo las posibles respuestas: “Nunca”, 
“1-2 veces por semana”, “3 o más veces por semana”, 
“Alergia” y “No sabe”.
Se desarrolló una puntuación de la dieta mediterrá-
nea en base a la clasificación usada por García-Mar-
cos et al.14. Como alimentos de una dieta mediterránea 
se incluyeron: pescado (blanco y azul), fruta, verdura 
fresca y cocinada, ensaladas, legumbres, cereales, pas-
ta, arroz, patatas y frutos secos, valorando su consumo 
con una puntuación entre 0 (Nunca), 1 (1-2 veces por 
semana), y 2 (3 o más veces por semana). Los alimen-
tos considerados no adecuados en la dieta mediterrá-
nea fueron: carne, comida rápida, leche y snacks, pun-
tuando su consumo entre 2 (Nunca), 1 (1-2 veces por 
semana), y 0 (3 o más veces por semana).
Se excluyeron del estudio aquellas mujeres que no 
habían contestado la frecuencia de consumo de más de 
seis alimentos incluidos en la encuesta.
Análisis estadístico
Se utilizó el test chi cuadrado de independencia 
con el método Montecarlo para cada alimento, con 
un intervalo de confianza del 95%, según el nivel de 
educación, la ocupación y el lugar de nacimiento de 
la madre. Para la diferencia entre las medias según el 
número de hermanos y la edad de la madre se utilizó 
un test ANOVA.
En la puntuación de la dieta mediterránea se calculó 
la media y la desviación típica, y la puntuación mínima 
y máxima de cada grupo, y se estudiaron las diferen-
cias mediante un test ANOVA.
El nivel de significación estadística se estableció 
en α<0,05.
Todos los cálculos se hicieron con el software IBM 
SPSS Statistics versión 20 (Chicago, Illinois, EEUU).
Resultados
El número total de participantes en el EISL fue 1065 
mujeres. De ellas, 1051 (98,69%) cumplieron con los 
requisitos y fueron la muestra de este estudio.
En ninguno de los factores estudiados existieron di-
ferencias significativas en el consumo de carne, yogur 
y huevos.
Las mujeres con un menor nivel de estudios comían 
más platos precocinados, hamburguesas de burguers, 
frituras, y snacks. Por el contrario, el consumo de pesca-
do azul, verdura fresca y cocinada, y cereales fue mayor 
en mujeres con un nivel más alto de estudios (Tabla I).
El consumo de hamburguesas caseras y en burguers 
fue mayor en mujeres con una peor ocupación. La 
misma tendencia se observó en el caso de las frituras, 
ensaladas, verdura fresca y cocinada, y margarina. Por 
otro lado, son las mujeres con mejores ocupaciones las 
que comían significativamente menos arroz (tabla I).
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Según el lugar de nacimiento, existieron diferencias 
significativas en el consumo de hamburguesas caseras 
y de burguers, platos precocinados, frituras, pescado 
blanco y azul, legumbres, cereales, pasta, arroz, man-
tequilla y margarina, patatas, leche, y bebidas alcohó-
licas y gaseosas (Tabla I).
En la tabla II se exponen los resultados que mues-
tran que aquellas mujeres que tuvieron más hijos co-
mieron significativamente más hamburguesas caseras, 
frituras, mantequilla y margarina. Asimismo, son estas 
mujeres las que más frecuentemente comían pescado 
blanco durante el embarazo. 
Las embarazadas más jóvenes consumieron signifi-
cativamente más platos precocinados y hamburguesas 
en burguers, arroz, y bebidas gaseosas. Por el contra-
rio, aquellas mujeres de más edad, durante el embara-
zo, comieron más pescado blanco y azul, fruta fresca, 
ensaladas, verdura fresca y cocinada, cereales, marga-
rina, y frutos secos (Tabla III).
En la tabla IV se exponen las puntuaciones de la die-
ta mediterránea, que muestran diferencias significati-
vas en el nivel de estudios (p=<0,001), la ocupación 
(p=0,015), y la edad de la madre (p=<0,001). No se 
encontraron diferencias significativas según el lugar 
de nacimiento de la madre o el número previo de hijos. 
Discusión
En este estudio los resultados sugieren que la ad-
hesión a la dieta mediterránea por parte de mujeres 
embarazadas es significativamente mayor en aquellas 
que poseen un mejor nivel educativo, una ocupación 
de más nivel, y en mujeres con mayor edad.
Las mujeres embarazadas con un mejor nivel educati-
vo presentaron una mayor adherencia a la dieta medite-
rránea, una afirmación refrendada por otros estudios15,16. 
Esto puede ser debido a que un mayor nivel educativo 
puede indicar un mayor autoconocimiento de la salud 
y cuidado personal, lo que puede influir en adoptar una 
dieta saludable, más aún en el embarazo. El hecho de 
poseer conocimientos sobre nutrición está asociado a la 
adhesión a la dieta mediterránea17, pudiendo estar este 
hecho relacionado con un mayor nivel educativo.
Aquellas mujeres con unos mayores ingresos, medidos 
por su ocupación, mostraron una mayor adherencia a la 
dieta mediterránea, un resultado concordante con otros 
estudios16,18. Un mayor poder adquisitivo permite com-
prar una variedad mayor de alimentos. Además, una parte 
de los alimentos que forman parte de la dieta mediterrá-
nea tienen precios altos (frutas, pescados), lo que puede 
dificultar el acceso para alguna gente con ingresos más 
bajos, que seleccionará productos más baratos, pese a que 
no se adapten a los estándares de la dieta mediterránea.
La edad es otro factor que muestra diferencias sig-
nificativas, siendo las mujeres de mayor edad las que 
muestran una mayor adhesión a la dieta mediterránea, 
algo que también se encontró en otros estudios19. Una 
posible explicación es que las mujeres más mayores 
suelen tener mayor conciencia de su salud y tienden a 
cuidarse más, como sucede en este caso, con la elec-
ción de una dieta más saludable.
No obstante, hay estudios que con resultados contra-
rios a los encontrados. Un estudio en población marro-
quí20 no encontró ninguna asociación entre la adhesión 
a la dieta mediterránea y la edad, los ingresos o el nivel 
educativo. Un posible motivo que explique este hecho 
puede venir de las diferencias culturales que existen 
entre Marruecos y los países europeos, existiendo en 
Marruecos estándares dietéticos adecuados y asumi-
dos por la población, sin importar los factores que sí 
influyen en las dietas de otros países.
Los resultados de otro estudio portugués21 mostra-
ron que las familias con un mejor nivel socioeconó-
mico tienen una dieta más pobre. Esto está motivado, 
según dicho estudio por cambios en los patrones de 
alimentación al cambiar el estilo de vida (la vida urba-
na y mayores ingresos conducen a consumir otro tipo 
de alimentos menos saludables que las personas que 
viven en áreas rurales y mantienen una dieta más salu-
dable). En nuestro estudio no se ha tenido en cuenta el 
entorno donde viven las familias, pero los resultados 
hallados indicaron que las mujeres con mayor nivel 
socioeconómico, al contrario de lo encontrado en este 
estudio, mostraron una mayor adhesión.
Las fortalezas de este estudio son la amplia muestra 
estudiada, más aun tratándose de una población de ta-
maño pequeño como es la comarca de Pamplona, y que 
el estudio haya sido dirigido a estudiar patrones de ali-
mentación en mujeres embarazadas, un colectivo sobre 
el que apenas existe bibliografía en relación a este tema.
Las debilidades serían el hecho de no disponer de un 
cuestionario más detallado para este tipo de estudios, 
ya que el modelo utilizado, si bien ha sido validado, 
fue concebido inicialmente para estudios de otra ín-
dole. Otra de las debilidades es el posible sesgo de re-
cuerdo que pueda existir, ya que las madres respondían 
al cuestionario cuando su hijo acudía a una revisión a 
los 15 meses de edad.
Los resultados obtenidos según el factor de lugar de 
nacimiento de la madre pueden ser confusos, ya que la 
población extranjera participante en el estudio fue muy 
minoritaria. Otros estudios centrados estos colectivos 
sería útil para hallar resultados más sólidos.
En conclusión, aquellas mujeres con un mayor nivel 
educativo, una mejor ocupación y mayor edad mues-
tran una mayor adhesión a la dieta mediterránea, un 
estilo de vida con beneficios contrastados, tanto para 
la madre como para su descendencia.
Sería conveniente realizar más estudios sobre este 
tema, con cuestionarios más amplios y específicos, a 
fin de contrastar si los resultados obtenidos en este es-
tudio son acordes, y en ese caso, plantear políticas para 
la promoción de la dieta mediterránea entre aquellas 
mujeres embarazadas que muestren adhesiones más 
bajas, vistos los numerosos beneficios que conlleva 
una alimentación saludable, tanto para la madre como 
para el recién nacido. 
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Tabla IV 
 Puntuaciones de la dieta mediterránea según los factores
N Media Desv. típica Mínimo Máximo p
Nivel de educación <0,001
Educación universitaria 537 24,24 3,049 7 33
Educación secundaria completa 416 23,61 3,291 14 32
Educación secundaria incompleta 57 24,14 3,335 15 32
Educación básica 30 21,93 3,648 12 29
Ocupación 0,015
Directivos, administrativos 160 24,66 2,668 17 31
Otros directivos, técnicos medios 144 24,26 2,938 15 31
Cuadros intermedios, administrativos 219 23,78 3,146 14 33
Trabajadores manuales cualificados 126 23,83 3,505 14 32
Trabajadores manuales semicualificados 32 23,47 3,121 14 30
Trabajadores manuales no cualificados 28 23,68 3,255 17 29
Otros casos, mal especificado 36 24,39 2,930 16 29
Actualmente no trabaja 278 23,47 3,548 7 32
Lugar de nacimiento 0,204
España 954 23,97 3,200 7 33
Europa 31 23,13 3,149 16 28
América 48 23,19 3,606 14 30
Resto del mundo 8 23,88 3,563 17 27
Edad de la madre <0,001
≥40 77 24,57 3,105 14 30
35-39 375 24,27 3,006 14 33
30-34 471 23,87 3,013 14 32
25-29 108 22,66 3,824 7 29
≤25 16 22,63 5,536 12 30
Número previo de hijos 0,861
0 533 23,90 3,338 7 33
1 434 23,90 3,098 12 32
2 63 23,78 3,195 15 30
3 10 23,30 2,312 20 27
4 o más 10 25,40 1,897 23 28
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Abstract
Background:  Wheezing  in  the  ﬁrst  year  of  life  affects  the  baby’s  and  family’s  quality  of  life.  Risk
factors such  as  male  gender,  nursery  attending  or  a  family  history  of  asthma,  and  protective
factors such  as  breastfeeding  more  than  six  months  have  been  previously  described.  The  aim  of
this  study  is  to  study  the  prevalence  and  risk  factors  for  wheezing  ever  and  recurrent  wheezing
in  the  ﬁrst  year  of  life  in  infants  in  the  region  of  Pamplona,  Spain.
Material  and  methods:  This  cross-sectional  study  was  part  of  the  International  Study  of  Wheez-
ing in  Infants  (Estudio  Internacional  de  Sibilancias  en  Lactantes,  EISL).  Between  2006  and  2008,
participating  families  answered  a  standardised  validated  questionnaire  on  respiratory  symp-
toms,  environmental  factors  or  family  issues.  An  analysis  with  the  chi  square  test  (statistical
signiﬁcance  p  <  0.05)  identiﬁed  the  risk  factors  for  wheezing  ever  and  recurrent  wheezing,  which
were  assessed  using  logistic  regression.
Results:  1065  questionnaires  were  answered.  The  prevalence  of  wheezing  ever  and  recurrent
wheezing were  31.2%  and  12.3%,  respectively.  Male  gender  (p  =  <  0.001),  a  history  of  pneu-
monia  (p  =  <  0.001)  or  nursery  attendance  (p  =  <  0.001)  were  some  of  the  risk  factors  found
for wheezing  ever.  Infant  eczema  (p  =  <  0.001),  nursery  attendance  (p  =  <  0.001)  or  prematurity
(p  =  <  0.001)  were  risk  factors  for  recurrent  wheezing.  No  associations  with  duration  of  breast-
feeding  (p  =  0.116  and  p  =  0.851)  or  mould  stains  at  home  (p  =  0.153  and  p  =  0.992)  were  found.
Conclusion:  The  study  of  prevalence  and  risk  factors  for  wheezing  shows  the  importance  of  this
public health  problem,  and  allows  the  development  of  control  and  treatment  strategies  against
preventable  factors.
© 2015  SEICAP.  Published  by  Elsevier  Espan˜a,  S.L.U.  All  rights  reserved.
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Introduction
Wheezing  in  infants  is  an  important  problem,  affecting  chil-
dren’s health-related  quality  of  life,1 and  can  lead  to  asthma
in childhood.2,3
Prevalence  of  wheezing  ever  in  infants  varies  across  dif-
ferent regions,  from  29%  in  countries  in  Northern  Europe,  to
48% in  countries  in  Southern  Europe,  and  27%  in  the  United
States of  America  (USA).4 Previous  studies  have  found  asso-
ciations between  rainy  weather  and  severe  current  wheeze
in schoolchildren,5 and  stronger  associations  of  some  risk
and protective  factors  of  recurrent  wheezing  when  latitude
increases.6
Several  risk  factors  have  been  described,  with  the  most
important being  male  sex,  familiar  history  of  asthma,
nursery attendance,  history  of  pneumonia,  smoking  dur-
ing pregnancy,  mould  stains  in  the  house  and  breastfeeding
fewer than  six  months.7--9 Protective  factors  such  as  breast-
feeding more  than  eight  months10 and  adherence  to  the
Mediterranean diet11 have  been  found.
Although  previous  studies  about  wheezing  in  infants  have
been conducted,  none  of  them  have  studied  the  epidemiol-
ogy of  the  disease  in  the  North  of  Spain.  The  aim  of  this
cross-sectional study  is  to  examine  the  prevalence  and  risk
factors of  wheezing  ever  and  recurrent  wheezing  in  the  ﬁrst
year of  life  in  infants  from  the  region  of  Pamplona.
Materials and methods
Study  population
This  study  was  part  of  the  International  Study  of  Wheezing
in Infants  (in  Spanish,  Estudio  Internacional  de  Sibilancias
en Lactantes,  EISL),  an  observational  cross-sectional  mul-
ticentre study  conducted  in  countries  of  Europe  and  Latin
America.12
In  the  region  of  Pamplona,  this  study  was  conducted
between 2006  and  2008,  where  20  primary  care  centres  par-
ticipated. The  population  of  the  study  were  the  infants  of
the metropolitan  area  of  Pamplona  (an  urban  area  consist-
ing of  Pamplona  and  adjacent  cities)  who  went  to  a  health
check-up at  15  months  of  age.  The  sample  size  was  3284
infants (from  urban  localities),  all  the  children  in  the  age
range (12--15  months  of  age).  Random  sampling  was  not  car-
ried out,  the  questionnaire  was  given  to  all  families,  who
were asked  to  complete  it  and  return  after  completion.  The
study was  approved  by  the  Management  of  Primary  Care  of
Navarre’s Health  Service  and  the  Scientiﬁc  Ethic  Committee
of University  of  Murcia.
Data  collection
Paediatric  nurses  of  the  primary  health  centres  explained
the study  to  the  families,  and  if  they  agreed  to  participate,
after signing  a  full-informed  written  consent,  a  question-
naire and  the  instructions  to  complete  it  were  given.
Families ﬁlled  out  the  questionnaire  and  could  hand  it  in
at the  same  primary  health  centre  on  the  following  visit,  or
send it  to  the  Public  University  of  Navarre  by  mail.
The questionnaire  consisted  of  74  questions  about  the
infant (respiratory  symptoms,  feeding),  his/her  family
(habits, diseases),  environmental  factors  and  pregnancy.  No
personal data  were  collected.  This  questionnaire  has  been
previously validated.13 A  Spanish  version  of  the  question-
naire was  back  translated  to  Basque  (an  ofﬁcial  regional
language) by  the  Department  of  Euskera  of  the  Public  Uni-
versity of  Navarre,  and  both  models  were  available.
Wheeze  ever  was  deﬁned  as  a positive  answer  to  the
question ‘‘Has  your  child  wheeze  in  the  ﬁrst  12  months  of
his/her life?’’  Recurrent  wheeze  was  deﬁned  as  three  or
more episodes  of  wheezing  in  the  ﬁrst  year  of  life.
Statistical  analysis
A  descriptive  analysis  was  carried  out.  Chi  Square  and
Student’s-t test  (as  appropriate),  with  a statistical  signiﬁ-
cance set  at  ˛  <  0.05,  were  performed  in  a  univariate  analysis
to study  the  associations  between  the  presence  of  wheez-
ing ever  and  recurrent  wheezing  and  factors,  and  the  odds
ratios (OR)  with  a  conﬁdence  interval  of  95%  (95%  CI)  were
calculated.
Non-conditional logistic  regression  analysis  to  calculate
adjusted odds  ratios  (aOR)  by  sex  and  age  was  used  in  those
factors with  p  < 0.1.  Analyses  were  performed  with  IBM  SPSS
version 20  (Armonk,  NY,  USA).
Results
A  total  of  1065  questionnaires  were  answered,  which  meant
a participation  rate  of  32.4%.  Results  from  the  descriptive
analysis are  shown  in  Table  1.  Prevalence  of  wheezing  in  the
ﬁrst year  was  31.2%  (327),  and  12.3%  (106)  were  recurrent
wheezers. Most  of  the  questionnaires  were  completed  by  the
mothers (79.9%)  or  both  parents  (15.8%),  and  almost  all  the
infants were  Caucasian  and  had  been  born  in  Spain  (96.8%
and 99.5%,  respectively).  121  (13.1%)  infants  had  attended
the Emergency  Department  due  to  the  severity  of  wheezing,
and 27  (2.7%)  had  been  hospitalised  once  and  three  (0.3%)
twice for  this  cause.
Risk factors  for  wheezing  ever  are  shown  in  Table  2.  A
history of  pneumonia,  paternal  allergic  dermatitis  and  nurs-
ery attendance  presented  the  largest  OR.  There  were  also
associations between  wheezing  ever  and  a higher  number
of colds  (p  =  <  0.001;  aOR  1.164,  95%  CI  1.102--1.230)  and
number of  persons  at  home  (p  =  0.037;  aOR  1.155,  95%  CI
1.008--1.323).
No associations  were  found  with  low  weight  at  birth
(p =  0.268),  pets,  nor  at  birth  or  when  the  questionnaire
was answered  (p  = 0.810  and  p  =  0.372,  respectively),  mould
stains in  the  house  (p  =  0.153),  or  breastfeeding  fewer  than
six months  (p  =  0.116).
In  Table  3,  risk  factors  for  recurrent  wheezing  are  pre-
sented. A  history  or  pneumonia,  infant  eczema,  nursery
attendance and  prematurity  at  birth  were  the  most  impor-
tant risk  factors.  Higher  number  of  colds  (p  =  <  0.001;  aOR
1.381, 95%  CI  1.266--1.505)  and  higher  number  of  smokers
at home  (p  =  0.029;  aOR  1.328;  95%  CI  1.017--1.735)  were
also risk  factors  for  recurrent  wheezing.  There  were  no  asso-
ciations with  low  weight  at  birth  (p  =  0.158),  mould  stains
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Table  1  Results  from  the  descriptive  analysis.
Variables  N  %
Study  participation 1065 32.4
Male  gender  519  50.3
Age  (in  months)  12.08  ±  0.94
Low weight  at  birth  (<2500  g)  82  7.7
Wheezing
Ever 327  31.2
Recurrent  106  12.3
Age  of  ﬁrst  episode  (in  months)  6.88  ±  5.66
Colds
Number of  colds 3.78  ±  3.60
Age of  the  ﬁrst  cold  (in  months) 5.84  ±  4.25
Pneumonia 42  4.2
Eczema 134  13.2
Smoking  mother  216  20.6
Smoking  father  306  29.8
Smoking  in  pregnancy  170  16.2
Asthma
Father  44  4.2
Mother 53  5.3
Siblings 28  2.8
Allergic rhinitis
Father 135  13.1
Mother  138  13.2
Siblings  22  2.2
Allergic dermatitis
Father 38  3.7
Mother 61  5.9
Siblings 55  5.9
Number of  siblings
0 542  50.9
1  438  41.1
2  64  6.0
3 or  more 20 1.9
Number of  persons  at  home 3.45  ±  0.99
Nursery attendance 349 33.2
Breastfeeding  (in  months) 5.50  ±  4.99
Pets (at  birth)
No pets  853  81.9
Dog  63  6.0
Cat 33  3.2
Pets (when  questionnaire  was  completed)
No  pets  840  81.0
Dog  55  5.3
Cat 33  3.2
Mould stains  at  home  45  4.3
Atmospheric contamination  263  25.1
(p  =  0.992),  atmospheric  contamination  (p  =  0.708)  or  breast-
feeding fewer  than  six  months  (p  =  0.851).
Discussion
Wheezing  in  infants  is  a  major  problem,  affecting  not  only
the quality  of  life  of  infants,  but  also  of  their  families.  Our
study has  found  several  risk  factors  related  to  wheezing  ever
and recurrent  wheezing  in  infants  from  the  region  of  Pam-
plona.
Prevalence  of  wheezing  ever  in  infants  in  our  study  was
31.2%, a similar  prevalence  compared  to  other  EISL  studies
conducted in  Spain,  in  the  city  of  Salamanca,  which  found
32.3%14 and  in  Netherlands,  28.5%,7 but  less  prevalence  than
in Latin  America  countries,  where  mean  prevalence  was
47.3%.15 Prevalence  of  recurrent  wheezing  was  12.3%,  sim-
ilar to  the  other  Spanish  EISL  study,14 but  lower  than  other
European and  Latin  American  studies.7,9
Male  gender  was  a  risk  factor  for  wheezing  ever  and
recurrent wheezing  in  our  study.  This  ﬁnding  is  in  accordance
with what  has  been  found  in  other  studies,16,17 suggesting  a
genetic role  in  the  appearance  of  wheezing.
In  our  study,  low  birth  weight  did  not  show  any  associa-
tion with  wheezing  ever  or  recurrent  wheezing.  Our  results
contrast with  ﬁndings  from  another  Brazilian  study  in  which
low birth  was  an  independent  risk  factor  for  occasional
wheezing.18
Both  a  history  of  pneumonia  and  a  higher  number  of  colds
were risk  factors  for  wheezing  ever  and  recurrent  wheezing.
Several studies  agree  with  these  ﬁndings,19,20 with  pneu-
monia being  a  strong  risk  factor  for  recurrent  wheezing  in
European and  Latin  American  countries.21 The  relevance  of
infections of  the  respiratory  tract  has  been  previously  stud-
ied, describing  the  relation  between  viral  infections22 and
the development  of  wheezing.
In  our  study,  infant  eczema  presented  a  higher  risk  for
both wheezing  ever  and  recurrent  wheezing.  This  rela-
tion was  also  found  in  another  EISL  study,14 although  it  is
not a  general  ﬁnding,  suggesting  it  affects  some  popula-
tions. Garcia-Marcos  et  al.21 found  that  infant  eczema  was
a risk  factor  for  pneumonia  in  infants,  which  suggests  a  role
between eczema  and  the  development  of  other  risk  factors
which lead  to  wheezing.
We  found  that  smoking  mother,  as  well  as  smoking
during pregnancy,  were  risk  factors  for  wheezing  ever
and recurrent  wheezing,  ﬁndings  which  have  been  previ-
ously described  in  many  studies.23--25 Although  a  Spanish
study found  that  paternal  smoking  was  not  associated  with
wheezing,26 we  found  it  as  risk  factor  for  recurrent  wheez-
ing. Our  results  also  show  that  number  of  smokers  at  home
was a  risk  factor  for  recurrent  wheezing,  according  to
the ﬁnding  that  household  smoking  increases  the  risk  of
wheeze.24 Exposure  to  smoke,  especially  during  pregnancy,
is related  to  decreased  lung  function  in  children,27 sug-
gesting an  important  inﬂuence  in  the  apparition  of  the
disease.
As in  our  study,  a  parental  history  of  asthma  has  been
found as  risk  factors  in  many  studies.9,15 These  results  may
suggest the  existence  of  a  hereditary  mechanism  for  asthma
and wheezing.28 Maternal  allergic  rhinitis  was  found  as  a
risk factor  for  recurrent  wheezing,  and  paternal  allergic  der-
matitis for  wheezing  ever.  These  results  agree  with  results
from others  EISL  studies,7,9 where  allergic  diseases  were  risk
factors for  wheezing  ever  and  recurrent  wheezing.
Attending  nursery  school  was  found  as  a risk  factor  for
both wheezing  ever  and  recurrent  wheezing.  Previous  results
are conﬂictive,  with  several  studies  which  either  not  found
any association,29 or  described  a  protective  effect,30 while
others agree  with  our  results.31 An  explanation  for  our
results may  be  that  children  who  attended  a nursery  school
were in  contact  with  other  children  and  a  different  environ-
ment, increasing  the  exposure  to  possible  risk  factors.
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Table  2  Risk  factors  for  wheezing  ever  in  the  ﬁrst  year  of  life.
Variables  N  (%)  p-Value  OR
(95%  CI)
Adjusted  OR
(95% CI)
Male  gender  193  (60.7%)  <0.001  1.825
(1.393--2.390)
1.836
(1.398--2.413)
Pneumonia  33  (10.5%)  <0.001  11.173
(4.885--25.558)
10.745
(4.638--24.896)
Eczema 57  (18.0%)  0.003  1.764
(1.215--2.561)
1.886
(1.278--2.783)
Smoking mother  79  (24.6%)  0.027  1.429
(1.042--1.962)
1.462
(1.054--2.029)
Smoking father 98 (31.2%) 0.444 1.120
(0.838--1.496)
--
Smoking  in  pregnancy  65  (20.1%)  0.022  1.491
(1.058--2.102)
1.617
(1.133--2.308)
Asthma
Father 20  (6.2%)  0.036  1.900
(1.034--3.492)
1.926
(1.027--3.611)
Mother 25  (8.0%)  0.015  1.978
(1.133--3.452)
1.749
(0.978--3.126)
Siblings 7  (2.2%)  0.428  0.706
(0.297--1.678)
--
Allergic rhinitis
Father 38  (12.0%)  0.546  0.883
(0.590--1.322)
--
Mother 53  (16.5%)  0.050  1.447
(0.998--2.099)
1.391
(0.946--2.045)
Siblings 6  (2.0%) 0.674  0.816
(0.316--2.106)
--
Allergic dermatitis
Father 19  (6.0%)  0.012  2.258
(1.178--4.326)
2.492
(1.268--4.896)
Mother 19  (5.9%)  0.956  0.984
(0.563--1.721)
--
Siblings 20  (6.5%)  0.454  1.241
(0.704--2.188)
--
Nursery attendance  138  (42.7%)  <0.001  1.867
(1.419--2.455)
2.003
(1.507--2.663)
Mould stains  at  home  18  (5.6%)  0.153  1.561
(0.843--2.891)
--
Gestational  diabetes  29  (9.6%)  0.075  1.572
(0.952--2.596)
1.501
(0.882--2.553)
Prematurity  32  (11.0%)  0.077  1.526
(0.953--2.442)
1.461
(0.892--2.393)
We  did  not  ﬁnd  any  relation  between  mould  stains  in  the
house and  wheezing  ever  or  recurrent  wheezing,  contrary
to the  Dutch  EISL  study,7 which  found  damp  housing  as  a
strong risk  factor  in  both  cases.  In  our  study,  only  a  few
families reported  mould  stains  or  damp  at  home,  which  may
have  affected  our  ﬁndings,  causing  an  underestimation  of  its
inﬂuence.
Complications during  pregnancy,  speciﬁcally  prematurity
and malposition  of  the  foetus,  were  risk  factors  for  recur-
rent wheezing.  Both,  prematurity32 and  malpresentation  of
the foetus33 were  previously  found  associated  with  recur-
rent wheezing  and  asthma.  Premature  infants  are  born  with
abnormalities in  their  airways,  which  probably  provoke  the
apparition  of  wheezing.34 In  the  same  way,  malposition  is
supposed to  affect  the  lung  function  of  the  foetus,  which
can cause  respiratory  problems  at  an  early  age.
Breastfeeding  showed  no  association  in  our  study.  Find-
ings from  previous  studies  are  conﬂictive.  Breastfeeding
was found  as  a  protective  factor  in  some  of  them.10 How-
ever, other  studies  did  not  reach  any  relationship,35 or
even described  breastfeeding  as  a  risk  factor  for  asthma  in
childhood.36
Although  previous  studies  have  described  a  protective
effect in  those  children  with  pets  in  the  house,37 probably
due to  the  exposition  at  early  age  to  certain  microor-
ganisms that  confer  protection  against  asthma,  ﬁndings
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Table  3  Risk  factors  for  recurrent  wheezing  in  the  ﬁrst  year  of  life.
Variables  N  (%)  p-Value  OR
(95%  CI)
Adjusted OR
(95% CI)
Male  gender  64  (61.0%)  0.004  1.852
(1.208--2.842)
1.838
(1.198--2.821)
Pneumonia 15  (14.6%)  <0.001  14.574
(5.506--38.575)
15.758
(5.852--42.430)
Eczema 25  (24.0%)  <0.001  2.941
(1.723--5.019)
3.134
(1.811--5.425)
Smoking mother  27  (25.7%)  0.028  1.731
(1.057--2.833)
1.665
(1.008--2.748)
Smoking father 42 (40.0%) 0.022 1.654
(1.072--2.551)
1.605
(1.033--2.493)
Smoking  in  pregnancy  25  (24.0%)  0.006  2.033
(1.217--3.396)
2.034
(1.208--3.426)
Asthma
Father 7  (6.7%)  0.195  1.780
(0.737--4.302)
--
Mother 11  (10.9%)  0.005  2.858
(1.332--6.131)
2.806
(1.290--6.102)
Siblings 2  (2.1%)  0.662  0.718
(0.161--3.190)
--
Allergic rhinitis
Father 14  (13.6%)  0.822  1.073
(0.578--1.992)
--
Mother 24  (22.9%)  0.002  2.275
(1.343--3.852)
2.234
(1.298--3.845)
Siblings 3  (3.1%) 0.566 1.458
(0.399--5.326)
--
Allergic dermatitis
Father 6  (5.9%)  0.266  1.699
(0.661--4.364)
--
Mother 6  (5.8%)  0.987  1.008
(0.409--2.480)
--
Siblings 6  (6.1%)  0.539  1.334
(0.531--3.354)
--
Nursery attendance  55  (53.4%)  <0.001  2.906
(1.890--4.467)
3.045
(1.960--4.731)
Mould stains  at  home  4  (3.9%)  0.992  0.995
(0.334--2.960)
--
Malposition of  the  foetus  6  (6.2%)  0.036  2.853
(1.029--7.910)
2.933
(1.039--8.277)
Placental problems  8  (8.3%)  0.055  2.268
(0.963--5.342)
2.285
(0.956--5.460)
Prematurity 18  (18.8%)  <0.001  3.115
(1.676--5.789)
3.112
(1.653--5.856)
are  conﬂictive.38 Our  results  did  not  show  any  association
between the  presence  of  pets  at  home  and  wheezing  ever
or recurrent  wheezing.
We  did  not  ﬁnd  any  relation  with  air  pollution  in  our  study.
However, several  studies  have  found  associations  between
this factor  and  wheezing.39,40 The  questionnaire  asked  for
a personal  perception  of  air  pollution  level,  which  means  a
subjective measure  that  may  have  led  to  underestimation.
One  of  the  strengths  of  this  study  was  the  use  of  a
validated questionnaire,  a  well-recognised  tool  which  has
been used  in  other  studies.  Moreover,  this  study  is  part  of
the  multicentre  EISL  project,  which  enables  the  compari-
son of  the  results  obtained  with  other  centres  from  Spain
or other  countries.  One  of  the  limitations  of  the  study  is
its cross-sectional  design,  although  the  main  weakness  is
its low  participation,  probably  due  to  the  low  participa-
tion of  the  immigrant  population,  and  to  data  protection
issues and  authorisations  of  the  Health  System,  which  made
it not  possible  to  send  reminder  letters  or  telephone  calls  to
participants, which  would  have  increased  the  participation,
reducing the  confusion  of  some  results,  or  allows  ﬁnding
others.
420  I.  Alvarez-Alvarez  et  al.
In  conclusion,  wheezing  in  infants  is  a  common  disease,
with several  identiﬁed  risk  factors,  like  pneumonia,  family
history of  asthma  and  nursery  attendance.  Further  stud-
ies are  needed  to  test  if  these  ﬁndings  are  consistent,
and intervention  against  the  preventable  factors  should  be
addressed.
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Abstract
Background: Wheezing affects children’s quality of life, and is related with asthma in childhood.
Although prevalence of wheezing has been previously studied in several countries, there is no
reference of worldwide prevalence in infants. The aim of this meta-analysis is to estimate the
prevalence of wheezing and recurrent wheezing in infants aged up to two years, and compare
the prevalence across world regions.
Methods: Literature search was conducted in MEDLINE and SCOPUS databases, looking for
observational studies published up to June 2016, including as keywords ‘‘prevalence’’ or
‘‘epidemiology’’ combined with ‘‘wheeze’’, ‘‘wheezing’’ or ‘‘asthma symptoms’’ and ‘‘infant’’
or ‘‘preschool’’. Fast*Pro software and random effects Bayesian model were used. Heterogene-
ity was estimated using I2 statistic, and sensitivity analyses were performed.
Results: We identiﬁed 109 studies after duplicates were removed. After exclusions, 14 stud-
ies were included in the meta-analysis. Prevalence of wheezing and recurrent wheezing
were 36.06% (95% CI 35.17--36.96), and 17.41% (95% CI 16.74--18.09), respectively. In Euro-
pean countries, prevalence of wheezing was 30.68% (95% CI 28.97--32.45), and 12.35% (95%
CI 11.27--13.47) for recurrent wheezing. Prevalence of wheezing and recurrent wheezing in
Latin America were higher, 40.55% (95% CI 39.40--41.71), and 19.27% (95% CI 18.44--20.11),
respectively. In Africa, prevalence of wheezing was 15.97% (95% CI 14.05--18.00). Low or no
heterogeneity was found in all cases.
Conclusions: More than one third of infants suffer from wheezing and almost one ﬁfth from
recurrent wheezing, being these illnesses especially prevalent in Latin American countries,
pointing out an important public health problem.
© 2016 SEICAP. Published by Elsevier Espan˜a, S.L.U. All rights reserved.
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1. Background 
The Institut de Santé Publique, d’Epidémiologie et de Développement 
In 1989, the Victor Segalen Bordeaux II University created a Training and 
Research Unit of Public Health, transformed in 1997 into the Institut de Santé Publique, 
d’Epidémiologie et de Développement (ISPED), nowadays known as the Bordeaux 
School of Public Health. 
It provides both teaching and research activities, and promotes a multidisciplinary 
approach around epidemiology, biostatistics, health management and social sciences. 
Their main areas of research are related to brain aging, HIV, clinical research, nutrition, 
trauma, occupational health, environmental health, cancer, hospital management, public 
health policy evaluation, etcetera. 
The ISPED provides teaching and research activities at national and international 
level, with relations with many developing countries, allowing the reception of foreign 
students or realization of cooperative research (ISPED webpage). 
Figure 1. Institut de Santé Publique, d’Epidémiologie et de Développement logo.  
 
My internship took place in the ISPED during three months in the year 2014, 
under the academic supervision of Dr. Chantal Raherison, from the “Equipe Santé travail 
environnement”. 
I worked in the Etude Longitudinale Française depuis l’Enfance (Elfe, in English 
French Longitudinal Study in Children). The Elfe study is divided in twenty thematic 
groups, divided in social sciences, health, environmental heath, and cross-cutting groups, 
where Dr. Raherison, is responsible of the “Respiratory disease, asthma & allergies” 
group. 
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2. Methods 
Etude Longitudinale Française depuis l’Enfance 
The Elfe study is a multidisciplinary national longitudinal study conducted in 
France. Longitudinal studies in the first years of life are essential to identify health risk 
factors which can affect children’s development. 
The Elfe study is the result of the coalescence of several projects which were 
promoted by different research and government institutions. In 2005, these projects 
converged in this unique study. 
The purpose of the study was to build a national representative cohort of twenty 
thousand children, who will be followed from birth to adulthood, using a 
multidisciplinary approach, to characterise the relationship between environmental 
exposures and the socio-economic context on health and behaviours. 
The cohort was based on the INSEE Permanent Demographic Sample (in French, 
EDP), which include all French citizens born on specific days of the year. The base panel 
included all children born in hospital maternity units on sixteen days, four days in each 
of the four quarters, to enable a representative sample of births. The official starting date 
for enrolments in the cohort started in the beginning of 2011.  
Two pilot studies were carried out in 2007 in two different regions to validate data 
collection methods used in the first year of the study. They also allowed to estimate the 
participation acceptance rate, the field feasibility, and to test procedures of collection and 
bio-banking of biological samples. 
The project objectives cover fields as the epidemiology, public health and social 
sciences. In the field of health, the study gives a central place to children growth, 
examining all the relationships between growth, social, environmental exposures and 
health events. 
One of the research topics address asthma and allergies. During the study, 
prevalence and incidence data of asthma and its different degrees of severity at different 
ages and socioeconomic groups are collected to evaluate early determinants of asthma 
and allergies in childhood. 
The design of the cohort was based on an initial enrolment interview of mothers 
at child’s birth to obtain retrospective data about exposures during pregnancy, and then a 
prospective follow-up of the child along the childhood and adolescence. 
The follow-up is based on data retrieval and record linkage from existing 
databases, as the INSEE demographic data, health insurance records, school follow-up, 
etcetera, and several waves of cross-sectional surveys at different ages: six weeks, and 
one, two, three, five, six, eight, ten, eleven and fourteen years old. 
Appendix 3 
 
 
154 
 
Surveys are based on face-to-face interview surveys or telephone interviews, 
biological samples collection, clinical examinations and psychomotor development tests, 
self-administered questionnaires, environmental measurements, etcetera. 
The strengths of the study are the large size of the cohort and its statistical power, 
which allows to test a wide variety of hypothesis, and the multiple fields involved, which 
lead to a better understanding of the factors involved in child growth and their interaction.  
The main weaknesses are the absence of data collection before birth, and the 
difficulties of maintaining the representativeness of the sample throughout the follow-up 
(Léridon, 2007; Vandentorren et al., 2009). 
Nowadays, the Elfe study continues, and new results are highlighted. For more 
information about the study and main findings, the official webpage could be visited (Elfe 
study webpage). 
Statistical analysis 
The following analyses were conducted using data from participating one-year-
old infants. First, a descriptive analysis was performed, computing frequencies for the 
categorical variables included. Furthermore, a descriptive analysis by gender was also 
conducted.  
Bivariate analyses were performed, using the chi-squared test, to study the 
relationships between potential risk factors (maternal asthma, bronchiolitis and smoking 
during pregnancy) and outcomes of interest. A p value lower than 0.05 was regarded as 
statistically significant.  
Finally, a cluster analysis, to classify participants in homogenous groups, and then 
explore similarities and divergences among different groups, was performed. The cluster 
analysis was repeated classifying infants into three, four and nine groups. 
All analyses were performed using IBM SPSS version 20 software (Armonk, NY, 
USA). 
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3. Results 
Descriptive analysis 
Almost half of infants in the study (48.6%) had at least one symptom in the first 
year of life. 6.5% of the children had wheezing in the chest, and 25.5% suffered night 
cough. Besides, 4.5% of the children suffered from both wheezing and cough. 4,624 
infants (29.1%) had difficulties when they breathed, and more frequently, had their 
airways congested (34.7%). 2,475 children (15.6%) suffered from atopic dermatitis.  
On the other hand, the 7.9% of children had colds or rhinitis in the first year of 
life, and 5.7% went to see a doctor for these causes. Frequencies of the illnesses are 
presented in Table 1. 
Table 1. Baseline characteristics of the sample. 
 N (%) 
Symptoms 7,733 (48.6) 
Wheezing in the chest  
Yes 1,027 (6.5) 
No 14,884 (93.5) 
Night cough  
Yes 4,051 (25.5) 
No 11,862 (74.5) 
Difficulty breathing  
Yes 4,624 (29.1) 
No 11,289 (70.9) 
Congested airways  
Yes 5,523 (34.7) 
No 10,389 (65.3) 
Atopic dermatitis  
Yes 2,475 (15.6) 
No 13,432 (84.4) 
Colds, rhinitis  
Yes 1,450 (43.9) 
No 1,854 (56.1) 
First medical consult (colds, rhinitis)  
Yes 1,052 (24.5) 
No 3,220 (75.1) 
Do not know 14 (0.3) 
In Figure 2, frequencies of symptoms in the first year of life are shown. Severity 
was defined as infants with difficulties to breathe and congested airways. 
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Figure 2. Frequencies of symptoms in the first year of life. 
 
Respiratory symptoms (48.6%) 
Wheezing (6.5%) 
Night cough (25.5%) 
Wheezing and cough (4.5%) 
Atopic dermatitis (20.8%) 
Severity (70.7%) 
Atopic dermatitis (18.9%) 
Severity (49.2%) 
Atopic dermatitis (20.8%) 
Severity (83.8%) 
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After the analysis, we searched for different phenotypes described in the literature 
to classify the children. 20.8% of infants who had wheezing in the chest also suffered 
from atopic dermatitis. Therefore, they can be considered atopic wheezers (Taussig et al., 
2003). They can also be classified as late onset wheezers according to the phenotypes 
proposed in the ALSPAC study (Henderson et al., 2008). 
A 4.5% of children were atopic persistent wheezers (or had persistent cough), 
because they suffered from wheezing and cough. Also, the 18.9% of children who had 
cough and atopic dermatitis were classified in the atopic persistent phenotype. 
Analysis by gender 
The 7.4% of boys, and 5.5% of girls, had wheezing in the chest. More frequently, 
26.7% of boys, and 24.2% of girls, had night cough. Nearly 30% of the boys had 
difficulties to breathe, compared to 27.9% of girls. Both 35.8% of boys, and 33.5% of 
girls had congested airways. 
Atopic dermatitis was reported by 15.7% of boys and 15.5% of girls. The 43.6% 
of boys suffered from colds or rhinitis, against 44.2% of girls. Further, 23.8% of boys, 
and 25.4% of girls, went to a medical consult for colds or rhinitis. (Table 2) 
Table 2. Frequencies of the illnesses by gender. 
 Boys Girls Do not know 
 N (%) N (%) N (%) 
Wheezing in the chest    
Yes 596 (7.4) 424 (5.5) 0 (0) 
No 7,490 (92.6) 7,258 (94.5) 20 (100) 
Night cough    
Yes 2,159 (26.7) 1,857 (24.2) 4 (20.0) 
No 5,926 (73.3) 5,825 (75.8) 16 (80.0) 
Difficulty breathing    
Yes 2,443 (30.2) 2,140 (27.9) 5 (25.0) 
No 5,642 (69.8) 5,542 (72.1) 15 (75.0) 
Congested airways    
Yes 2,893 (35.8) 2,575 (33.5) 6 (30.0) 
No 5,191 (64.2) 5,107 (66.5) 14 (70.0) 
Atopic dermatitis    
Yes 1,265 (15.7) 1,191 (15.5) 2 (10.0) 
No 6,815 (84.3) 6,490 (84.5) 18 (90.0) 
Colds, rhinitis    
Yes 755 (43.6) 677 (44.2) 0 (0) 
No 976 (56.4) 854 (55.8) 5 (100) 
First medical consult (colds, rhinitis)    
Yes 526 (23.8) 517 (25.4) 0 (0) 
No 1,683 (76.1) 1,506 (74.1) 4 (100) 
Do not know 4 (0.2) 9 (0.4) 0 (0) 
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Bivariate analysis 
Among asthmatic mothers, 8.5% had children who wheezed, compared to 6.1% 
of non-asthmatic mothers, finding significant differences (p<0.001). Almost half of 
children with bronchiolitis (48.4%) suffered from wheezing, against 6.2% who did not 
report the condition, also detecting statistical differences (p<0.001). Furthermore, 8.5% 
of mothers who smoked during pregnancy had a child who wheezed, against 5.9% of non-
smoking mothers, also showing evidence of a statistical association (p<0.001). (Table 3) 
Table 3. Associations between maternal asthma, bronchiolitis and smoking during 
pregnancy and wheezing in the chest. 
Wheezing in the chest Yes No  
 N (%) N (%) p value 
Maternal asthma   <0.001 
Yes 159 (8.5) 1,707 (91.5)  
No 856 (6.1) 13,075 (93.9) 
Do not know 0 (0) 5 (100) 
Bronchiolitis   <0.001 
Yes 133 (48.4) 142 (51.6) 
 
No 189 (6.2) 2,837 (93.8) 
Smoking during pregnancy   <0.001 
Yes 263 (8.5) 2,825 (91.5) 
 
No 750 (5.9) 11,896 (94.1) 
A 30.1% of asthmatics mothers had children who had night cough, compared to 
24.8% who were not asthmatics, detecting a significant relation (p<0.001). Furthermore, 
statistical differences were observed between the 86.9% of children who had bronchiolitis 
and coughed at night, against 36.2% who did not suffer from bronchiolitis (p<0.001). 
Conversely, no significant association was found between prenatal exposure to tobacco 
smoke and night cough in the offspring (p=0.126). (Table 4) 
Table 4. Associations between maternal asthma, bronchiolitis and smoking during 
pregnancy and night cough. 
Night cough Yes No  
 N (%) N (%) p value 
Maternal asthma   <0.001 
Yes 562 (30.1) 1,304 (69.9)  
 No 3,460 (24.8) 10,471 (75.2) 
Do not know 2 (40.0) 3 (60.0) 
Bronchiolitis   <0.001 
Yes 239 (86.9) 36 (13.1) 
 
No 1,096 (36.2) 1,930 (63.8) 
Smoking during pregnancy   0.126 
Yes 817 (26.5) 2,270 (73.5) 
 
No 3,178 (25.1) 9,468 (74.9) 
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A statistically significant association was observed between history of maternal 
asthma and difficulties to breathe (p<0.001). Among asthmatic mothers, 32.6% had a 
child with difficulty breathing, in contrast to 28.6% of non-asthmatics mothers. Most of 
the children with bronchiolitis (84.7%) had difficulties to breath, compared to 40.9% of 
children who did not have bronchiolitis, also showing statistical differences (p<0.001). A 
significant relation was also observed when prenatal exposure to smoke was studied 
(p<0.001). Among smoking mothers, 31.3% had offspring with difficulties to breathe, 
compared to 28.4% of non-smoking mothers. (Table 5) 
Table 5. Associations between maternal asthma, bronchiolitis and smoking during 
pregnancy and difficulties to breathe. 
Difficulties to breathe Yes No  
 N (%) N (%) p value 
Maternal asthma   <0.001 
Yes 609 (32.6) 1,257 (67.4)  
 No 3,984 (28.6) 9,947 (71.4) 
Do not know 4 (80.0) 1 (20.0) 
Bronchiolitis   <0.001 
Yes 233 (84.7) 42 (15.3) 
 
No 1,237 (40.9) 1,789 (59.1) 
Smoking during pregnancy   0.001 
Yes 967 (31.3) 2,120 (68.7) 
 
No 3,591 (28.4) 9,055 (71.6) 
The 38.1% of asthmatics mothers had a child with congested airways, compared 
to 34.3% of non-asthmatic mothers, detecting statistical differences (p=0.002). Similarly, 
93.8% of children who suffered from bronchiolitis also had congested airways, against 
47.5% who did not suffer from bronchiolitis, also finding a significant relation (p<0.001). 
In addition, the 38.9% of mothers who smoked during pregnancy, and 33.6% who did not, 
had a child with congested airways, showing statistical differences (p<0.001). (Table 6) 
Table 6. Associations between maternal asthma, bronchiolitis and smoking during 
pregnancy and congested airways. 
Congested airways Yes No  
 N (%) N (%) p value 
Maternal asthma   0.002 
Yes 711 (38.1) 1,155 (61.9)  
 No 4,773 (34.3) 9,158 (65.7) 
Do not know 3 (60.0) 2 (40.0) 
Bronchiolitis   <0.001 
Yes 258 (93.8) 17 (6.2) 
 
No 1,436 (47.5) 1,590 (52.5) 
Smoking during pregnancy   <0.001 
Yes 1,200 (38.9) 1,887 (61.1) 
 
No 4,249 (33.6) 8,396 (66.4) 
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Among asthmatic mothers, 19.5% had a child with atopic dermatitis, against 15.1% 
of non-asthmatic mothers, finding a significant relation (p<0.001). On the contrary, no 
statistical differences were found between bronchiolitis and atopic dermatitis (p=0.062). 
The 14.5% of children who had bronchiolitis, and 19.1% who did not, reported atopic 
dermatitis. Moreover, 15.0% of mothers who smoked during pregnancy, and 15.7% who 
were non-smokers, had children with atopic dermatitis, not finding statistical differences 
(p=0.321). (Table 7) 
Table 7. Associations between maternal asthma, bronchiolitis and smoking during 
pregnancy and atopic dermatitis. 
Atopic dermatitis Yes No  
 N (%) N (%) p value 
Maternal asthma   <0.001 
Yes 357 (19.1) 1,509 (80.9)  
 No 2,099 (15.1) 11,832 (84.9) 
Do not know 3 (60.0) 2 (40.0) 
Bronchiolitis   0.062 
Yes 40 (14.5) 235 (85.5) 
 
No 579 (19.1) 2,447 (80.9) 
Smoking during pregnancy   0.321 
Yes 462 (15.0) 2,625 (85.0) 
 
No 1,983 (15.7) 10,657 (84.3) 
No significant association was found between maternal history of asthma and 
colds/rhinitis in the offspring (p=0.456). A 43.7% of asthmatic mothers, and 43.9% of 
non-asthmatic, had a child with colds or rhinitis. On the other hand, 61.1% of children 
with bronchiolitis also had colds or rhinitis, against 42.3% of children who did not report 
bronchiolitis, finding statistical differences (p<0.001). The 44.6% of mothers who 
smoked during pregnancy, and 43.6% who did not, had children with colds/rhinitis, not 
detecting any statistically significant relation (p=0.651). (Table 8) 
Table 8. Associations between maternal asthma, bronchiolitis and smoking during 
pregnancy and colds and rhinitis. 
Colds, rhinitis Yes No  
 N (%) N (%) p value 
Maternal asthma   0.456 
Yes 202 (43.7) 260 (56.3)  
 No 1,241 (43.9) 1,584 (56.1) 
Do not know 0 (0) 2 (100) 
Bronchiolitis   <0.001 
Yes 168 (61.1) 107 (38.9) 
 
No 1,282 (42.3) 1,747 (57.7) 
Smoking during pregnancy   0.651 
Yes 275 (44.6) 342 (55.4) 
 
No 1,158 (43.6) 1,500 (56.4) 
Appendix 3 
 
 
161 
 
Among asthmatic mothers, 27.7% had children who went to see a doctor for colds 
or rhinitis, compared to 24.1% of non-asthmatic mothers, not finding any significant 
association (p=0.383). On the contrary, statistical differences were observed between 
bronchiolitis and the first medical consult for colds or rhinitis (p=0.001). The 34.0% of 
children with bronchiolitis went to the doctor for these causes, compared to 18.6% of 
children who did not report bronchiolitis. Among smoking mothers during pregnancy, 
25.9% went with their child to a medical consult for colds/rhinitis, compared to 23.8% 
who did not smoke, not finding a statistical relation (p=0.378). (Table 9) 
Table 9. Associations between maternal asthma, bronchiolitis and smoking during 
pregnancy and first medical consult. 
First medical consult 
(colds, rhinitis) 
Yes No Do not know  
N (%) N (%) N (%) p value 
Maternal asthma    0.383 
Yes 159 (27.7) 412 (71.9) 2 (0.3)  
 No 883 (24.1) 2,774 (75.7) 9 (0.2) 
Do not know 0 (0) 1 (100) 0 (0) 
Bronchiolitis    0.001 
Yes 33 (34.0) 64 (66.0) 0 (0) 
 
No 161 (18.6) 703 (81.2) 2 (0.2) 
Smoking during pregnancy    0.378 
Yes 250 (25.9) 713 (73.7) 4 (0.4) 
 
No 780 (23.8) 2,481 (75.8) 10 (0.3) 
Cluster analysis 
In the following sections, three, four and nine cluster analyses’ results are 
presented. 
 Three cluster analysis 
Wheezing, cough and atopic dermatitis 
Table 10. Final cluster centres (wheezing, cough and atopic dermatitis) and distances 
between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 1 (Yes) 2 (No) 
    
Distances 1 2 3 
1  1.218 1.011 
2 1.218  1.049 
3 1.011 1.049  
Appendix 3 
 
 
162 
 
Children who only cough (Cluster 1) were more related to children without 
symptoms (Cluster 3) than children with atopic dermatitis (Cluster 2). Children with 
cough (Cluster 1) and those who suffered from atopic dermatitis (Cluster 2) were farther. 
(Table 10) 
Wheezing, cough and severity 
Table 11. Final cluster centres (wheezing, cough and severity) and distances between 
centres. 
Clusters 1 2 3 
Wheezing 2 (No) 1 (Yes) 2 (No) 
Cough 1 (Yes) 2 (No) 2 (No) 
Severity 0.64 0.30 0.00 
    
Distances 1 2 3 
1  1.058 0.980 
2 1.058  1.078 
3 0.980 1.078  
Children with cough and medium severity (Cluster 1) were more related to 
children with no symptoms or severity (Cluster 3), than to children with wheezing and 
low severity (Cluster 2). Children from Cluster 2 and Cluster 3 were farther between them. 
(Table 11) 
Wheezing, cough, atopic dermatitis and severity 
Table 12. Final cluster centres (wheezing, cough, atopic dermatitis and severity) and 
distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 1 (Yes) 2 (No) 
Severity 0.50 0.22 0.13 
    
Distances 1 2 3 
1  1.250 1.085 
2 1.250  1.041 
3 1.085 1.041  
Children with no wheezing or cough, but with atopic dermatitis and low severity 
(Cluster 2) were more related to children with no symptoms and low severity (Cluster 3) 
than to children with cough and medium severity (Cluster 1). This latter group was also 
more related to children classified in Cluster 3, than to children in Cluster 2. (Table 12) 
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Wheezing, cough, atopic dermatitis, severity and rhinitis 
Table 13. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
rhinitis) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 2 (No) 1 (Yes) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.11 0.26 0.98 
Rhinitis 2 (No) 2 (No) 1 (Yes) 
    
Distances 1 2 3 
1  1.022 1.440 
2 1.022  1.070 
3 1.440 1.070  
Children with no symptoms, low severity and no rhinitis (Cluster 1) were related 
to children who also did not have symptoms, low severity and no rhinitis (Cluster 2). This 
latter group was farther from children with cough, very high severity and rhinitis (Cluster 
3). Moreover, Clusters 1 and 3 were the farthest. (Table 13) 
Wheezing, cough, atopic dermatitis, severity and gender 
Table 14. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
gender) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 1 (Yes) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.20 0.84 0.09 
Gender 3 (Unknown) 1 (Male) 1 (Male) 
    
Distances 1 2 3 
1  7.616 7.506 
2 7.616  1.129 
3 7.506 1.129  
Boys who had cough and high severity (Cluster 2) were related to boys without 
symptoms and very low severity (Cluster 3). Cluster 1 (children without symptoms, low 
severity and unknown gender) were not related neither to Cluster 3 nor Cluster 2. (Table 
14) 
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Wheezing, cough, atopic dermatitis, severity and maternal asthma 
Table 15. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
maternal asthma) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 1 (Yes) 2 (No) 
Severity 0.49 0.60 0.13 
Maternal asthma 2 (No) 3 (Unknown) 2 (No) 
    
Distances 1 2 3 
1  7.180 1.076 
2 7.180  7.152 
3 1.076 7.152  
Children with cough, medium severity and non-asthmatic mother (Cluster 1) were 
related to children with no symptoms, low severity and non-asthmatic mother (Cluster 3). 
Children with atopic dermatitis, medium severity and mothers with unknown asthmatic 
status (Cluster 2) were also more related to Cluster 3 subjects than with Cluster 1 children. 
(Table 15) 
Wheezing, cough, atopic dermatitis, severity and paternal asthma 
Table 16. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
paternal asthma) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 1 (Yes) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.09 0.83 0.00 
Paternal asthma 2 (No) 2 (No) 3 (Unknown) 
    
Distances 1 2 3 
1  1.121 7.140 
2 1.121  7.208 
3 7.140 7.208  
Children with no symptoms and very low severity, whose fathers were not 
asthmatics (Cluster 1), were related to those with cough, high severity, and non-asthmatic 
fathers (Cluster 2). These groups were not related to children with no symptoms or 
severity, and unknown paternal asthmatic status (Cluster 3). (Table 16) 
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Wheezing, cough, atopic dermatitis, severity and smoking mother 
Table 17. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking mother) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 1 (Yes) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.10 0.84 0.13 
Smoking mother 2 (No) 2 (No) 1 (Yes) 
    
Distances 1 2 3 
1  1.206 0.799 
2 1.206  1.268 
3 0.799 1.268  
Children with no symptoms, very low severity and non-smoking mothers (Cluster 
1) were related to children with no symptoms and low severity, but exposed to tobacco 
smoke (Cluster 3). These groups were not related to children with cough, high severity 
and non-smoking mothers (Cluster 2). (Table 17) 
Wheezing, cough, atopic dermatitis, severity and smoking father 
Table 18. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking father) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 2 (No) 1 (Yes) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.11 0.11 0.96 
Smoking father 1 (Yes) 2 (No) 2 (No) 
    
Distances 1 2 3 
1  1.000 1.379 
2 1.000  1.280 
3 1.379 1.280  
Children with no symptoms and low severity, whose fathers smoked (Cluster 1), 
were related to children with no symptoms, low severity, and non-smoking fathers 
(Cluster 2). Children from Cluster 1 were farther from those with cough, very high 
severity, and non-smoking fathers (Cluster 3). (Table 18) 
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Wheezing, cough, atopic dermatitis, severity and smoking during pregnancy 
Table 19. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking during pregnancy) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 1 (Yes) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.10 0.84 0.13 
Smoking during pregnancy 2 (No) 2 (No) 1 (Yes) 
    
Distances 1 2 3 
1  1.204 0.797 
2 1.204  1.266 
3 0.797 1.266  
Children with no symptoms, very low severity, and non-smoking mothers during 
pregnancy (Cluster 1), were related to children who also had no symptoms and very low 
severity, but prenatally exposed to tobacco smoke (Cluster 3). Both groups were farther 
from children with cough and high severity, but non-smoking mothers during pregnancy 
(Cluster 2). (Table 19) 
Wheezing, cough, atopic dermatitis, severity and exposure to smoke at home 
Table 20. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
exposure to smoke at home) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.25 0.22 0.24 
Exposure to smoke 3 (2-5 hours/day) 0 (Never) 1 (<1 hour/day) 
    
Distances 1 2 3 
1  3.042 2.088 
2 3.042  1.314 
3 2.088 1.314  
Children with no symptoms and low severity, and not exposed to tobacco smoke 
(Cluster 2), were related to children with no symptoms, low severity and low exposition 
to tobacco smoke (Cluster 3). Cluster 2 was farther from children with no symptoms and 
low severity, but high exposition to tobacco smoke (Cluster 1). (Table 20) 
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Wheezing, cough, atopic dermatitis, severity and bronchiolitis 
Table 21. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
bronchiolitis) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 1 (Yes) 1 (Yes) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.18 0.00 1.00 
Bronchiolitis 2 (No) 2 (No) 2 (No) 
    
Distances 1 2 3 
1  1.019 1.310 
2 1.019  1.056 
3 1.310 1.056  
Children with no symptoms and low severity (Cluster 1) were related to children 
with cough, but no severity nor bronchiolitis (Cluster 2). Moreover, children from Cluster 
1 were farther from children with cough and severity, but who did not report bronchiolitis 
(Cluster 3). (Table 21) 
Wheezing, cough, atopic dermatitis, severity and reflux 
Table 22. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
reflux) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 1 (Yes) 2 (No) 
Severity 0.20 0.26 0.25 
Reflux 2 (No) 2 (No) 1 (Yes) 
    
Distances 1 2 3 
1  1.030 1.003 
2 1.030  1.266 
3 1.003 1.266  
Children with no symptoms, low severity and no reflux (Cluster 1), were related 
to children with no symptoms, low severity and reflux (Cluster 3). Children in this latter 
group were farther from children with atopic dermatitis and low severity, but with no 
other symptoms or reflux (Cluster 2). (Table 22) 
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Wheezing, cough, atopic dermatitis, severity and breastfeeding 
Table 23. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
breastfeeding) and distances between centres. 
Clusters 1 2 3 
Wheezing 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 
Severity 0.95 0.10 0.11 
Breastfeeding 1 (Yes) 2 (No) 1 (Yes) 
    
Distances 1 2 3 
1  1.343 1.305 
2 1.343  1.000 
3 1.305 1.000  
Children with no symptoms, low severity, who did not breastfeed (Cluster 2), were 
related to children without symptoms, low severity, and who breastfed (Cluster 3). On the 
contrary, children from Cluster 2 were farther from children with cough and very high 
severity who breastfed (Cluster 1). (Table 23) 
 Four cluster analysis 
Wheezing, cough and atopic dermatitis 
Table 24. Final cluster centres (wheezing, cough and atopic dermatitis) and distances 
between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 1 (Yes) 2 (No) 
Cough 1 (Yes) 2 (No) 1 (Yes) 2 (No) 
Atopic dermatitis 2 (No) 1 (Yes) 2 (No) 2 (No) 
     
Distances 1 2 3 4 
1  1.241 1.044 1.000 
2 1.241  1.374 1.035 
3 1.044 1.374  1.256 
4 1.000 1.035 1.256  
Children with cough, but who did not wheeze or suffer from atopic dermatitis 
(Cluster 1) were related to children with no symptoms (Cluster 4). Children in Cluster 2 
(children with atopic dermatitis but who did not wheeze or cough) were also related to 
those in Cluster 4. On the other hand, children who wheezed and coughed but did not 
suffer from atopic dermatitis (Cluster 3) and children classified in Cluster 2 were the 
farthest. (Table 24) 
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Wheezing, cough and severity 
Table 25. Final cluster centres (wheezing, cough and severity) and distances between 
centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 2 (No) 1 (Yes) 
Severity 0.00 1.00 0.00 1.00 
     
Distances 1 2 3 4 
1  1.414 1.001 1.029 
2 1.414  1.002 1.023 
3 1.001 1.002  1.442 
4 1.029 1.023 1.442  
Children with cough who did not wheeze or reported severity (Cluster 1) were 
related to children with no symptoms (Cluster 3). Children classified in Cluster 2 (no 
cough or wheeze, but very high severity) were also related to those in Cluster 3. The 
farthest clusters were children in Cluster 3 and children with cough and very high severity 
(Cluster 4). (Table 25) 
Wheezing, cough, atopic dermatitis and severity 
Table 26. Final cluster centres (wheezing, cough, atopic dermatitis and severity) and 
distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 1 (Yes) 
Cough 1 (Yes) 2 (No) 2 (No) 1 (Yes) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.00 1.00 0.00 0.97 
     
Distances 1 2 3 4 
1  1.120 1.001 1.373 
2 1.120  1.117 1.057 
3 1.001 1.117  1.615 
4 1.373 1.057 1.615  
Children with cough but who did not wheeze, or have atopic dermatitis or severity 
(Cluster 1) were related to children with no symptoms (Cluster 3). On the other hand, 
children who did not wheeze, cough or suffer from atopic dermatitis, but showed very 
high severity (Cluster 2) were related to those who wheezed, coughed and reported very 
high severity, but did not have atopic dermatitis (Cluster 4). Children from this latter 
cluster and those in Cluster 3 were the farthest. (Table 26) 
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Wheezing, cough, atopic dermatitis, severity and rhinitis 
Table 27. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
rhinitis) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 1 (Yes) 2 (No) 1 (Yes) 
Atopic dermatitis 2 (No) 2 (No) 1 (Yes) 2 (No) 
Severity 0.10 0.77 0.05 0.97 
Rhinitis 2 (No) 1 (Yes) 1 (Yes) 2 (No) 
     
Distances 1 2 3 4 
1  1.379 0.844 1.284 
2 1.379  1.169 1.004 
3 0.844 1.169  1.358 
4 1.284 1.004 1.358  
Children with no symptoms and low severity (Cluster 1) were related to children 
with atopic dermatitis, rhinitis and very low severity (Cluster 3). Children with cough, 
rhinitis and high severity (Cluster 2) were related to children with cough and very high 
severity (Cluster 4). Children classified in Clusters 1 and 2 were the farthest. (Table 27) 
Wheezing, cough, atopic dermatitis, severity and gender 
Table 28. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
gender) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 2 (No) 1 (Yes) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.00 0.20 0.10 1.00 
Rhinitis 1 (Male) 3 (Unknown) 1 (Male) 1 (Male) 
     
Distances 1 2 3 4 
1  7.570 1.008 1.048 
2 7.570  7.505 7.633 
3 1.008 7.505  1.282 
4 1.048 7.633 1.282  
Boys with cough, but without any other symptoms (Cluster 1) were related to boys 
who did not wheeze, cough or suffer from atopic dermatitis and reported low severity 
(Cluster 3). Children from Cluster 1 were also related to boys with cough and very high 
severity (Cluster 4). Children in this latter cluster, and children from Cluster 2 (unknown 
gender, no symptoms and low severity) were the less related groups. (Table 28) 
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Wheezing, cough, atopic dermatitis, severity and maternal asthma 
Table 29. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
maternal asthma) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 1 (Yes) 2 (No) 
Atopic dermatitis 2 (No) 1 (Yes) 2 (No) 2 (No) 
Severity 0.00 0.60 1.00 0.10 
Maternal asthma 2 (No) 3 (Unknown) 2 (No) 2 (No) 
     
Distances 1 2 3 4 
1  7.476 1.072 0.790 
2 7.476  7.236 7.045 
3 1.072 7.236  1.260 
4 0.790 7.045 1.260  
Children with cough, but without any other symptoms and non-asthmatics 
mothers (Cluster 1) were related to children with no symptoms, very low severity and 
asthmatic mothers (Cluster 4). Children classified in Cluster 1 were also related to 
children with cough and very high severity, but with no other symptoms, and non-
asthmatic mothers (Cluster 3). Children who suffered from atopic dermatitis, showed 
medium severity, and unknown maternal asthmatic status (Cluster 2), were the farthest 
from children from Cluster 1. (Table 29) 
Wheezing, cough, atopic dermatitis, severity and paternal asthma 
Table 30. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
paternal asthma) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.84 0.07 0.12 0.00 
Paternal asthma 2 (No) 1 (Yes) 2 (No) 3 (Unknown) 
     
Distances 1 2 3 4 
1  1.061 1.248 7.188 
2 1.061  0.771 7.576 
3 1.248 0.771  7.018 
4 7.188 7.576 7.018  
Children with cough, very low severity and asthmatic fathers (Cluster 2) were 
related to children with no symptoms, low severity, and non-asthmatic fathers (Cluster 3).  
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Children in Cluster 2 were farther from those with no symptoms or severity, and 
unknown paternal asthmatic status (Cluster 4). Children from this latter group were less 
related to children with cough, high severity and non-asthmatic fathers (Cluster 1) and 
children in Cluster 3. (Table 30) 
Wheezing, cough, atopic dermatitis, severity and smoking mother 
Table 31. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking mother) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.00 1.00 0.09 0.12 
Smoking mother 2 (No) 2 (No) 1 (Yes) 2 (No) 
     
Distances 1 2 3 4 
1  1.045 1.142 1.034 
2 1.045  1.377 1.322 
3 1.142 1.377  0.805 
4 1.034 1.322 0.805  
Children with no symptoms, very low severity, and smoking mothers (Cluster 3) 
were related to children with no symptoms, low severity, and non-smoking mothers 
(Cluster 4). Children in these two groups were farther from children with cough and 
severity, whose mothers were not smokers (Cluster 2). (Table 31) 
Wheezing, cough, atopic dermatitis, severity and smoking father 
Table 32. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking father) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 1 (Yes) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.26 0.12 0.97 0.13 
Smoking father 2 (No) 2 (No) 1 (Yes) 1 (Yes) 
     
Distances 1 2 3 4 
1  1.041 0.934 1.257 
2 1.041  1.475 1.000 
3 0.934 1.475  1.414 
4 1.257 1.000 1.414  
Children with cough, low severity and non-smoking father (Cluster 1) were related 
to children with cough, very high severity, and smoking father (Cluster 3). 
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On the other hand, both children in Cluster 2 (no symptoms, low severity and non-
smoking father) and children in Cluster 4 (no symptoms, low severity and smoking father) 
were farther from children classified in Cluster 3. (Table 32) 
Wheezing, cough, atopic dermatitis, severity and smoking during pregnancy 
Table 33. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking during pregnancy) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.00 1.00 0.09 0.11 
Smoking during pregnancy 0 (No) 0 (No) 1 (Yes) 0 (No) 
     
Distances 1 2 3 4 
1  1.045 1.142 1.034 
2 1.045  1.379 1.319 
3 1.142 1.379  0.803 
4 1.034 1.319 0.803  
Children with no symptoms, very low severity, and smoking mothers during 
pregnancy (Cluster 3) were related to children with no symptoms, low severity and non-
smoking mothers (Cluster 4). Children in these groups were farther from children with 
cough, severity, who were not prenatally exposed to tobacco smoke (Cluster 2). (Table 
33) 
Wheezing, cough, atopic dermatitis, severity and exposure to smoke at home 
Table 34. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
exposure to smoke at home) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 2 (No) 2 (No) 2 (No) 1 (Yes) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.25 0.00 0.16 1.00 
Exposure to smoke 3 (2-5 hours/day) 0 (Never) 1 (<1 hour/day) 0 (Never) 
     
Distances 1 2 3 4 
1  3.414 2.063 3.444 
2 3.414  1.354 1.106 
3 2.063 1.354  1.592 
4 3.444 1.106 1.592  
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Children with no symptoms, no severity, and not exposed to tobacco smoke 
(Cluster 2) were related to children with cough and severity, but not exposed to smoke 
(Cluster 4). On the other hand, children in this latter group were farther from children 
with no symptoms, low severity, but highly exposed to tobacco smoke (Cluster 1). (Table 
34) 
Wheezing, cough, atopic dermatitis, severity and bronchiolitis 
Table 35. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
bronchiolitis) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 1 (Yes) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.96 0.43 0.00 1.00 
Bronchiolitis 1 (Yes) 2 (No) 2 (No) 2 (No) 
     
Distances 1 2 3 4 
1  0.952 1.577 1.219 
2 0.952  1.090 1.156 
3 1.577 1.090  1.002 
4 1.219 1.156 1.002  
Children who wheezed, coughed, reported very high severity and bronchiolitis 
(Cluster 1) were related to children with cough, medium severity, but who did not suffer 
from bronchiolitis (Cluster 2). Children in Cluster 1 were far from children with no 
symptoms or bronchiolitis, but high severity (Cluster 4), and even farther from children 
with no symptoms, severity or bronchiolitis (Cluster 3). (Table 35) 
Wheezing, cough, atopic dermatitis, severity and reflux 
Table 36. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
reflux) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 1 (Yes) 2 (No) 2 (No) 
Atopic dermatitis 2 (No) 1 (Yes) 2 (No) 2 (No) 
Severity 0.38 0.91 0.00 0.40 
Reflux 2 (No) 1 (Yes) 2 (No) 1 (Yes) 
     
Distances 1 2 3 4 
1  0.941 1.085 1.153 
2 0.941  1.454 1.120 
3 1.085 1.454  0.801 
4 1.153 1.120 0.801  
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Children with no symptoms, no severity or reflux (Cluster 3) were related to 
children with no symptoms, medium severity, and reflux (Cluster 4). Children classified 
in Cluster 3 were far from those with cough, atopic dermatitis, very high severity and 
reflux (Cluster 2), while children in Cluster 4 were far from those with cough, medium 
severity and no reflux (Cluster 1). (Table 36) 
Wheezing, cough, atopic dermatitis, severity and breastfeeding 
Table 37. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
breastfeeding) and distances between centres. 
Clusters 1 2 3 4 
Wheezing 2 (No) 2 (No) 2 (No) 2 (No) 
Cough 1 (Yes) 2 (No) 2 (No) 1 (Yes) 
Atopic dermatitis 2 (No) 2 (No) 2 (No) 2 (No) 
Severity 0.83 0.10 0.00 1.00 
Breastfeeding 1 (Yes) 1 (Yes) 2 (No) 2 (No) 
     
Distances 1 2 3 4 
1  1.129 1.539 1.089 
2 1.129  1.006 1.429 
3 1.539 1.006  1.094 
4 1.089 1.429 1.094  
Children with no symptoms, low severity, and who breastfed (Cluster 2) were 
related to children with no symptoms, no severity, who were not breastfed (Cluster 3). 
Children classified in Cluster 2 were far from those who had cough, severity, and were 
not breastfed (Cluster 4), whilst children in Cluster 3 were far from those with cough, 
high severity, who breastfed (Cluster 1). (Table 37) 
 Nine cluster analysis 
Wheezing, cough, atopic dermatitis, severity and maternal asthma 
Children with atopic dermatitis, low severity, and non-asthmatic mother (Cluster 
3) were related to those with no symptoms, low severity, and non-asthmatic mother 
(Cluster 4). On the other hand, children who had atopic dermatitis, low severity and an 
unknown maternal asthmatic status (Cluster 2) were the farthest from those with cough, 
atopic dermatitis, medium severity, and asthmatic mother (Cluster 9). (Table 38) 
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Table 38. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
maternal asthma) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No No No No Yes No No Yes No 
Cough Yes No No No Yes Yes Yes No Yes 
Atopic dermatitis No Yes Yes No Yes No No No Yes 
Severity 1.00 0.33 0.11 0.10 0.74 0.21 1.00 1.00 0.65 
Maternal asthma UNK UNK No No No Yes No No Yes 
UNK: Unknown          
Distances 1 2 3 4 5 6 7 8 9 
1  1.213 7.530 7.128 7.101 7.849 7.096 7.315 8.029 
2 1.213  7.425 7.037 7.123 7.882 7.208 7.290 8.052 
3 7.530 7.425  0.769 1.428 1.239 1.425 1.510 1.112 
4 7.128 7.037 0.769  1.637 1.236 1.275 1.351 1.653 
5 7.101 7.123 1.428 1.637  1.490 1.238 1.248 1.282 
6 7.849 7.882 1.239 1.236 1.490  1.094 1.477 1.169 
7 7.096 7.208 1.425 1.275 1.238 1.094  1.276 1.331 
8 7.315 7.290 1.510 1.351 1.248 1.477 1.276  1.742 
9 8.029 8.052 1.112 1.653 1.282 1.169 1.331 1.742  
Wheezing, cough, atopic dermatitis, severity and paternal asthma 
Table 39. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
paternal asthma) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No No No Yes No No Yes Yes Yes 
Cough No No No Yes Yes  Yes Yes No Yes 
Atopic dermatitis Yes No No Yes No No No No No 
Severity 0.10 0.10 0.00 0.72 0.61 1.00 0.00 0.30 1.00 
Paternal asthma No No UNK No Yes No No No Yes 
UNK: Unknown          
Distances 1 2 3 4 5 6 7 8 9 
1  1.000 7.117 1.301 1.416 1.516 1.653 1.436 1.907 
2 1.000  7.119 1.655 1.190 1.293 1.334 1.029 1.750 
3 7.114 7.119  7.149 8.036 7.115 7.255 7.194 8.141 
4 1.301 1.655 7.149  1.625 1.215 1.270 1.297 1.306 
5 1.416 1.190 8.036 1.625  1.146 1.501 1.552 1.077 
6 1.516 1.293 7.115 1.215 1.146  1.279 1.454 1.288 
7 1.653 1.334 7.255 1.270 1.501 1.279  1.046 1.358 
8 1.436 1.029 7.194 1.297 1.552 1.454 1.046  1.382 
9 1.907 1.750 8.141 1.306 1.077 1.288 1.358 1.382  
Children with atopic dermatitis, very low severity and non-asthmatic father 
(Cluster 1) were related to children who did not report any symptoms, had very low 
severity and non-asthmatic fathers (Cluster 2). 
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Children classified in Cluster 3, who did not report any symptoms nor severity, 
and the paternal asthmatic status was unknown, were the farthest from children who 
wheezed, coughed, presented very high severity, and had asthmatic fathers (Cluster 9). 
(Table 39) 
Wheezing, cough, atopic dermatitis, severity and smoking mother 
Table 40. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking mother) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No No No No No No No Yes Yes 
Cough Yes No No No No Yes Yes No Yes 
Atopic dermatitis Yes No No No No No No No Yes 
Severity 0.00 1.00 0.00 1.00 0.00 0.22 1.00 1.00 0.81 
Smoking mother No Yes Yes No No Yes No No No 
          
Distances 1 2 3 4 5 6 7 8 9 
1  1.470 1.218 1.212 0.781 1.148 1.171 1.625 1.392 
2 1.470  1.101 1.101 1.494 1.031 1.159 1.264 1.603 
3 1.218 1.101  1.415 1.009 1.090 1.744 1.528 1.909 
4 1.212 1.101 1.415  1.012 1.591 1.026 1.070 1.536 
5 0.781 1.494 1.009 1.012  1.401 1.439 1.459 1.799 
6 1.148 1.031 1.090 1.591 1.401  1.187 1.499 1.448 
7 1.171 1.159 1.744 1.026 1.439 1.187  1.319 1.188 
8 1.625 1.264 1.528 1.070 1.459 1.499 1.319  1.203 
9 1.392 1.603 1.909 1.536 1.799 1.448 1.188 1.203  
Children with cough, atopic dermatitis, and no severity or smoking mother 
(Cluster 1) were related to children with no symptoms or severity, and non-smoking 
mothers (Cluster 5). On the other hand, children with no symptoms or severity, but whose 
mothers smoked (Cluster 3), were the farthest to children who suffered from wheeze, 
cough, atopic dermatitis and high severity, but had non-smoking mothers (Cluster 9). 
(Table 40) 
Wheezing, cough, atopic dermatitis, severity and smoking father 
Children who wheezed, had medium severity and smoking fathers (Cluster 2) 
were related to children who also wheezed, but did not report any other symptoms or 
severity, and whose fathers did not smoke (Cluster 5). Children in this latter group were 
the farthest from children with cough, atopic dermatitis, medium severity, and who also 
had smoking fathers (Cluster 9). (Table 41) 
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Table 41. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking father) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No Yes No No Yes No No Yes No 
Cough Yes No No No No No Yes Yes Yes 
Atopic dermatitis No No No No No No Yes No Yes 
Severity 0.73 0.61 0.00 0.00 0.00 1.00 0.52 0.82 0.63 
Smoking father Yes Yes No Yes No No No No Yes 
          
Distances 1 2 3 4 5 6 7 8 9 
1  1.298 1.195 1.135 1.621 1.081 1.253 1.060 1.067 
2 1.298  1.344 1.231 0.885 1.247 1.638 1.070 1.457 
3 1.195 1.344  1.009 1.009 1.010 1.352 1.612 1.618 
4 1.135 1.231 1.009  1.414 1.415 1.747 1.746 1.336 
5 1.621 0.885 1.009 1.414  1.414 1.624 1.362 1.867 
6 1.081 1.247 1.010 1.415 1.414  1.396 1.491 1.568 
7 1.253 1.638 1.352 1.747 1.624 1.396  1.382 1.030 
8 1.060 1.070 1.612 1.746 1.362 1.491 1.382  1.482 
9 1.067 1.457 1.618 1.336 1.867 1.568 1.030 1.482  
Wheezing, cough, atopic dermatitis, severity and smoking during pregnancy 
Table 42. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
smoking during pregnancy) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No No No Yes No No No Yes No 
Cough No Yes No Yes No Yes Yes No No 
Atopic dermatitis No Yes Yes Yes No No No No Yes 
Severity 0.08 0.48 0.00 0.88 1.00 0.51 1.00 0.20 1.00 
Smoking during pregnancy No No Yes No Yes Yes No No No 
          
Distances 1 2 3 4 5 6 7 8 9 
1  1.337 1.256 1.722 1.276 1.339 1.326 1.017 1.298 
2 1.337  1.336 1.105 1.770 1.379 1.163 1.597 1.132 
3 1.256 1.336  1.653 1.426 1.412 1.939 1.628 1.299 
4 1.722 1.105 1.653  1.753 1.547 1.273 1.298 1.289 
5 1.276 1.770 1.426 1.753  1.119 1.426 1.512 1.292 
6 1.339 1.379 1.412 1.547 1.119  1.115 1.441 1.716 
7 1.326 1.163 1.939 1.273 1.426 1.115  1.327 1.454 
8 1.017 1.597 1.628 1.298 1.512 1.441 1.327  1.608 
9 1.298 1.132 1.299 1.289 1.292 1.716 1.454 1.608  
The nearest groups were children with no symptoms, very low severity, and not 
prenatally exposed to tobacco smoke (Cluster 1) and children who wheezed and had low 
severity, but did not suffer from any other symptoms, and whose mothers did not smoke 
during pregnancy (Cluster 8). 
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On the contrary, children with atopic dermatitis, but without any other symptoms 
or severity, whose mothers smoked during pregnancy (Cluster 3) were the farthest from 
children who had cough and very high severity, but did not report any other symptoms, 
and were not prenatally exposed to tobacco smoke (Cluster 7). (Table 42). 
Wheezing, cough, atopic dermatitis, severity and exposure to smoke at home 
Table 43. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
exposure to smoke at home) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No No No Yes No No No Yes No 
Cough No No No Yes Yes Yes Yes No No 
Atopic dermatitis No No Yes Yes No No No No No 
Severity 0.12 0.00 0.16 0.61 1.00 0.64 0.78 0.28 0.00 
Exposure to smoke 1 0 1 3 0 3 1 0 3 
0: Never; 1: <1 hour/day; 2: 1-2 hours/day; 3: 2-5 hours/day; 4: >5 hours/day    
Distances 1 2 3 4 5 6 7 8 9 
1  1.301 1.008 1.860 1.649 2.334 1.164 1.605 2.138 
2 1.301  1.554 2.974 1.103 3.580 1.866 1.048 3.416 
3 1.008 1.554  1.794 1.784 2.471 1.345 1.763 2.301 
4 1.860 2.974 1.794  2.861 1.069 1.506 2.761 1.364 
5 1.649 1.103 1.784 2.861  3.496 1.522 1.142 3.608 
6 2.334 3.580 2.471 1.069 3.496  2.065 3.572 0.977 
7 1.164 1.866 1.345 1.506 1.522 2.065  1.780 2.362 
8 1.605 1.048 1.763 2.761 1.142 3.572 1.780  3.519 
9 2.138 3.416 2.301 1.364 3.608 0.977 2.362 3.519  
Children with cough, medium severity, who were exposed to tobacco smoke for 
2-5 hours/day (Cluster 6) were related to children with no symptoms nor severity, but the 
same exposition to tobacco smoke (Cluster 9). On the other hand, children in this latter 
group were the farthest from those with cough, severity, but not exposed to tobacco smoke 
(Cluster 5). (Table 43) 
Wheezing, cough, atopic dermatitis, severity and bronchiolitis 
Children with cough, but no severity nor bronchiolitis (Cluster 1) were related to 
children with cough and atopic dermatitis, but who did not report severity nor 
bronchiolitis (Cluster 8). Children who suffered from wheeze, cough, very high severity 
and bronchiolitis (Cluster 2) were the farthest from children who had atopic dermatitis, 
low severity, and did not suffer from bronchiolitis (Cluster 9). (Table 44) 
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Table 44. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
bronchiolitis) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No Yes No No Yes No No No No 
Cough Yes Yes No Yes No Yes No Yes No 
Atopic dermatitis No No No No Yes Yes No Yes Yes 
Severity 0.00 0.98 0.00 1.00 0.50 1.00 0.65 0.00 0.18 
Bronchiolitis No Yes No No No No Yes No No 
          
Distances 1 2 3 4 5 6 7 8 9 
1  1.366 1.001 1.099 1.783 1.430 1.542 1.000 1.426 
2 1.366  1.721 1.091 1.609 1.220 1.188 1.644 1.882 
3 1.001 1.721  1.140 1.493 1.750 1.218 1.416 1.016 
4 1.099 1.091 1.140  1.581 1.123 1.217 1.486 1.406 
5 1.783 1.609 1.493 1.581  1.350 1.538 1.462 1.053 
6 1.430 1.220 1.750 1.123 1.350  1.700 1.018 1.320 
7 1.542 1.188 1.218 1.217 1.538 1.700  1.814 1.492 
8 1.000 1.644 1.416 1.486 1.462 1.018 1.814  1.019 
9 1.426 1.882 1.016 1.406 1.053 1.320 1.492 1.019  
Wheezing, cough, atopic dermatitis, severity and reflux  
Table 45. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
reflux) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No No No No Yes No No Yes No 
Cough No No No No Yes Yes No No Yes 
Atopic dermatitis No Yes Yes No No No No No Yes 
Severity 0.00 0.14 0.12 1.00 0.89 0.00 0.21 0.27 1.00 
Bronchiolitis No Yes No No No No Yes Yes No 
          
Distances 1 2 3 4 5 6 7 8 9 
1  1.438 1.007 1.110 1.617 1.015 1.053 1.470 1.751 
2 1.438  1.024 1.678 1.789 1.521 1.003 1.280 1.383 
3 1.007 1.024  1.416 1.727 1.303 1.440 1.638 1.356 
4 1.110 1.678 1.416  1.125 1.140 1.294 1.621 1.155 
5 1.617 1.789 1.727 1.125  1.363 1.575 1.157 1.282 
6 1.015 1.521 1.303 1.140 1.363  1.277 1.612 1.322 
7 1.053 1.003 1.440 1.294 1.575 1.277  1.024 1.654 
8 1.470 1.280 1.638 1.621 1.157 1.612 1.024  1.800 
9 1.751 1.383 1.356 1.155 1.282 1.322 1.654 1.800  
Children with atopic dermatitis, low severity, and reflux (Cluster 2) were related 
to children with no symptoms, low severity, and reflux (Cluster 7). Children who wheezed, 
and had low severity and reflux (Cluster 8) were the farthest from children with cough, 
atopic dermatitis, very high severity, but no reflux (Cluster 9). (Table 45) 
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Wheezing, cough, atopic dermatitis, severity and breastfeeding 
Table 46. Final cluster centres (wheezing, cough, atopic dermatitis, severity and 
breastfeeding) and distances between centres. 
Clusters 1 2 3 4 5 6 7 8 9 
Wheezing No Yes Yes No No No No Yes Yes 
Cough Yes No Yes Yes No No No Yes No 
Atopic dermatitis Yes No No No No Yes No No No 
Severity 0.07 0.43 0.85 1.00 0.00 0.57 0.00 1.00 0.00 
Breastfeeding Yes Yes Yes Yes No No Yes No No 
          
Distances 1 2 3 4 5 6 7 8 9 
1  1.299 1.357 1.113 1.206 1.166 0.898 1.701 1.451 
2 1.299  1.088 1.384 1.508 1.424 1.119 1.448 1.143 
3 1.357 1.088  1.131 1.869 1.727 1.663 1.020 1.469 
4 1.113 1.384 1.131  1.319 1.153 1.232 1.248 1.616 
5 1.206 1.508 1.869 1.319  0.865 1.011 1.596 1.034 
6 1.166 1.424 1.727 1.153 0.865  1.276 1.422 1.263 
7 0.898 1.119 1.663 1.232 1.011 1.276  1.945 1.466 
8 1.701 1.448 1.020 1.248 1.596 1.422 1.945  1.131 
9 1.451 1.143 1.469 1.616 1.034 1.263 1.466 1.131  
Children with no symptoms nor severity, and who were not breastfed (Cluster 5) 
were related to children with atopic dermatitis, medium severity, who also were not 
breastfeed (Cluster 6). On the contrary, children with no symptoms nor severity, and who 
breastfed (Cluster 7) were the less related to children who wheezed, had cough and very 
high severity, and who were not breastfeed (Cluster 8). (Table 46) 
 Twelve cluster analysis 
Children with no symptoms, no severity, and who did not suffer from bronchiolitis, 
whose mothers did not smoke during pregnancy and were not current smokers nor 
asthmatics, and whose fathers were neither smokers nor asthmatics (Cluster 1) were 
related to children with cough and atopic dermatitis, no severity nor bronchiolitis, whose 
mothers did not smoke during the pregnancy, and whose parents were non-smokers and 
non-asthmatics (Cluster 9). 
On the contrary, children who reported suffering from cough and atopic dermatitis, 
but no severity nor bronchiolitis, whose mothers did not smoke during pregnancy, and 
were non-smokers and non-asthmatics, and whose fathers were non-smokers and showed 
an unknown paternal asthmatic status (Cluster 5) were the farthest from those children 
who did not report any symptoms, no severity nor bronchiolitis, but whose mothers 
smoked during pregnancy and were current smokers, and showed an unknown maternal 
asthmatic status, and whose fathers were smokers and asthmatics (Cluster 10). (Table 47) 
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Table 47. Final cluster centres (multiple risk factors) and distances between centres 
Clusters 1 2 3 4 5 6 7 8 9 10 11 12 
Wheezing No No No No No No Yes No No No No No 
Cough No No Yes No Yes No Yes Yes Yes No Yes Yes 
Atopic dermatitis No Yes No No Yes No No No Yes No No No 
Severity 0.00 1.00 1.00 0.18 0.00 0.15 0.95 0.94 0.00 0.00 0.71 0.98 
Maternal asthma No DNK No No No No No No No DNK Yes No 
Paternal asthma No No No No DNK No No No No Yes No No 
Smoking mother No No No Yes No No No Yes No Yes No No 
Smoking father No No No Yes No Yes No Yes No Yes No Yes 
Smoking during pregnancy No No No Yes No No No Yes No Yes No No 
Bronchiolitis No No No No No No Yes No No No No No 
DNK: Do not know             
Distances 1 2 3 4 5 6 7 8 9 10 11 12 
1  7.269 1.176 1.574 7.277 1.039 1.713 2.098 0.833 7.380 1.397 1.745 
2 7.269  7.070 7.385 10.000 7.248 7.245 7.433 7.210 2.449 8.084 7.213 
3 1.176 7.070  1.795 7.251 1.386 1.085 1.654 1.067 7.351 1.099 1.119 
4 1.574 7.385 1.795  7.408 1.315 2.121 1.207 1.639 7.177 1.854 1.759 
5 7.277 10.000 7.251 7.408  7.313 7.380 7.410 7.140 10.863 7.290 7.370 
6 1.039 7.248 1.386 1.315 7.313  1.777 1.732 1.167 7.240 1.427 1.207 
7 1.713 7.245 1.085 2.121 7.380 1.777  1.555 1.466 7.490 1.377 1.216 
8 2.098 7.433 1.654 1.207 7.410 1.732 1.555  1.896 7.344 1.713 1.291 
9 0.833 7.210 1.067 1.639 7.140 1.167 1.466 1.896  7.393 1.235 1.497 
10 7.380 2.449 7.351 7.177 10.863 7.240 7.490 7.344 7.393  8.261 7.320 
11 1.397 8.084 1.099 1.854 7.290 1.427 1.377 1.713 1.235 8.261  1.288 
12 1.745 7.213 1.119 1.759 7.370 1.207 1.216 1.291 1.497 7.320 1.288  
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